HRP20151325T1 - Pripravci i postupci za inhibiciju jak puta - Google Patents
Pripravci i postupci za inhibiciju jak puta Download PDFInfo
- Publication number
- HRP20151325T1 HRP20151325T1 HRP20151325TT HRP20151325T HRP20151325T1 HR P20151325 T1 HRP20151325 T1 HR P20151325T1 HR P20151325T T HRP20151325T T HR P20151325TT HR P20151325 T HRP20151325 T HR P20151325T HR P20151325 T1 HRP20151325 T1 HR P20151325T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- ylamino
- oxazol
- oxo
- benzo
- Prior art date
Links
- 230000005764 inhibitory process Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 26
- 125000004093 cyano group Chemical group *C#N 0.000 claims 25
- -1 -ORa Chemical group 0.000 claims 24
- 229910020008 S(O) Inorganic materials 0.000 claims 21
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 14
- 125000005605 benzo group Chemical group 0.000 claims 12
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 12
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 10
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N 2-benzoxazolinone Chemical compound C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 claims 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 9
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 125000005842 heteroatom Chemical group 0.000 claims 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 6
- 125000002091 cationic group Chemical group 0.000 claims 6
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 6
- 125000002950 monocyclic group Chemical group 0.000 claims 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 6
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 5
- 125000004429 atom Chemical group 0.000 claims 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 claims 4
- 125000002619 bicyclic group Chemical group 0.000 claims 4
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- QCQYMMPEFGDXOM-XQRVVYSFSA-N (7z)-1,2,3,4,5,6-hexahydroazocine Chemical compound C1CCN\C=C/CC1 QCQYMMPEFGDXOM-XQRVVYSFSA-N 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- VBUSXUKJEOMRAR-UHFFFAOYSA-N 1,2,3,4,5,6-hexahydrodiazocine Chemical compound C1CCC=CNNC1 VBUSXUKJEOMRAR-UHFFFAOYSA-N 0.000 claims 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 3
- SCEIUGQQBYRBPP-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-azepine Chemical compound C1CCC=CNC1 SCEIUGQQBYRBPP-UHFFFAOYSA-N 0.000 claims 3
- OYFMQDVLFYKOPZ-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 OYFMQDVLFYKOPZ-UHFFFAOYSA-N 0.000 claims 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 3
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 claims 3
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 claims 3
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims 3
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- ZXIJMRYMVAMXQP-UHFFFAOYSA-N cycloheptene Chemical compound C1CCC=CCC1 ZXIJMRYMVAMXQP-UHFFFAOYSA-N 0.000 claims 3
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 claims 3
- 239000004914 cyclooctane Substances 0.000 claims 3
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 claims 3
- 239000004913 cyclooctene Substances 0.000 claims 3
- QPMLSUSACCOBDK-UHFFFAOYSA-N diazepane Chemical compound C1CCNNCC1 QPMLSUSACCOBDK-UHFFFAOYSA-N 0.000 claims 3
- KJGHYQZXEYTDSW-UHFFFAOYSA-N diazocane Chemical compound C1CCCNNCC1 KJGHYQZXEYTDSW-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- VMDHJFCXMLRQPZ-UHFFFAOYSA-N oxathiazinane Chemical compound C1CNSOC1 VMDHJFCXMLRQPZ-UHFFFAOYSA-N 0.000 claims 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 3
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims 2
- UNKOKUNFRCIYFW-UHFFFAOYSA-N 5-[[2-(3-methoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 UNKOKUNFRCIYFW-UHFFFAOYSA-N 0.000 claims 2
- NZEBOXHOGASNTD-UHFFFAOYSA-N 5-[[2-[(2,2-dimethyl-1,3-benzodioxol-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4OC(C)(C)OC4=CC=3)=NC=C2C)=C1 NZEBOXHOGASNTD-UHFFFAOYSA-N 0.000 claims 2
- NVCQXGOQVIMBOO-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methyl-1-oxo-3h-2-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound O=C1N(C)CC=CC2=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=C21 NVCQXGOQVIMBOO-UHFFFAOYSA-N 0.000 claims 2
- CIXFVRYXZKRULW-UHFFFAOYSA-N 5-[[5-methyl-2-[3-[1-(propan-2-ylamino)ethyl]anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(C)NC(C)C1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 CIXFVRYXZKRULW-UHFFFAOYSA-N 0.000 claims 2
- OZPZKVBHIBZOJU-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(8-methyl-4,8-diazabicyclo[3.2.1]octan-4-yl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(C=C2)N2C3CCC(CC2)N3C)=C1 OZPZKVBHIBZOJU-UHFFFAOYSA-N 0.000 claims 2
- VWTMLTACDPDABU-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C(F)(F)F)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VWTMLTACDPDABU-UHFFFAOYSA-N 0.000 claims 2
- AUSBFUSJWUNPCN-QGZVFWFLSA-N 5-[[5-methyl-2-[[6-[(3r)-3-(methylamino)piperidin-1-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1[C@H](NC)CCCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 AUSBFUSJWUNPCN-QGZVFWFLSA-N 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- QANAZZSSQPRKPF-UHFFFAOYSA-L disodium;[5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound [Na+].[Na+].CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4N(COP([O-])([O-])=O)C(=O)OC4=CC=3)C(C)=CN=2)=C1 QANAZZSSQPRKPF-UHFFFAOYSA-L 0.000 claims 2
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 claims 2
- 125000004404 heteroalkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- SGWFFAIWIGKGGY-UHFFFAOYSA-N n-cyclopropyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide;formic acid Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CC1 SGWFFAIWIGKGGY-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- KRTGIIYAZKHCRH-UHFFFAOYSA-N 1,3-dimethyl-5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]benzimidazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3N(C)C(=O)N(C)C3=CC=2)=N1 KRTGIIYAZKHCRH-UHFFFAOYSA-N 0.000 claims 1
- ABSKNCGIGLLQKW-UHFFFAOYSA-N 1-benzyl-3-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]urea Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N(C1)CCC1NC(=O)NCC1=CC=CC=C1 ABSKNCGIGLLQKW-UHFFFAOYSA-N 0.000 claims 1
- QOWSNXWFPGJQNJ-UHFFFAOYSA-N 1-ethyl-3-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]urea Chemical compound C1C(NC(=O)NCC)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QOWSNXWFPGJQNJ-UHFFFAOYSA-N 0.000 claims 1
- FXKCMYPRHYVMKB-UHFFFAOYSA-N 1-tert-butyl-3-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]urea Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCC(NC(=O)NC(C)(C)C)C1 FXKCMYPRHYVMKB-UHFFFAOYSA-N 0.000 claims 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims 1
- AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 claims 1
- RDXGQFYDVDYYQR-UHFFFAOYSA-N 2,2-dimethyl-7-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-4h-1,4-benzoxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4OC(C)(C)C(=O)NC4=CC=3)=NC=C2C)=C1 RDXGQFYDVDYYQR-UHFFFAOYSA-N 0.000 claims 1
- QXSDGLOONQZIID-UHFFFAOYSA-N 2,2-dimethyl-n-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]propanamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCC(NC(=O)C(C)(C)C)C1 QXSDGLOONQZIID-UHFFFAOYSA-N 0.000 claims 1
- VYBOYBQNRVVFQF-ROUUACIJSA-N 2-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridine-3-carbonitrile Chemical class C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C#N)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 VYBOYBQNRVVFQF-ROUUACIJSA-N 0.000 claims 1
- NIKOJQMSHIBKNI-UHFFFAOYSA-N 2-chloro-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(N)=O)C(Cl)=C1 NIKOJQMSHIBKNI-UHFFFAOYSA-N 0.000 claims 1
- QIYPEWDJHDSJHN-UHFFFAOYSA-N 2-methoxy-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-n-phenylbenzamide Chemical compound COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(=O)NC1=CC=CC=C1 QIYPEWDJHDSJHN-UHFFFAOYSA-N 0.000 claims 1
- MBLVXKDPWYYVKZ-UHFFFAOYSA-N 2-methoxy-n,n-dimethyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=C(C(=O)N(C)C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 MBLVXKDPWYYVKZ-UHFFFAOYSA-N 0.000 claims 1
- PNDNWNABZFTFCE-UHFFFAOYSA-N 2-methoxy-n,n-dimethyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=C(C(=O)N(C)C)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 PNDNWNABZFTFCE-UHFFFAOYSA-N 0.000 claims 1
- QJMQUHOFWLFUIH-UHFFFAOYSA-N 2-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzoic acid Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(O)=O)C(C)=C1 QJMQUHOFWLFUIH-UHFFFAOYSA-N 0.000 claims 1
- FDMDHJVSUKDYDZ-UHFFFAOYSA-N 2-methyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound C1=C(C#N)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 FDMDHJVSUKDYDZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- RJSPKFINHAOCFF-UHFFFAOYSA-N 3-[[5-fluoro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC1=CC=CC(C#N)=C1 RJSPKFINHAOCFF-UHFFFAOYSA-N 0.000 claims 1
- CLAKPYAFZQLQSU-UHFFFAOYSA-N 3-[[5-methyl-4-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)NC3=CC=2)C(C)=CN=C1NC1=CC=CC(C#N)=C1 CLAKPYAFZQLQSU-UHFFFAOYSA-N 0.000 claims 1
- KEPOUNKKMPTLMC-UHFFFAOYSA-N 3-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzaldehyde Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C=O)=C1 KEPOUNKKMPTLMC-UHFFFAOYSA-N 0.000 claims 1
- XSDWMJDKFNPMHI-UHFFFAOYSA-N 3-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C(N)=O)=C1 XSDWMJDKFNPMHI-UHFFFAOYSA-N 0.000 claims 1
- FKKDYXALQYMGCW-UHFFFAOYSA-N 3-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C#N)=C1 FKKDYXALQYMGCW-UHFFFAOYSA-N 0.000 claims 1
- XOKJPIGFKDBQIJ-UHFFFAOYSA-N 3-chloro-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Cl)=CC(C#N)=C1 XOKJPIGFKDBQIJ-UHFFFAOYSA-N 0.000 claims 1
- OOVNXBYXYZNFJN-UHFFFAOYSA-N 3-methoxy-n,n-dimethyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound CN(C)C(=O)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 OOVNXBYXYZNFJN-UHFFFAOYSA-N 0.000 claims 1
- PKWWCQJCERQWDU-UHFFFAOYSA-N 3-methyl-5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3N(C)C(=O)OC3=CC=2)=N1 PKWWCQJCERQWDU-UHFFFAOYSA-N 0.000 claims 1
- WHCPOUZRGXFBDX-UHFFFAOYSA-N 3-methyl-6-[[5-methyl-2-(2-morpholin-3-ylanilino)pyrimidin-4-yl]amino]-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3OC(=O)N(C)C3=CC=2)C(C)=CN=C1NC1=CC=CC=C1C1COCCN1 WHCPOUZRGXFBDX-UHFFFAOYSA-N 0.000 claims 1
- YXCAJCUYCWQXQU-UHFFFAOYSA-N 3-methyl-6-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3OC(=O)N(C)C3=CC=2)=N1 YXCAJCUYCWQXQU-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- NASHXEGHCWPLIN-UHFFFAOYSA-N 4-(2-methoxyethyl)-2,2-dimethyl-7-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyrido[3,2-b][1,4]oxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC=2C=C3OC(C)(C)C(=O)N(C3=NC=2)CCOC)=C1 NASHXEGHCWPLIN-UHFFFAOYSA-N 0.000 claims 1
- IGCCNBKLMPRBQB-UHFFFAOYSA-N 4-(2-methoxyethyl)-7-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-1,4-benzoxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC=2C=C3OCC(=O)N(C3=CC=2)CCOC)=C1 IGCCNBKLMPRBQB-UHFFFAOYSA-N 0.000 claims 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- MZOOEORYLZREKA-UHFFFAOYSA-N 4-[[5-fluoro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC1=CC=C(C#N)C=C1 MZOOEORYLZREKA-UHFFFAOYSA-N 0.000 claims 1
- BEBZOSZAXYNFGL-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)NC3=CC=2)C(C)=CN=C1NC1=CC=C(C#N)C=C1 BEBZOSZAXYNFGL-UHFFFAOYSA-N 0.000 claims 1
- VREMVJPKICGOON-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3-propanoyl-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C=1C=C2OC(=O)N(C(=O)CC)C2=CC=1NC(C(=CN=1)C)=NC=1NC1=CC=C(C(N)=O)C=C1 VREMVJPKICGOON-UHFFFAOYSA-N 0.000 claims 1
- GAYZIGNRQANVSO-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-(4-methylpiperidin-1-yl)benzamide Chemical compound C1CC(C)CCN1C1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(N)=O GAYZIGNRQANVSO-UHFFFAOYSA-N 0.000 claims 1
- WWDCEJCGVLDMEJ-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-(trifluoromethyl)benzoic acid Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(O)=O)C(C(F)(F)F)=C1 WWDCEJCGVLDMEJ-UHFFFAOYSA-N 0.000 claims 1
- YLKORKADBWYVRL-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-pyrrolidin-1-ylbenzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(C(N)=O)C=1N1CCCC1 YLKORKADBWYVRL-UHFFFAOYSA-N 0.000 claims 1
- MTSWIUVAHVZONC-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-n-phenyl-2-(trifluoromethyl)benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C(F)(F)F)=CC=C1C(=O)NC1=CC=CC=C1 MTSWIUVAHVZONC-UHFFFAOYSA-N 0.000 claims 1
- SQQCRYKVXLWDLV-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-n-phenylbenzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1=CC=CC=C1 SQQCRYKVXLWDLV-UHFFFAOYSA-N 0.000 claims 1
- DZCYFMPQCUPQGY-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-n-propan-2-ylbenzamide Chemical compound C1=CC(C(=O)NC(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DZCYFMPQCUPQGY-UHFFFAOYSA-N 0.000 claims 1
- YZSMIFFIELVBMR-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzaldehyde Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C=O)C=C1 YZSMIFFIELVBMR-UHFFFAOYSA-N 0.000 claims 1
- ARRXOYIIRJAAOL-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(N)=O)C=C1 ARRXOYIIRJAAOL-UHFFFAOYSA-N 0.000 claims 1
- KZTHSNCQJMFXCS-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzoic acid Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(O)=O)C=C1 KZTHSNCQJMFXCS-UHFFFAOYSA-N 0.000 claims 1
- UOTDFXYEFWAKEU-UHFFFAOYSA-N 4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C#N)C=C1 UOTDFXYEFWAKEU-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- NWFGXHTYXHEQKA-UHFFFAOYSA-N 5-[(2-anilino-5-methylpyrimidin-4-yl)amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC=C1 NWFGXHTYXHEQKA-UHFFFAOYSA-N 0.000 claims 1
- CGSAKFUVSQEXRH-UHFFFAOYSA-N 5-[(6-amino-9-methyl-8-phenyl-2,3-dihydropyrimido[1,6-b][1,4,2]dioxazin-9a-yl)amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(N)N2OCCOC2(NC=2C=C3NC(=O)OC3=CC=2)C(C)=C1C1=CC=CC=C1 CGSAKFUVSQEXRH-UHFFFAOYSA-N 0.000 claims 1
- WTUCTILCOMRTQG-UHFFFAOYSA-N 5-[[2-(1,2-benzoxazol-6-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4ON=CC4=CC=3)=NC=C2C)=C1 WTUCTILCOMRTQG-UHFFFAOYSA-N 0.000 claims 1
- FBKIUFHKBYEMLT-UHFFFAOYSA-N 5-[[2-(1h-indazol-5-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=NNC4=CC=3)=NC=C2C)=C1 FBKIUFHKBYEMLT-UHFFFAOYSA-N 0.000 claims 1
- IFNGTUMTIJDKAV-UHFFFAOYSA-N 5-[[2-(1h-indazol-6-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4NN=CC4=CC=3)=NC=C2C)=C1 IFNGTUMTIJDKAV-UHFFFAOYSA-N 0.000 claims 1
- XGJNDXAXMXYNER-UHFFFAOYSA-N 5-[[2-(2,3-difluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(F)=C1F XGJNDXAXMXYNER-UHFFFAOYSA-N 0.000 claims 1
- BORMJLDGTKFKCF-UHFFFAOYSA-N 5-[[2-(2,3-dihydro-1h-isoindol-5-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CNCC4=CC=3)=NC=C2C)=C1 BORMJLDGTKFKCF-UHFFFAOYSA-N 0.000 claims 1
- GYZJQPIYSSPIPW-UHFFFAOYSA-N 5-[[2-(2,3-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C)=C1C GYZJQPIYSSPIPW-UHFFFAOYSA-N 0.000 claims 1
- RGMAWKGTJLAYQW-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F RGMAWKGTJLAYQW-UHFFFAOYSA-N 0.000 claims 1
- VUFCNHIRXLAAHM-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-7-fluoro-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1F VUFCNHIRXLAAHM-UHFFFAOYSA-N 0.000 claims 1
- PKMMPIWIRROFNV-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1F PKMMPIWIRROFNV-UHFFFAOYSA-N 0.000 claims 1
- SKBXYWRCOLPCBK-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-5-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F SKBXYWRCOLPCBK-UHFFFAOYSA-N 0.000 claims 1
- OLCDMYIZSSFQET-UHFFFAOYSA-N 5-[[2-(2,4-difluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(F)C=C1F OLCDMYIZSSFQET-UHFFFAOYSA-N 0.000 claims 1
- QKCGPZPMCIUCFX-UHFFFAOYSA-N 5-[[2-(2,5-difluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=CC=C1F QKCGPZPMCIUCFX-UHFFFAOYSA-N 0.000 claims 1
- TWIXEDFUKKEBPB-UHFFFAOYSA-N 5-[[2-(2,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=C(C)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 TWIXEDFUKKEBPB-UHFFFAOYSA-N 0.000 claims 1
- YPBVAPXTADXQGJ-UHFFFAOYSA-N 5-[[2-(2,6-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=C(C)C=CC=C1C YPBVAPXTADXQGJ-UHFFFAOYSA-N 0.000 claims 1
- RSFXEVKMPMCDJZ-UHFFFAOYSA-N 5-[[2-(2-chloro-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=C(Cl)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 RSFXEVKMPMCDJZ-UHFFFAOYSA-N 0.000 claims 1
- BKDDBVFNVZECQG-UHFFFAOYSA-N 5-[[2-(2-chloroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC=C1Cl BKDDBVFNVZECQG-UHFFFAOYSA-N 0.000 claims 1
- LLBJMXKKPDWLDG-UHFFFAOYSA-N 5-[[2-(2-ethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CCC1=CC=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 LLBJMXKKPDWLDG-UHFFFAOYSA-N 0.000 claims 1
- QSJFULVUGRWWNI-UHFFFAOYSA-N 5-[[2-(2-fluoro-3,4,5-trimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(C)C(C)=C1F QSJFULVUGRWWNI-UHFFFAOYSA-N 0.000 claims 1
- IJVGSSSEVCQKRK-UHFFFAOYSA-N 5-[[2-(2-fluoro-3-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F IJVGSSSEVCQKRK-UHFFFAOYSA-N 0.000 claims 1
- SUDWSMZOJVAAJQ-UHFFFAOYSA-N 5-[[2-(2-fluoro-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(C)=CC(F)=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 SUDWSMZOJVAAJQ-UHFFFAOYSA-N 0.000 claims 1
- BBWCSWNSLWIDTL-UHFFFAOYSA-N 5-[[2-(2-fluoro-4-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC1=CC(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 BBWCSWNSLWIDTL-UHFFFAOYSA-N 0.000 claims 1
- SUJWFNGBPASYLT-UHFFFAOYSA-N 5-[[2-(2-fluoro-5-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(F)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 SUJWFNGBPASYLT-UHFFFAOYSA-N 0.000 claims 1
- RYZUMUYXSVFTFF-UHFFFAOYSA-N 5-[[2-(2-fluoro-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=C(F)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 RYZUMUYXSVFTFF-UHFFFAOYSA-N 0.000 claims 1
- SBBGJYVESBWJGR-UHFFFAOYSA-N 5-[[2-(2-fluoro-6-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC(F)=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 SBBGJYVESBWJGR-UHFFFAOYSA-N 0.000 claims 1
- SNPOYBFDGHMJSR-UHFFFAOYSA-N 5-[[2-(2-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC=C1F SNPOYBFDGHMJSR-UHFFFAOYSA-N 0.000 claims 1
- TUBVOAQAKUPGHR-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 TUBVOAQAKUPGHR-UHFFFAOYSA-N 0.000 claims 1
- GGMROVXJDQBWGR-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-fluoro-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 GGMROVXJDQBWGR-UHFFFAOYSA-N 0.000 claims 1
- XMISXJAGJAMRBV-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 XMISXJAGJAMRBV-UHFFFAOYSA-N 0.000 claims 1
- ABZOFIKNDLHNJA-UHFFFAOYSA-N 5-[[2-(3,4-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ABZOFIKNDLHNJA-UHFFFAOYSA-N 0.000 claims 1
- QVAMBHXXRJXBKL-UHFFFAOYSA-N 5-[[2-(3,5-dichloroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Cl)=CC(Cl)=C1 QVAMBHXXRJXBKL-UHFFFAOYSA-N 0.000 claims 1
- PQLVXMMCTLNMPZ-UHFFFAOYSA-N 5-[[2-(3,5-dimethoxy-4-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 PQLVXMMCTLNMPZ-UHFFFAOYSA-N 0.000 claims 1
- OPAGYMXUKVYVEH-UHFFFAOYSA-N 5-[[2-(3,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-7-fluoro-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 OPAGYMXUKVYVEH-UHFFFAOYSA-N 0.000 claims 1
- ZFPPIEHMYVYPRA-UHFFFAOYSA-N 5-[[2-(3,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 ZFPPIEHMYVYPRA-UHFFFAOYSA-N 0.000 claims 1
- OXYZCRREHDQNFH-UHFFFAOYSA-N 5-[[2-(3-acetyl-5-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(=O)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 OXYZCRREHDQNFH-UHFFFAOYSA-N 0.000 claims 1
- GPOWNMABKONSPE-UHFFFAOYSA-N 5-[[2-(3-acetylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(=O)C1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 GPOWNMABKONSPE-UHFFFAOYSA-N 0.000 claims 1
- BOXKDDIMOIHGDQ-UHFFFAOYSA-N 5-[[2-(3-bromo-5-chloroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Cl)=CC(Br)=C1 BOXKDDIMOIHGDQ-UHFFFAOYSA-N 0.000 claims 1
- PYDRWNXDBVUABB-UHFFFAOYSA-N 5-[[2-(3-bromoanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(Br)=C1 PYDRWNXDBVUABB-UHFFFAOYSA-N 0.000 claims 1
- WUHDJUZEWVFHFN-UHFFFAOYSA-N 5-[[2-(3-chloro-4,5-dimethoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound ClC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 WUHDJUZEWVFHFN-UHFFFAOYSA-N 0.000 claims 1
- CBWNMVFREAZGMZ-UHFFFAOYSA-N 5-[[2-(3-chloro-4-ethoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OCC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CBWNMVFREAZGMZ-UHFFFAOYSA-N 0.000 claims 1
- VWNBAOHXZBFVMT-UHFFFAOYSA-N 5-[[2-(3-chloro-4-hydroxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(O)C(Cl)=C1 VWNBAOHXZBFVMT-UHFFFAOYSA-N 0.000 claims 1
- BZYITCCRZOIJMS-UHFFFAOYSA-N 5-[[2-(3-chloro-4-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OC)=C(C)C=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 BZYITCCRZOIJMS-UHFFFAOYSA-N 0.000 claims 1
- ZIVXSCHUIYJEHT-UHFFFAOYSA-N 5-[[2-(3-chloro-4-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZIVXSCHUIYJEHT-UHFFFAOYSA-N 0.000 claims 1
- NKPMNGNYNBFYIE-UHFFFAOYSA-N 5-[[2-(3-chloro-5-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=CC(Cl)=C1 NKPMNGNYNBFYIE-UHFFFAOYSA-N 0.000 claims 1
- KGXNCQAMPKHLAO-UHFFFAOYSA-N 5-[[2-(3-chloroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(Cl)=C1 KGXNCQAMPKHLAO-UHFFFAOYSA-N 0.000 claims 1
- UYJWVMRIJLCSNG-UHFFFAOYSA-N 5-[[2-(3-cyclopentylsulfonylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=CC=1S(=O)(=O)C1CCCC1 UYJWVMRIJLCSNG-UHFFFAOYSA-N 0.000 claims 1
- GMGVFYLHYUTFAN-UHFFFAOYSA-N 5-[[2-(3-ethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CCC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 GMGVFYLHYUTFAN-UHFFFAOYSA-N 0.000 claims 1
- MLLAQAOSTSDWCR-UHFFFAOYSA-N 5-[[2-(3-fluoro-4-pyridin-3-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1F)=CC=C1C1=CC=CN=C1 MLLAQAOSTSDWCR-UHFFFAOYSA-N 0.000 claims 1
- GRFCMTRMQZZRRE-UHFFFAOYSA-N 5-[[2-(3-fluoro-4-pyridin-4-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1F)=CC=C1C1=CC=NC=C1 GRFCMTRMQZZRRE-UHFFFAOYSA-N 0.000 claims 1
- CFZHJQOKVMOXTO-UHFFFAOYSA-N 5-[[2-(3-fluoro-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(F)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 CFZHJQOKVMOXTO-UHFFFAOYSA-N 0.000 claims 1
- WZGHGUASCHYXEY-UHFFFAOYSA-N 5-[[2-(3-fluoro-5-morpholin-4-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC(F)=CC=1N1CCOCC1 WZGHGUASCHYXEY-UHFFFAOYSA-N 0.000 claims 1
- YIBSESZNXRQSJN-UHFFFAOYSA-N 5-[[2-(3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YIBSESZNXRQSJN-UHFFFAOYSA-N 0.000 claims 1
- VEEOQTDGOLBTDV-UHFFFAOYSA-N 5-[[2-(3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 VEEOQTDGOLBTDV-UHFFFAOYSA-N 0.000 claims 1
- AOXDTSYXYOTVMK-UHFFFAOYSA-N 5-[[2-(4-acetylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(C(=O)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 AOXDTSYXYOTVMK-UHFFFAOYSA-N 0.000 claims 1
- HHRLBGLNZGEKBE-UHFFFAOYSA-N 5-[[2-(4-chloro-2,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(Cl)C=C1C HHRLBGLNZGEKBE-UHFFFAOYSA-N 0.000 claims 1
- JYCWRXJUDMOPNV-UHFFFAOYSA-N 5-[[2-(4-chloro-3-ethoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JYCWRXJUDMOPNV-UHFFFAOYSA-N 0.000 claims 1
- OTCRBRVJJGICDM-UHFFFAOYSA-N 5-[[2-(4-chloro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 OTCRBRVJJGICDM-UHFFFAOYSA-N 0.000 claims 1
- FYQHFUMUARPRBZ-UHFFFAOYSA-N 5-[[2-(4-chloroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(Cl)C=C1 FYQHFUMUARPRBZ-UHFFFAOYSA-N 0.000 claims 1
- QMLPTIUNLCXODE-UHFFFAOYSA-N 5-[[2-(4-ethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(CC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QMLPTIUNLCXODE-UHFFFAOYSA-N 0.000 claims 1
- AIBONUWYLTVRTC-UHFFFAOYSA-N 5-[[2-(4-fluoro-3,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C)C=2)C(C)=CN=C1NC1=CC(C)=C(F)C(C)=C1 AIBONUWYLTVRTC-UHFFFAOYSA-N 0.000 claims 1
- AVPSARGPEWYAPR-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 AVPSARGPEWYAPR-UHFFFAOYSA-N 0.000 claims 1
- HFRIGYIEWAOTRK-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 HFRIGYIEWAOTRK-UHFFFAOYSA-N 0.000 claims 1
- HDACITRHWCMJQD-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methylsulfonylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(F)C(S(C)(=O)=O)=C1 HDACITRHWCMJQD-UHFFFAOYSA-N 0.000 claims 1
- HNPHJVJDZCEJPJ-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methylsulfonylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C)C=2)C(C)=CN=C1NC1=CC=C(F)C(S(C)(=O)=O)=C1 HNPHJVJDZCEJPJ-UHFFFAOYSA-N 0.000 claims 1
- PPKGUFKUMZPZIR-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-pyridin-3-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(F)C=1C1=CC=CN=C1 PPKGUFKUMZPZIR-UHFFFAOYSA-N 0.000 claims 1
- FUPFPHKAAWYHBN-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-pyridin-4-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(F)C=1C1=CC=NC=C1 FUPFPHKAAWYHBN-UHFFFAOYSA-N 0.000 claims 1
- VBAPQIZQTJYVCJ-UHFFFAOYSA-N 5-[[2-(4-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(F)C=C1 VBAPQIZQTJYVCJ-UHFFFAOYSA-N 0.000 claims 1
- GEPSFDLLLKURQS-UHFFFAOYSA-N 5-[[2-(4-hydroxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(O)C=C1 GEPSFDLLLKURQS-UHFFFAOYSA-N 0.000 claims 1
- BEZONTFFZOKDHU-UHFFFAOYSA-N 5-[[2-(4-iodo-3,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(I)C(C)=C1 BEZONTFFZOKDHU-UHFFFAOYSA-N 0.000 claims 1
- NSFKTMQFOVNSJK-UHFFFAOYSA-N 5-[[2-(4-methoxy-3-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NSFKTMQFOVNSJK-UHFFFAOYSA-N 0.000 claims 1
- POSXADPNSKVOFY-UHFFFAOYSA-N 5-[[2-(4-methoxy-3-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=C(C)C=2)=N1 POSXADPNSKVOFY-UHFFFAOYSA-N 0.000 claims 1
- VQQLPINKOAQPHD-UHFFFAOYSA-N 5-[[2-(4-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VQQLPINKOAQPHD-UHFFFAOYSA-N 0.000 claims 1
- WCXUFVFHPMYAGW-UHFFFAOYSA-N 5-[[2-(4-tert-butylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(C)(C)C)C=C1 WCXUFVFHPMYAGW-UHFFFAOYSA-N 0.000 claims 1
- GELBDSAVYSYJAG-UHFFFAOYSA-N 5-[[2-(5-acetyl-2-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(=O)C1=CC=C(F)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 GELBDSAVYSYJAG-UHFFFAOYSA-N 0.000 claims 1
- IJHLSQGUPPYPRE-UHFFFAOYSA-N 5-[[2-(isoquinolin-6-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=CN=CC4=CC=3)=NC=C2C)=C1 IJHLSQGUPPYPRE-UHFFFAOYSA-N 0.000 claims 1
- QHZYAIODSHVUOU-UHFFFAOYSA-N 5-[[2-(isoquinolin-7-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=NC=CC4=CC=3)=NC=C2C)=C1 QHZYAIODSHVUOU-UHFFFAOYSA-N 0.000 claims 1
- WLEMKJQIPXBCDQ-UHFFFAOYSA-N 5-[[2-[(1,3-dimethylpyrazolo[3,4-b]pyridin-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C3N(C)N=C(C3=C2)C)=C1 WLEMKJQIPXBCDQ-UHFFFAOYSA-N 0.000 claims 1
- LKNXKCHMIICLPW-UHFFFAOYSA-N 5-[[2-[(2,2-difluoro-1,3-benzodioxol-4-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=4OC(F)(F)OC=4C=CC=3)=NC=C2C)=C1 LKNXKCHMIICLPW-UHFFFAOYSA-N 0.000 claims 1
- UXTHZPAVGRYPPY-UHFFFAOYSA-N 5-[[2-[(2,2-difluoro-1,3-benzodioxol-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4OC(F)(F)OC4=CC=3)=NC=C2C)=C1 UXTHZPAVGRYPPY-UHFFFAOYSA-N 0.000 claims 1
- NIRHTEOZEUKHGF-UHFFFAOYSA-N 5-[[2-[(2-acetyl-1,3-dihydroisoindol-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)C(=O)C)=C1 NIRHTEOZEUKHGF-UHFFFAOYSA-N 0.000 claims 1
- MAVFVNHZZAOGJX-UHFFFAOYSA-N 5-[[2-[(2-ethyl-1,3-dihydroisoindol-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)CC)=C1 MAVFVNHZZAOGJX-UHFFFAOYSA-N 0.000 claims 1
- QHEPYHPMEDCYFK-UHFFFAOYSA-N 5-[[2-[(2-hydroxy-1,3-dihydroisoindol-5-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CN(O)CC4=CC=3)=NC=C2C)=C1 QHEPYHPMEDCYFK-UHFFFAOYSA-N 0.000 claims 1
- VHOHJBVNXHEWFB-UHFFFAOYSA-N 5-[[2-[(3,3-dimethyl-2-oxo-1h-indol-6-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C(C(C(=O)N4)(C)C)=CC=3)=NC=C2C)=C1 VHOHJBVNXHEWFB-UHFFFAOYSA-N 0.000 claims 1
- FTNPZQBQNYIVKI-UHFFFAOYSA-N 5-[[2-[(3-fluoropyridin-4-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=NC=C1F FTNPZQBQNYIVKI-UHFFFAOYSA-N 0.000 claims 1
- ZAZMAHHBGMFCEQ-UHFFFAOYSA-N 5-[[2-[(3-fluoropyridin-4-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=NC=C1F ZAZMAHHBGMFCEQ-UHFFFAOYSA-N 0.000 claims 1
- OABOCYQSTAYTBE-UHFFFAOYSA-N 5-[[2-[(4-hydroxynaphthalen-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=CC=CC4=C(O)C=3)=NC=C2C)=C1 OABOCYQSTAYTBE-UHFFFAOYSA-N 0.000 claims 1
- DWLADSMCKCNLNN-UHFFFAOYSA-N 5-[[2-[(4-methoxynaphthalen-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC=C2C(OC)=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC2=C1 DWLADSMCKCNLNN-UHFFFAOYSA-N 0.000 claims 1
- YMBPSHIONLANSP-UHFFFAOYSA-N 5-[[2-[(4-methoxypyridin-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=NC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YMBPSHIONLANSP-UHFFFAOYSA-N 0.000 claims 1
- FLZKVDONMJZPLN-UHFFFAOYSA-N 5-[[2-[(5,6-dimethoxypyridin-3-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 FLZKVDONMJZPLN-UHFFFAOYSA-N 0.000 claims 1
- KISULLOVAZFCPS-UHFFFAOYSA-N 5-[[2-[(5,6-dimethylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CN=C(C)C(C)=C1 KISULLOVAZFCPS-UHFFFAOYSA-N 0.000 claims 1
- IHQHKFMONLZCLC-UHFFFAOYSA-N 5-[[2-[(5-bromopyridin-3-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CN=CC(Br)=C1 IHQHKFMONLZCLC-UHFFFAOYSA-N 0.000 claims 1
- JPTYHKBMURMKFP-UHFFFAOYSA-N 5-[[2-[(6-methoxy-5-methylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(OC)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 JPTYHKBMURMKFP-UHFFFAOYSA-N 0.000 claims 1
- XJYXQARRXVQRMF-UHFFFAOYSA-N 5-[[2-[(6-methoxypyridin-3-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=NC(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 XJYXQARRXVQRMF-UHFFFAOYSA-N 0.000 claims 1
- BVQQBVGCNBKJFM-UHFFFAOYSA-N 5-[[2-[2-fluoro-4-methyl-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C)C(C(F)(F)F)=C1F BVQQBVGCNBKJFM-UHFFFAOYSA-N 0.000 claims 1
- ZMZTWJFIKUZIEG-UHFFFAOYSA-N 5-[[2-[2-fluoro-5-(1-hydroxyethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(O)C1=CC=C(F)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 ZMZTWJFIKUZIEG-UHFFFAOYSA-N 0.000 claims 1
- SZPFAKCUEVBNTJ-UHFFFAOYSA-N 5-[[2-[2-methoxy-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 SZPFAKCUEVBNTJ-UHFFFAOYSA-N 0.000 claims 1
- HDJDLJLCIKWFTJ-UHFFFAOYSA-N 5-[[2-[3,5-bis(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 HDJDLJLCIKWFTJ-UHFFFAOYSA-N 0.000 claims 1
- STYDEWOANNRPHT-UHFFFAOYSA-N 5-[[2-[3,5-dimethyl-4-(2-morpholin-4-ylethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C)=CC(C)=C1OCCN1CCOCC1 STYDEWOANNRPHT-UHFFFAOYSA-N 0.000 claims 1
- KORNEVFZPBNUEJ-UHFFFAOYSA-N 5-[[2-[3-(1-hydroxyethyl)-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(O)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 KORNEVFZPBNUEJ-UHFFFAOYSA-N 0.000 claims 1
- GUCSGSQUDYRSNF-UHFFFAOYSA-N 5-[[2-[3-(1-hydroxyethyl)-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(O)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 GUCSGSQUDYRSNF-UHFFFAOYSA-N 0.000 claims 1
- ZXDLOROIYZIKCD-UHFFFAOYSA-N 5-[[2-[3-(cyclobutylmethoxy)-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C(C=1)C(F)(F)F)=CC=1OCC1CCC1 ZXDLOROIYZIKCD-UHFFFAOYSA-N 0.000 claims 1
- HDGZLKVFNGUWNM-UHFFFAOYSA-N 5-[[2-[3-(cyclopropylmethoxy)-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C(C=1)C(F)(F)F)=CC=1OCC1CC1 HDGZLKVFNGUWNM-UHFFFAOYSA-N 0.000 claims 1
- RZNMMJYWXVMZFN-UHFFFAOYSA-N 5-[[2-[3-(difluoromethoxy)-4-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(OC(F)F)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 RZNMMJYWXVMZFN-UHFFFAOYSA-N 0.000 claims 1
- OZPOGLPTXPBEMR-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-4-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)F)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 OZPOGLPTXPBEMR-UHFFFAOYSA-N 0.000 claims 1
- DPGLVQUQUQVYOR-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-4-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)F)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DPGLVQUQUQVYOR-UHFFFAOYSA-N 0.000 claims 1
- HXRHQLSAMGVMPZ-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 HXRHQLSAMGVMPZ-UHFFFAOYSA-N 0.000 claims 1
- WNDBJCCYMNDKQF-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.FC(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 WNDBJCCYMNDKQF-UHFFFAOYSA-N 0.000 claims 1
- WCEXVWLBXVZSKD-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-5-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)C1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 WCEXVWLBXVZSKD-UHFFFAOYSA-N 0.000 claims 1
- XHUJJIJHIQYCDF-UHFFFAOYSA-N 5-[[2-[3-(fluoromethyl)-4-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(CF)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 XHUJJIJHIQYCDF-UHFFFAOYSA-N 0.000 claims 1
- PUWKGIFUJCSXAR-UHFFFAOYSA-N 5-[[2-[3-(fluoromethyl)-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(CF)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 PUWKGIFUJCSXAR-UHFFFAOYSA-N 0.000 claims 1
- FHSVFWLLNXOEHP-UHFFFAOYSA-N 5-[[2-[3-(fluoromethyl)-5-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(CF)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 FHSVFWLLNXOEHP-UHFFFAOYSA-N 0.000 claims 1
- UIQWNAHXEPCQGO-UHFFFAOYSA-N 5-[[2-[3-[1-(azetidin-1-yl)ethyl]-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCC1 UIQWNAHXEPCQGO-UHFFFAOYSA-N 0.000 claims 1
- VKUKRWRNWFTCDL-UHFFFAOYSA-N 5-[[2-[3-[1-(azetidin-1-yl)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCC1 VKUKRWRNWFTCDL-UHFFFAOYSA-N 0.000 claims 1
- UPRMRESRLBUCLL-UHFFFAOYSA-N 5-[[2-[3-[1-(benzylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)NCC1=CC=CC=C1 UPRMRESRLBUCLL-UHFFFAOYSA-N 0.000 claims 1
- VLCICFGJZVTPKO-UHFFFAOYSA-N 5-[[2-[3-[1-(cyclobutylamino)ethyl]-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC(C(F)(F)F)=CC=1C(C)NC1CCC1 VLCICFGJZVTPKO-UHFFFAOYSA-N 0.000 claims 1
- GVKVFJRMJWBQMI-UHFFFAOYSA-N 5-[[2-[3-[1-(cyclopropylamino)ethyl]-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC(C(F)(F)F)=CC=1C(C)NC1CC1 GVKVFJRMJWBQMI-UHFFFAOYSA-N 0.000 claims 1
- JDHYVYKQJLFGBM-UHFFFAOYSA-N 5-[[2-[3-[1-(cyclopropylamino)ethyl]-5-methoxyanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)NC1CC1 JDHYVYKQJLFGBM-UHFFFAOYSA-N 0.000 claims 1
- RPINBQQJFXQPHV-UHFFFAOYSA-N 5-[[2-[3-[1-(diethylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CCN(CC)C(C)C1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 RPINBQQJFXQPHV-UHFFFAOYSA-N 0.000 claims 1
- QRBIAZGBTYITNM-UHFFFAOYSA-N 5-[[2-[3-[1-(ethylamino)ethyl]-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(C)NCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 QRBIAZGBTYITNM-UHFFFAOYSA-N 0.000 claims 1
- JSRBALYEWQVILM-UHFFFAOYSA-N 5-[[2-[3-acetyl-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(=O)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JSRBALYEWQVILM-UHFFFAOYSA-N 0.000 claims 1
- NRYHGAHUJJKVDV-UHFFFAOYSA-N 5-[[2-[3-bromo-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Br)=CC(C(F)(F)F)=C1 NRYHGAHUJJKVDV-UHFFFAOYSA-N 0.000 claims 1
- KNMHTJWVUPREDY-UHFFFAOYSA-N 5-[[2-[3-chloro-4-(2-morpholin-4-ylethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1Cl)=CC=C1OCCN1CCOCC1 KNMHTJWVUPREDY-UHFFFAOYSA-N 0.000 claims 1
- SESSWRBQEJTFQR-UHFFFAOYSA-N 5-[[2-[3-chloro-4-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(F)(F)F)C(Cl)=C1 SESSWRBQEJTFQR-UHFFFAOYSA-N 0.000 claims 1
- UVTCAGZOTMBJMS-UHFFFAOYSA-N 5-[[2-[3-chloro-4-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(F)(F)F)C(Cl)=C1 UVTCAGZOTMBJMS-UHFFFAOYSA-N 0.000 claims 1
- KNHRLKSTZITIQJ-UHFFFAOYSA-N 5-[[2-[3-chloro-4-[2-(diethylamino)ethoxy]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(Cl)C(OCCN(CC)CC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 KNHRLKSTZITIQJ-UHFFFAOYSA-N 0.000 claims 1
- KJDCRGVTHXVEOS-UHFFFAOYSA-N 5-[[2-[3-chloro-4-fluoro-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Cl)=C(F)C(C(F)(F)F)=C1 KJDCRGVTHXVEOS-UHFFFAOYSA-N 0.000 claims 1
- HNKPGBRPKRSAFB-UHFFFAOYSA-N 5-[[2-[3-chloro-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(Cl)=CC(C(F)(F)F)=C1 HNKPGBRPKRSAFB-UHFFFAOYSA-N 0.000 claims 1
- PLUZSMUCGOHNNB-UHFFFAOYSA-N 5-[[2-[3-cyclobutyloxy-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C(C=1)C(F)(F)F)=CC=1OC1CCC1 PLUZSMUCGOHNNB-UHFFFAOYSA-N 0.000 claims 1
- KFSALNQOWFCADQ-UHFFFAOYSA-N 5-[[2-[3-fluoro-4-(1,5,7-trimethyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(C(=C2)F)N2CC3(C)CN(CC(C)(C2)C3)C)=C1 KFSALNQOWFCADQ-UHFFFAOYSA-N 0.000 claims 1
- XCPFODCQOSYZIZ-UHFFFAOYSA-N 5-[[2-[3-fluoro-5-(4-methylpiperazin-1-yl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC(F)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 XCPFODCQOSYZIZ-UHFFFAOYSA-N 0.000 claims 1
- QZRJSJXPYHRGCR-UHFFFAOYSA-N 5-[[2-[3-fluoro-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=CC(C(F)(F)F)=C1 QZRJSJXPYHRGCR-UHFFFAOYSA-N 0.000 claims 1
- VAHWFZFQWUIMDU-UHFFFAOYSA-N 5-[[2-[3-methoxy-4-(4-methylpiperazine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(=O)N1CCN(C)CC1 VAHWFZFQWUIMDU-UHFFFAOYSA-N 0.000 claims 1
- LAJROFFJWUISEX-UHFFFAOYSA-N 5-[[2-[3-methoxy-4-(morpholine-4-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(=O)N1CCOCC1 LAJROFFJWUISEX-UHFFFAOYSA-N 0.000 claims 1
- NYGMBCVVJQKKPU-UHFFFAOYSA-N 5-[[2-[3-methoxy-4-(pyrrolidine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(=O)N1CCCC1 NYGMBCVVJQKKPU-UHFFFAOYSA-N 0.000 claims 1
- MYSOVOJLJFRAHW-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(1-pyrrolidin-1-ylethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCCC1 MYSOVOJLJFRAHW-UHFFFAOYSA-N 0.000 claims 1
- ZUCMCIHOVGWDPE-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(4-methylpiperazine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(=O)N1CCN(C)CC1 ZUCMCIHOVGWDPE-UHFFFAOYSA-N 0.000 claims 1
- IYYJCXZWJJJJKT-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(morpholine-4-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(=O)N1CCOCC1 IYYJCXZWJJJJKT-UHFFFAOYSA-N 0.000 claims 1
- MZPYQLQMIJYNIH-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(pyrrolidine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(=O)N1CCCC1 MZPYQLQMIJYNIH-UHFFFAOYSA-N 0.000 claims 1
- JUGHSGBRFRGUBW-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 JUGHSGBRFRGUBW-UHFFFAOYSA-N 0.000 claims 1
- SSAJJNILMYQJTO-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-[1-(methylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(C(C)NC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 SSAJJNILMYQJTO-UHFFFAOYSA-N 0.000 claims 1
- CYYWMDOPUOLDBU-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-[1-(propan-2-ylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(C)NC(C)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 CYYWMDOPUOLDBU-UHFFFAOYSA-N 0.000 claims 1
- MOGUTBPUNLPLAO-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-[1-(propylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(C(C)NCCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 MOGUTBPUNLPLAO-UHFFFAOYSA-N 0.000 claims 1
- YAGAXLSKINZLNU-UHFFFAOYSA-N 5-[[2-[4-(2-methoxyethoxy)-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)(F)F)C(OCCOC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YAGAXLSKINZLNU-UHFFFAOYSA-N 0.000 claims 1
- NWQBBGDPVGDEAJ-UHFFFAOYSA-N 5-[[2-[4-(4-ethylpiperazin-1-yl)-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NWQBBGDPVGDEAJ-UHFFFAOYSA-N 0.000 claims 1
- KLEHUXSLFJCIGC-UHFFFAOYSA-N 5-[[2-[4-(6-chloropyridin-3-yl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C1=CC=C(Cl)N=C1 KLEHUXSLFJCIGC-UHFFFAOYSA-N 0.000 claims 1
- ZYRVKAKXRCOFNJ-UHFFFAOYSA-N 5-[[2-[4-(cyclobutylmethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1OCC1CCC1 ZYRVKAKXRCOFNJ-UHFFFAOYSA-N 0.000 claims 1
- CPHCQVTWPGPEIG-UHFFFAOYSA-N 5-[[2-[4-(cyclohexylmethoxy)-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C(F)(F)F)=CC=C1OCC1CCCCC1 CPHCQVTWPGPEIG-UHFFFAOYSA-N 0.000 claims 1
- ULZXFOQYOWBBRD-UHFFFAOYSA-N 5-[[2-[4-(difluoromethoxy)-3-(difluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(OC(F)F)C(C(F)F)=C1 ULZXFOQYOWBBRD-UHFFFAOYSA-N 0.000 claims 1
- LIIFWWLQOROHFD-UHFFFAOYSA-N 5-[[2-[4-(difluoromethoxy)-3-(fluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(OC(F)F)C(CF)=C1 LIIFWWLQOROHFD-UHFFFAOYSA-N 0.000 claims 1
- JFRXVDOJFUZDHQ-UHFFFAOYSA-N 5-[[2-[4-[1-(azetidin-1-yl)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=CC=1C(C)N1CCC1 JFRXVDOJFUZDHQ-UHFFFAOYSA-N 0.000 claims 1
- OGBPGZMYJBRIAU-UHFFFAOYSA-N 5-[[2-[4-[1-(benzylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=CC=1C(C)NCC1=CC=CC=C1 OGBPGZMYJBRIAU-UHFFFAOYSA-N 0.000 claims 1
- CDRURMWBYQDUHE-UHFFFAOYSA-N 5-[[2-[4-[1-(cyclopropylamino)ethyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=CC=1C(C)NC1CC1 CDRURMWBYQDUHE-UHFFFAOYSA-N 0.000 claims 1
- DTXILYTVNVZIBM-UHFFFAOYSA-N 5-[[2-[4-[2-(diethylamino)ethoxy]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(OCCN(CC)CC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DTXILYTVNVZIBM-UHFFFAOYSA-N 0.000 claims 1
- VNENECIORCRMEH-UHFFFAOYSA-N 5-[[2-[4-[2-(dimethylamino)ethoxy]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(OCCN(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VNENECIORCRMEH-UHFFFAOYSA-N 0.000 claims 1
- WKWMCRPXLCQWFJ-UHFFFAOYSA-N 5-[[2-[4-[3-(diethylamino)pyrrolidine-1-carbonyl]anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1C(N(CC)CC)CCN1C(=O)C(C=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WKWMCRPXLCQWFJ-UHFFFAOYSA-N 0.000 claims 1
- QPHNSWGICXJOER-UHFFFAOYSA-N 5-[[2-[4-[3-(dimethylamino)propoxy]-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)(F)F)C(OCCCN(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QPHNSWGICXJOER-UHFFFAOYSA-N 0.000 claims 1
- WJWKQPYCNJUMSD-UHFFFAOYSA-N 5-[[2-[4-bromo-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(Br)C(C(F)(F)F)=C1 WJWKQPYCNJUMSD-UHFFFAOYSA-N 0.000 claims 1
- MAQRBEJNRFLCMN-UHFFFAOYSA-N 5-[[2-[4-chloro-3-(trifluoromethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(Cl)C(OC(F)(F)F)=C1 MAQRBEJNRFLCMN-UHFFFAOYSA-N 0.000 claims 1
- ORKCAOWHFJNFTJ-UHFFFAOYSA-N 5-[[2-[4-chloro-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 ORKCAOWHFJNFTJ-UHFFFAOYSA-N 0.000 claims 1
- ZXYMMPYLTYISAE-UHFFFAOYSA-N 5-[[2-[4-ethoxy-3-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)(F)F)C(OCC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZXYMMPYLTYISAE-UHFFFAOYSA-N 0.000 claims 1
- NEUNVCFENZGRFL-UHFFFAOYSA-N 5-[[2-[4-fluoro-3-(trifluoromethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(F)C(OC(F)(F)F)=C1 NEUNVCFENZGRFL-UHFFFAOYSA-N 0.000 claims 1
- NEJSMJHUEGYLSB-UHFFFAOYSA-N 5-[[2-[4-methoxy-3-(4-methylpiperazine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=C1C(=O)N1CCN(C)CC1 NEJSMJHUEGYLSB-UHFFFAOYSA-N 0.000 claims 1
- MMELFFYUOOYHDX-UHFFFAOYSA-N 5-[[2-[4-methoxy-3-(morpholine-4-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=C1C(=O)N1CCOCC1 MMELFFYUOOYHDX-UHFFFAOYSA-N 0.000 claims 1
- CDMKAVGXFRJJIE-UHFFFAOYSA-N 5-[[2-[4-methoxy-3-(propan-2-yloxymethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(COC(C)C)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CDMKAVGXFRJJIE-UHFFFAOYSA-N 0.000 claims 1
- WCSLRDAJYIXAFB-UHFFFAOYSA-N 5-[[2-[4-methoxy-3-(pyrrolidine-1-carbonyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=C1C(=O)N1CCCC1 WCSLRDAJYIXAFB-UHFFFAOYSA-N 0.000 claims 1
- QRCXZWWEEFZMGN-UHFFFAOYSA-N 5-[[2-[[2-(3-bicyclo[2.2.1]heptanylmethyl)-1,3-dihydroisoindol-5-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CN(CC5C6CCC(C6)C5)CC4=CC=3)=NC=C2C)=C1 QRCXZWWEEFZMGN-UHFFFAOYSA-N 0.000 claims 1
- BJXHTOGVUDHCFO-UHFFFAOYSA-N 5-[[2-[[2-(cyclopentylmethyl)-1,3-dihydroisoindol-5-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C2)=CC=C1CN2CC1CCCC1 BJXHTOGVUDHCFO-UHFFFAOYSA-N 0.000 claims 1
- KBHRXJQPHICWFU-UHFFFAOYSA-N 5-[[2-[[5-[3-(diethylamino)pyrrolidin-1-yl]-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1C(N(CC)CC)CCN1C1C2=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=C2CCCC1 KBHRXJQPHICWFU-UHFFFAOYSA-N 0.000 claims 1
- JSRWKCZGSZFNOA-UHFFFAOYSA-N 5-[[2-[[5-chloro-6-(1,4-diazabicyclo[3.2.2]nonan-4-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1Cl)=CN=C1N1CCN2CCC1CC2 JSRWKCZGSZFNOA-UHFFFAOYSA-N 0.000 claims 1
- YJGLQVDCNHHXGY-UHFFFAOYSA-N 5-[[2-[[5-chloro-6-(2-ethyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)Cl)N2CC3CN(CC3C2)CC)=C1 YJGLQVDCNHHXGY-UHFFFAOYSA-N 0.000 claims 1
- ARHWPHLBYFBVFI-UHFFFAOYSA-N 5-[[2-[[5-chloro-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)Cl)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ARHWPHLBYFBVFI-UHFFFAOYSA-N 0.000 claims 1
- UGZYKDSIRHRPJY-UHFFFAOYSA-N 5-[[2-[[5-fluoro-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)F)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 UGZYKDSIRHRPJY-UHFFFAOYSA-N 0.000 claims 1
- HZUFGGHTZKMSER-HOTGVXAUSA-N 5-[[2-[[5-fluoro-6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)F)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 HZUFGGHTZKMSER-HOTGVXAUSA-N 0.000 claims 1
- LSMYLOATQXAJME-UHFFFAOYSA-N 5-[[2-[[6-(2,3,3a,4,5,6,7,7a-octahydro-1h-isoindol-1-yl)-5-chloropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(Cl)C(C4C5CCCCC5CN4)=NC=3)=NC=C2C)=C1 LSMYLOATQXAJME-UHFFFAOYSA-N 0.000 claims 1
- ZRFCXAJAMXPONZ-UHFFFAOYSA-N 5-[[2-[[6-(2,3,3a,4,5,6,7,7a-octahydro-1h-isoindol-1-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=NC(=CC=3)C3C4CCCCC4CN3)=NC=C2C)=C1 ZRFCXAJAMXPONZ-UHFFFAOYSA-N 0.000 claims 1
- IWLWHJVJUGHJBG-UHFFFAOYSA-N 5-[[2-[[6-(2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl)-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(F)C(N4CC5CNCC5C4)=NC=3)=NC=C2C)=C1 IWLWHJVJUGHJBG-UHFFFAOYSA-N 0.000 claims 1
- UDCVMRCXMGOHCC-UHFFFAOYSA-N 5-[[2-[[6-(2,5-diazabicyclo[2.2.1]heptan-2-yl)-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(F)C(N4C5CC(NC5)C4)=NC=3)=NC=C2C)=C1 UDCVMRCXMGOHCC-UHFFFAOYSA-N 0.000 claims 1
- MCSSGWSINHDLFI-UHFFFAOYSA-N 5-[[2-[[6-(2-ethyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-5-(trifluoromethyl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C(F)(F)F)N2CC3CN(CC3C2)CC)=C1 MCSSGWSINHDLFI-UHFFFAOYSA-N 0.000 claims 1
- JGJSZHRQQPQERQ-UHFFFAOYSA-N 5-[[2-[[6-(4,4-difluoropiperidin-1-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCC(F)(F)CC1 JGJSZHRQQPQERQ-UHFFFAOYSA-N 0.000 claims 1
- UDJPTSNBKDJQHQ-UHFFFAOYSA-N 5-[[2-[[6-(4,4-dimethylpiperidin-1-yl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCC(C)(C)CC1 UDJPTSNBKDJQHQ-UHFFFAOYSA-N 0.000 claims 1
- ZGGFIDAHXBMTHM-UHFFFAOYSA-N 5-[[2-[[6-(4-ethylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)C(F)(F)F)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZGGFIDAHXBMTHM-UHFFFAOYSA-N 0.000 claims 1
- ASLGBANAHJJSTO-UHFFFAOYSA-N 5-[[2-[[6-(4-ethylpiperazin-1-yl)-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)F)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ASLGBANAHJJSTO-UHFFFAOYSA-N 0.000 claims 1
- WXTHMJDUGVAVGP-UHFFFAOYSA-N 5-[[2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C(F)(F)F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WXTHMJDUGVAVGP-UHFFFAOYSA-N 0.000 claims 1
- MPBVCSMVYHEBAC-UHFFFAOYSA-N 5-[[2-[[6-(8-azabicyclo[3.2.1]octan-3-yl)-5-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(C)C(C4CC5CCC(N5)C4)=NC=3)=NC=C2C)=C1 MPBVCSMVYHEBAC-UHFFFAOYSA-N 0.000 claims 1
- VYTBHAUXVKRGLX-UHFFFAOYSA-N 5-[[2-[[6-(cyclopropylmethylamino)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1NCC1CC1 VYTBHAUXVKRGLX-UHFFFAOYSA-N 0.000 claims 1
- JVZBBOMPCYZBMS-UHFFFAOYSA-N 5-[[2-[[6-(dimethylamino)pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=NC(N(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 JVZBBOMPCYZBMS-UHFFFAOYSA-N 0.000 claims 1
- YXBRGDQOKUVHAS-CABCVRRESA-N 5-[[2-[[6-[(2s,5r)-2,5-dimethylpiperazin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C[C@H]1CN[C@H](C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YXBRGDQOKUVHAS-CABCVRRESA-N 0.000 claims 1
- XVSAILKGXHSPBT-QGZVFWFLSA-N 5-[[2-[[6-[(3r)-4-(cyclopropylmethyl)-3-methylpiperazin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C([C@H]1C)N(C=2N=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=2)CCN1CC1CC1 XVSAILKGXHSPBT-QGZVFWFLSA-N 0.000 claims 1
- NHDLZOOKWGPGLM-GASCZTMLSA-N 5-[[2-[[6-[(3r,5s)-3,5-dimethylpiperazin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NHDLZOOKWGPGLM-GASCZTMLSA-N 0.000 claims 1
- YPPHRSOZQNNEQR-MRXNPFEDSA-N 5-[[2-[[6-[(4r)-4-hydroxy-2-methylidenepyrrolidin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1C[C@H](O)CC1=C YPPHRSOZQNNEQR-MRXNPFEDSA-N 0.000 claims 1
- NMUMGNDOJWJNGX-UHFFFAOYSA-N 5-[[2-[[6-[2-(cyclopropylmethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1F)=CN=C1N(CC1C2)CC1CN2CC1CC1 NMUMGNDOJWJNGX-UHFFFAOYSA-N 0.000 claims 1
- QFEPWYZXJWSSDW-UHFFFAOYSA-N 5-[[2-[[6-[3-(cyclopropylmethylamino)pyrrolidin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N(C1)CCC1NCC1CC1 QFEPWYZXJWSSDW-UHFFFAOYSA-N 0.000 claims 1
- HAUJPPBRXSNDBO-UHFFFAOYSA-N 5-[[2-[[6-[3-(diethylamino)pyrrolidin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1C(N(CC)CC)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HAUJPPBRXSNDBO-UHFFFAOYSA-N 0.000 claims 1
- AKAPGVSPLMKWRF-UHFFFAOYSA-N 5-[[2-[[6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1C(N(C)C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 AKAPGVSPLMKWRF-UHFFFAOYSA-N 0.000 claims 1
- QEQDEUYOOCCEPK-UHFFFAOYSA-N 5-[[2-[[6-[4-(cyclopropylmethyl)piperazine-1-carbonyl]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1C(=O)N(CC1)CCN1CC1CC1 QEQDEUYOOCCEPK-UHFFFAOYSA-N 0.000 claims 1
- DCCGOYKKGUYXIZ-UHFFFAOYSA-N 5-[[2-[[6-[5-(cyclopropanecarbonyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-2-yl]-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1F)=CN=C1N(CC1C2)CC1CN2C(=O)C1CC1 DCCGOYKKGUYXIZ-UHFFFAOYSA-N 0.000 claims 1
- AVNMLYZSADGRAZ-UHFFFAOYSA-N 5-[[2-[[6-[5-(cyclopropylmethyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-5-fluoropyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1F)=CN=C1N1CC2CC1CN2CC1CC1 AVNMLYZSADGRAZ-UHFFFAOYSA-N 0.000 claims 1
- XUNIQJOBBUWJIA-UHFFFAOYSA-N 5-[[2-[[6-[8-(cyclopropylmethyl)-8-azabicyclo[3.2.1]octan-3-yl]-5-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C)=CN=C1C(C1)CC2CCC1N2CC1CC1 XUNIQJOBBUWJIA-UHFFFAOYSA-N 0.000 claims 1
- NHEOWLBWSYJWIH-XMMPIXPASA-N 5-[[2-[[6-[[(3r)-1-benzylpiperidin-3-yl]-methylamino]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C([C@H](C1)N(C)C=2N=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=2)CCN1CC1=CC=CC=C1 NHEOWLBWSYJWIH-XMMPIXPASA-N 0.000 claims 1
- NHEOWLBWSYJWIH-DEOSSOPVSA-N 5-[[2-[[6-[[(3s)-1-benzylpiperidin-3-yl]-methylamino]pyridin-3-yl]amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C([C@@H](C1)N(C)C=2N=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=2)CCN1CC1=CC=CC=C1 NHEOWLBWSYJWIH-DEOSSOPVSA-N 0.000 claims 1
- CDJWBVCPPNMNQH-UHFFFAOYSA-N 5-[[5-amino-8-(3-methylphenyl)-[1,4,2]dioxazolo[2,3-c]pyrimidin-8a-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC(C=2C3(OCON3C(N)=NC=2)NC=2C=C3NC(=O)OC3=CC=2)=C1 CDJWBVCPPNMNQH-UHFFFAOYSA-N 0.000 claims 1
- SOSQJXBOIXJBMR-UHFFFAOYSA-N 5-[[5-fluoro-2-(2-morpholin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC1=CC=CC=C1C1COCCN1 SOSQJXBOIXJBMR-UHFFFAOYSA-N 0.000 claims 1
- OFKHBFZTESMQMF-UHFFFAOYSA-N 5-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 OFKHBFZTESMQMF-UHFFFAOYSA-N 0.000 claims 1
- AYEBVXHXTUWAPZ-UHFFFAOYSA-N 5-[[5-fluoro-2-[(6-morpholin-2-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-1,3-dihydrobenzimidazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)NC3=CC=2)C(F)=CN=C1NC(C=N1)=CC=C1C1CNCCO1 AYEBVXHXTUWAPZ-UHFFFAOYSA-N 0.000 claims 1
- GABYOSQVHVEVAG-UHFFFAOYSA-N 5-[[5-fluoro-2-[(6-morpholin-2-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC(C=N1)=CC=C1C1CNCCO1 GABYOSQVHVEVAG-UHFFFAOYSA-N 0.000 claims 1
- CQRMWLMZVZGESU-UHFFFAOYSA-N 5-[[5-fluoro-2-[3-(trifluoromethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC1=CC=CC(OC(F)(F)F)=C1 CQRMWLMZVZGESU-UHFFFAOYSA-N 0.000 claims 1
- IZSITPHSTRUMMM-UHFFFAOYSA-N 5-[[5-fluoro-2-[[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C)=NC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 IZSITPHSTRUMMM-UHFFFAOYSA-N 0.000 claims 1
- JMXMLYQVDLGCCF-HOTGVXAUSA-N 5-[[5-fluoro-2-[[5-methyl-6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(F)=CN=C(N=2)NC2=CN=C(C(=C2)C)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 JMXMLYQVDLGCCF-HOTGVXAUSA-N 0.000 claims 1
- MPVCAJBGYRJWDO-UHFFFAOYSA-N 5-[[5-fluoro-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-dihydrobenzimidazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)NC3=CC=2)=N1 MPVCAJBGYRJWDO-UHFFFAOYSA-N 0.000 claims 1
- MNYZAXJIDKDMAS-UHFFFAOYSA-N 5-[[5-fluoro-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-dimethylbenzimidazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(F)C(NC=2C=C3N(C)C(=O)N(C)C3=CC=2)=N1 MNYZAXJIDKDMAS-UHFFFAOYSA-N 0.000 claims 1
- ZZUNOPIXFVHVDA-UHFFFAOYSA-N 5-[[5-fluoro-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3-methyl-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(F)C(NC=2C=C3N(C)C(=O)OC3=CC=2)=N1 ZZUNOPIXFVHVDA-UHFFFAOYSA-N 0.000 claims 1
- LPUOHHAMMPXABH-UHFFFAOYSA-N 5-[[5-fluoro-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 LPUOHHAMMPXABH-UHFFFAOYSA-N 0.000 claims 1
- YDTSZBPVOYWLMY-KBPBESRZSA-N 5-[[5-fluoro-2-[[6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(F)=CN=C(N=2)NC2=CC=C(N=C2)N2C[C@]3(OC[C@]2([H])C3)[H])=C1 YDTSZBPVOYWLMY-KBPBESRZSA-N 0.000 claims 1
- ZSDWCLGTFFZLAF-GJZGRUSLSA-N 5-[[5-fluoro-2-[[6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(F)=CN=C(N=2)NC2=CC=C(N=C2)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 ZSDWCLGTFFZLAF-GJZGRUSLSA-N 0.000 claims 1
- PXGNYCRKGFISCG-UHFFFAOYSA-N 5-[[5-methyl-2-(2,3,4,5-tetrafluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=C(F)C(F)=C1F PXGNYCRKGFISCG-UHFFFAOYSA-N 0.000 claims 1
- FHNBUJWPONWCDL-UHFFFAOYSA-N 5-[[5-methyl-2-(2,3,5-trifluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=CC(F)=C1F FHNBUJWPONWCDL-UHFFFAOYSA-N 0.000 claims 1
- WDGMGVWAYDQPQX-UHFFFAOYSA-N 5-[[5-methyl-2-(2,4,5-trifluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(F)=C(F)C=C1F WDGMGVWAYDQPQX-UHFFFAOYSA-N 0.000 claims 1
- LMWLGVFHFZOASS-UHFFFAOYSA-N 5-[[5-methyl-2-(2,4,6-trifluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=C(F)C=C(F)C=C1F LMWLGVFHFZOASS-UHFFFAOYSA-N 0.000 claims 1
- ACCSHFUASNBSHP-UHFFFAOYSA-N 5-[[5-methyl-2-(2,4,6-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(C)=CC(C)=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ACCSHFUASNBSHP-UHFFFAOYSA-N 0.000 claims 1
- HAQZPLFESKTAFW-UHFFFAOYSA-N 5-[[5-methyl-2-(2-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HAQZPLFESKTAFW-UHFFFAOYSA-N 0.000 claims 1
- VXZZNFWNBHRTIB-UHFFFAOYSA-N 5-[[5-methyl-2-(2-morpholin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC=C1C1COCCN1 VXZZNFWNBHRTIB-UHFFFAOYSA-N 0.000 claims 1
- WMKKUTLFBKVNAQ-UHFFFAOYSA-N 5-[[5-methyl-2-(3-methyl-4-propan-2-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(C(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WMKKUTLFBKVNAQ-UHFFFAOYSA-N 0.000 claims 1
- FGXKVFBCWFYGLH-UHFFFAOYSA-N 5-[[5-methyl-2-(3-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 FGXKVFBCWFYGLH-UHFFFAOYSA-N 0.000 claims 1
- YARROSPABWHAFQ-UHFFFAOYSA-N 5-[[5-methyl-2-(4-methyl-3-methylsulfonylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(S(C)(=O)=O)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YARROSPABWHAFQ-UHFFFAOYSA-N 0.000 claims 1
- SULAAQWULAZWTE-UHFFFAOYSA-N 5-[[5-methyl-2-(4-methyl-3-pyridin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(C)C=1C1=CC=CN=C1 SULAAQWULAZWTE-UHFFFAOYSA-N 0.000 claims 1
- OGPFNHRJFIMUEQ-UHFFFAOYSA-N 5-[[5-methyl-2-(4-methyl-3-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(C)C=1C1=CC=NC=C1 OGPFNHRJFIMUEQ-UHFFFAOYSA-N 0.000 claims 1
- LMHRIPVXOAUZCA-UHFFFAOYSA-N 5-[[5-methyl-2-(4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 LMHRIPVXOAUZCA-UHFFFAOYSA-N 0.000 claims 1
- HBENXIRGVZDZBZ-UHFFFAOYSA-N 5-[[5-methyl-2-(4-propan-2-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(C(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HBENXIRGVZDZBZ-UHFFFAOYSA-N 0.000 claims 1
- ZGARSQSDJYJHLU-UHFFFAOYSA-N 5-[[5-methyl-2-(naphthalen-2-ylamino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=CC=CC4=CC=3)=NC=C2C)=C1 ZGARSQSDJYJHLU-UHFFFAOYSA-N 0.000 claims 1
- AOOUTEXTIYKQMD-UHFFFAOYSA-N 5-[[5-methyl-2-(pyridin-3-ylamino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CN=C1 AOOUTEXTIYKQMD-UHFFFAOYSA-N 0.000 claims 1
- ABJCKENYPFDHMZ-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methyl-2-oxo-3h-benzimidazol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4NC(=O)N(C)C4=CC=3)=NC=C2C)=C1 ABJCKENYPFDHMZ-UHFFFAOYSA-N 0.000 claims 1
- VYVRBLHSRAVCPD-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methyl-2-oxo-3h-indol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC=2C=C3CC(=O)N(C3=CC=2)C)=C1 VYVRBLHSRAVCPD-UHFFFAOYSA-N 0.000 claims 1
- QAGXYVWGXODVDL-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methyl-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2CCCC(=O)N(C)C2=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QAGXYVWGXODVDL-UHFFFAOYSA-N 0.000 claims 1
- XZUWOAVBUYRFTL-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methyl-2-oxo-4,5-dihydro-3h-1-benzazepin-8-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CCC(=O)N(C)C2=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=C21 XZUWOAVBUYRFTL-UHFFFAOYSA-N 0.000 claims 1
- VDFZJHFYVYVEDM-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methylindazol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=NN(C)C4=CC=3)=NC=C2C)=C1 VDFZJHFYVYVEDM-UHFFFAOYSA-N 0.000 claims 1
- XAVQUEDZFFYTFC-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-methylindazol-6-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4N(C)N=CC4=CC=3)=NC=C2C)=C1 XAVQUEDZFFYTFC-UHFFFAOYSA-N 0.000 claims 1
- UUHRTNBBHWZTQU-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-oxo-2,3-dihydro-2-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CCNC(=O)C=2C1=CC(NC1=NC=C(C(=N1)NC=1C=C3NC(=O)OC3=CC=1)C)=CC=2 UUHRTNBBHWZTQU-UHFFFAOYSA-N 0.000 claims 1
- HPORBGWZUVWNND-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-oxo-3,4-dihydro-2h-isoquinolin-6-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CCNC(=O)C4=CC=3)=NC=C2C)=C1 HPORBGWZUVWNND-UHFFFAOYSA-N 0.000 claims 1
- FNVHWKXIBFGULD-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methyl-1,3-dihydroisoindol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)C)=C1 FNVHWKXIBFGULD-UHFFFAOYSA-N 0.000 claims 1
- CXMRAERQFITVJB-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methyl-1-oxo-3,4,5,6-tetrahydro-2-benzazocin-9-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2C(=O)N(C)CCCCC2=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CXMRAERQFITVJB-UHFFFAOYSA-N 0.000 claims 1
- GSBWUYJHFHJFCC-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methyl-1-oxo-4,5-dihydro-3h-2-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound O=C1N(C)CCCC2=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=C21 GSBWUYJHFHJFCC-UHFFFAOYSA-N 0.000 claims 1
- YQFGQCVVZISXBF-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methylsulfonyl-1,3-dihydroisoindol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CN(CC4=CC=3)S(C)(=O)=O)=NC=C2C)=C1 YQFGQCVVZISXBF-UHFFFAOYSA-N 0.000 claims 1
- YQWWJMDOYXAXLD-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1C(=O)CCCC2=CC(NC3=NC=C(C(=N3)NC=3C=C4NC(=O)OC4=CC=3)C)=CC=C21 YQWWJMDOYXAXLD-UHFFFAOYSA-N 0.000 claims 1
- YYLAHZOOFVDCRQ-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-8-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CCC(=O)NC2=CC(NC3=NC=C(C(=N3)NC=3C=C4NC(=O)OC4=CC=3)C)=CC=C21 YYLAHZOOFVDCRQ-UHFFFAOYSA-N 0.000 claims 1
- OCUQDWIKKNUCOT-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-oxo-3,4-dihydro-1h-quinolin-6-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CCC(=O)NC4=CC=3)=NC=C2C)=C1 OCUQDWIKKNUCOT-UHFFFAOYSA-N 0.000 claims 1
- VWWNHNRRJGDZCA-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-oxo-3,4-dihydro-1h-quinolin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4NC(=O)CCC4=CC=3)=NC=C2C)=C1 VWWNHNRRJGDZCA-UHFFFAOYSA-N 0.000 claims 1
- UGYHCBDPSCWEDF-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4NC(=O)OC4=CC=3)=NC=C2C)=C1 UGYHCBDPSCWEDF-UHFFFAOYSA-N 0.000 claims 1
- RIHDVINMPAWMFE-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-piperazin-1-ylpyridin-4-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=NC=1N1CCNCC1 RIHDVINMPAWMFE-UHFFFAOYSA-N 0.000 claims 1
- WMTGQRURAKDZTE-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-propyl-1,3-dihydroisoindol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)CCC)=C1 WMTGQRURAKDZTE-UHFFFAOYSA-N 0.000 claims 1
- IGTYNDYTLIUVGL-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-methyl-1,2-benzoxazol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3ON=C(C3=C2)C)=C1 IGTYNDYTLIUVGL-UHFFFAOYSA-N 0.000 claims 1
- QYYSLJFCKDAWEQ-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-methyl-2h-indazol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3NN=C(C3=C2)C)=C1 QYYSLJFCKDAWEQ-UHFFFAOYSA-N 0.000 claims 1
- ODIJUOBTWZLAKC-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-methyl-2h-indazol-6-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC=2C=C3NN=C(C3=CC=2)C)=C1 ODIJUOBTWZLAKC-UHFFFAOYSA-N 0.000 claims 1
- AWSXHYMRCHCBLN-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C3ON=C(C3=C2)C)=C1 AWSXHYMRCHCBLN-UHFFFAOYSA-N 0.000 claims 1
- WBWMSMYMJIUVPK-UHFFFAOYSA-N 5-[[5-methyl-2-[(5-methylpyridin-2-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=CC(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WBWMSMYMJIUVPK-UHFFFAOYSA-N 0.000 claims 1
- FULHKCNSXKHLJW-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-methylpyridin-2-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=N1 FULHKCNSXKHLJW-UHFFFAOYSA-N 0.000 claims 1
- RDJCKZRDNRTBEK-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(S(C)(=O)=O)N=C1 RDJCKZRDNRTBEK-UHFFFAOYSA-N 0.000 claims 1
- AREPKEPMAROKGK-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-morpholin-2-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1C1CNCCO1 AREPKEPMAROKGK-UHFFFAOYSA-N 0.000 claims 1
- VXXZAZAKPDCUST-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-piperazin-1-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCNCC1 VXXZAZAKPDCUST-UHFFFAOYSA-N 0.000 claims 1
- QBWFGDFWCSSUBA-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-propan-2-yloxypyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=NC(OC(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QBWFGDFWCSSUBA-UHFFFAOYSA-N 0.000 claims 1
- ZMKWXOHLMRKIJQ-UHFFFAOYSA-N 5-[[5-methyl-2-[(6-pyrrolidin-1-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCCC1 ZMKWXOHLMRKIJQ-UHFFFAOYSA-N 0.000 claims 1
- LRTNEKOMIRUIOV-UHFFFAOYSA-N 5-[[5-methyl-2-[(7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1CC2)=CC=C1CCC2N1CCCC1 LRTNEKOMIRUIOV-UHFFFAOYSA-N 0.000 claims 1
- YSKJORHIOKNALI-UHFFFAOYSA-N 5-[[5-methyl-2-[2-methyl-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C(F)(F)F)=C1C YSKJORHIOKNALI-UHFFFAOYSA-N 0.000 claims 1
- YQCSCJYIWQFPTH-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(1-morpholin-4-ylethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCOCC1 YQCSCJYIWQFPTH-UHFFFAOYSA-N 0.000 claims 1
- RSGDGCYDIHOHGI-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(1-piperidin-1-ylethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCCCC1 RSGDGCYDIHOHGI-UHFFFAOYSA-N 0.000 claims 1
- JARVAMCBFKMZAA-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(1-pyrrolidin-1-ylethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=1C(C)N1CCCC1 JARVAMCBFKMZAA-UHFFFAOYSA-N 0.000 claims 1
- RQCFAKPGXYRXBC-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(morpholine-4-carbonyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=CC=1C(=O)N1CCOCC1 RQCFAKPGXYRXBC-UHFFFAOYSA-N 0.000 claims 1
- HMLXTQAJOULZRV-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(pyrrolidine-1-carbonyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=CC=1C(=O)N1CCCC1 HMLXTQAJOULZRV-UHFFFAOYSA-N 0.000 claims 1
- LMAIDYZJSVNEPL-UHFFFAOYSA-N 5-[[5-methyl-2-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C(F)(F)F)=C1 LMAIDYZJSVNEPL-UHFFFAOYSA-N 0.000 claims 1
- JQBLENSPCMYYOO-UHFFFAOYSA-N 5-[[5-methyl-2-[3-[1-(methylamino)butyl]-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(NC)CCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JQBLENSPCMYYOO-UHFFFAOYSA-N 0.000 claims 1
- GKOOFNPLPBOCPE-UHFFFAOYSA-N 5-[[5-methyl-2-[3-[1-(methylamino)ethyl]-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(C)NC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 GKOOFNPLPBOCPE-UHFFFAOYSA-N 0.000 claims 1
- WNUDIFOQLHEGJE-UHFFFAOYSA-N 5-[[5-methyl-2-[3-[1-(propan-2-ylamino)ethyl]-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(C(C)NC(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 WNUDIFOQLHEGJE-UHFFFAOYSA-N 0.000 claims 1
- MJDAXTOZICACPW-UHFFFAOYSA-N 5-[[5-methyl-2-[3-[1-(propylamino)ethyl]anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CCCNC(C)C1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 MJDAXTOZICACPW-UHFFFAOYSA-N 0.000 claims 1
- BMAJEIQMCFXFGO-UHFFFAOYSA-N 5-[[5-methyl-2-[3-methyl-4-(1,5,7-trimethyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(C(=C2)C)N2CC3(C)CN(CC(C)(C2)C3)C)=C1 BMAJEIQMCFXFGO-UHFFFAOYSA-N 0.000 claims 1
- QPGAYKZFVPPACS-UHFFFAOYSA-N 5-[[5-methyl-2-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QPGAYKZFVPPACS-UHFFFAOYSA-N 0.000 claims 1
- NSFKTMQFOVNSJK-HPRDVNIFSA-N 5-[[5-methyl-2-[3-methyl-4-(trideuteriomethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(OC([2H])([2H])[2H])=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NSFKTMQFOVNSJK-HPRDVNIFSA-N 0.000 claims 1
- YIBSESZNXRQSJN-HPRDVNIFSA-N 5-[[5-methyl-2-[3-methyl-5-(trideuteriomethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound [2H]C([2H])([2H])OC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YIBSESZNXRQSJN-HPRDVNIFSA-N 0.000 claims 1
- IVDFUUVTVVIDIE-UHFFFAOYSA-N 5-[[5-methyl-2-[3-morpholin-4-yl-4-(trifluoromethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=C(OC(F)(F)F)C=1N1CCOCC1 IVDFUUVTVVIDIE-UHFFFAOYSA-N 0.000 claims 1
- LTLAPKBICLQDIZ-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(1-morpholin-4-ylethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=CC=1C(C)N1CCOCC1 LTLAPKBICLQDIZ-UHFFFAOYSA-N 0.000 claims 1
- GNIJOKASSSFASG-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(1-pyrrolidin-1-ylethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=CC=1C(C)N1CCCC1 GNIJOKASSSFASG-UHFFFAOYSA-N 0.000 claims 1
- CBWCOIIHMDCRQT-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(2-methylpropoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(OCC(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CBWCOIIHMDCRQT-UHFFFAOYSA-N 0.000 claims 1
- HDVOPESYYYMUQR-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1OCCN1CCOCC1 HDVOPESYYYMUQR-UHFFFAOYSA-N 0.000 claims 1
- KYEWREXZJFGKSK-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(3-methylbutoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(OCCC(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 KYEWREXZJFGKSK-UHFFFAOYSA-N 0.000 claims 1
- GFVDQPHZJBZUMZ-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(6-morpholin-4-ylpyridin-3-yl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(C=N1)=CC=C1N1CCOCC1 GFVDQPHZJBZUMZ-UHFFFAOYSA-N 0.000 claims 1
- HROCZXSFQWMJIE-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(morpholine-4-carbonyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)N1CCOCC1 HROCZXSFQWMJIE-UHFFFAOYSA-N 0.000 claims 1
- OAMXUXKHSUJNRR-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(pyrrolidine-1-carbonyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)N1CCCC1 OAMXUXKHSUJNRR-UHFFFAOYSA-N 0.000 claims 1
- BDCYQALFSVYSES-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(trifluoromethoxy)-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(OC(F)(F)F)C(C(F)(F)F)=C1 BDCYQALFSVYSES-UHFFFAOYSA-N 0.000 claims 1
- PNPSFULSCDDORO-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(OC(F)(F)F)C=C1 PNPSFULSCDDORO-UHFFFAOYSA-N 0.000 claims 1
- ZNFFBEGICZLFEB-UHFFFAOYSA-N 5-[[5-methyl-2-[4-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(F)(F)F)C=C1 ZNFFBEGICZLFEB-UHFFFAOYSA-N 0.000 claims 1
- AYVIEQKUYDSUPX-UHFFFAOYSA-N 5-[[5-methyl-2-[4-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(C=C2)NC2CC3CCC(C2)N3C)=C1 AYVIEQKUYDSUPX-UHFFFAOYSA-N 0.000 claims 1
- VCABXUPKOZKIKY-UHFFFAOYSA-N 5-[[5-methyl-2-[4-[1-(propan-2-ylamino)ethyl]anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(C(C)NC(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VCABXUPKOZKIKY-UHFFFAOYSA-N 0.000 claims 1
- RVDITCUXNOCJRD-UHFFFAOYSA-N 5-[[5-methyl-2-[4-methyl-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C)C(C(F)(F)F)=C1 RVDITCUXNOCJRD-UHFFFAOYSA-N 0.000 claims 1
- YPZSDTYTKLQCCW-UHFFFAOYSA-N 5-[[5-methyl-2-[4-methyl-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C(F)(F)F)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YPZSDTYTKLQCCW-UHFFFAOYSA-N 0.000 claims 1
- GUGOIWVCPSKCBT-UHFFFAOYSA-N 5-[[5-methyl-2-[4-methylsulfanyl-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)(F)F)C(SC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 GUGOIWVCPSKCBT-UHFFFAOYSA-N 0.000 claims 1
- DCHUKIOEQOXDPN-ARJAWSKDSA-N 5-[[5-methyl-2-[[(4z)-2-methyl-1-oxo-3,6-dihydro-2-benzazocin-9-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2C(=O)N(C)C\C=C/CC2=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DCHUKIOEQOXDPN-ARJAWSKDSA-N 0.000 claims 1
- HFHCTZYNFGCKRX-UHFFFAOYSA-N 5-[[5-methyl-2-[[2-(2-methylpropyl)-1,3-dihydroisoindol-5-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)CC(C)C)=C1 HFHCTZYNFGCKRX-UHFFFAOYSA-N 0.000 claims 1
- QKJBVKWVTXJBHW-UHFFFAOYSA-N 5-[[5-methyl-2-[[2-(3-methylbutyl)-1,3-dihydroisoindol-5-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C3CN(CC3=C2)CCC(C)C)=C1 QKJBVKWVTXJBHW-UHFFFAOYSA-N 0.000 claims 1
- OOJGLQNKMCGKCG-UHFFFAOYSA-N 5-[[5-methyl-2-[[2-(4-methylpiperazin-1-yl)pyridin-4-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=N1 OOJGLQNKMCGKCG-UHFFFAOYSA-N 0.000 claims 1
- WLOFMKZNHPHJEX-UHFFFAOYSA-N 5-[[5-methyl-2-[[4-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC(C)=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WLOFMKZNHPHJEX-UHFFFAOYSA-N 0.000 claims 1
- BSXRKAVRVWXPES-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-(propan-2-ylamino)-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2C(NC(C)C)CCCCC2=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 BSXRKAVRVWXPES-UHFFFAOYSA-N 0.000 claims 1
- XZZCFFTZLKSFJO-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-dihydrobenzimidazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)NC3=CC=2)=N1 XZZCFFTZLKSFJO-UHFFFAOYSA-N 0.000 claims 1
- DAEPBSFJUKJVBK-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C)=NC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DAEPBSFJUKJVBK-UHFFFAOYSA-N 0.000 claims 1
- YJNJAXPAEQTNLO-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-methyl-6-(8-methyl-3,8-diazabicyclo[3.2.1]octan-3-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C)N2CC3CCC(C2)N3C)=C1 YJNJAXPAEQTNLO-UHFFFAOYSA-N 0.000 claims 1
- UNHWBCFNFRPFSP-ROUUACIJSA-N 5-[[5-methyl-2-[[5-methyl-6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 UNHWBCFNFRPFSP-ROUUACIJSA-N 0.000 claims 1
- UDZBEDBMZPVPSL-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-methyl-6-[8-(2,2,2-trifluoroacetyl)-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(C)C(N4CC5CCC(N5C(=O)C(F)(F)F)C4)=NC=3)=NC=C2C)=C1 UDZBEDBMZPVPSL-UHFFFAOYSA-N 0.000 claims 1
- NSPQIZQVSAFZDC-UHFFFAOYSA-N 5-[[5-methyl-2-[[5-methyl-6-[8-(2,2,2-trifluoroacetyl)-8-azabicyclo[3.2.1]octan-3-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(C)C(C4CC5CCC(N5C(=O)C(F)(F)F)C4)=NC=3)=NC=C2C)=C1 NSPQIZQVSAFZDC-UHFFFAOYSA-N 0.000 claims 1
- AWMNYAYNACLRAO-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(1,5,7-trimethyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)N2CC3(C)CN(CC(C)(C2)C3)C)=C1 AWMNYAYNACLRAO-UHFFFAOYSA-N 0.000 claims 1
- XJKCTUSACGJCBF-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)N2CC3CN(CC3C2)C)=C1 XJKCTUSACGJCBF-UHFFFAOYSA-N 0.000 claims 1
- DUMIHBITNYYQLA-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(3-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CNC(C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 DUMIHBITNYYQLA-UHFFFAOYSA-N 0.000 claims 1
- HAASIIMHDGLDTJ-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(3-morpholin-4-ylpyrrolidin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N(C1)CCC1N1CCOCC1 HAASIIMHDGLDTJ-UHFFFAOYSA-N 0.000 claims 1
- UZHCTGFIBFPPQH-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methyl-1,4-diazepan-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 UZHCTGFIBFPPQH-UHFFFAOYSA-N 0.000 claims 1
- YJRDRJOJQUURCO-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridazin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=N1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YJRDRJOJQUURCO-UHFFFAOYSA-N 0.000 claims 1
- SRJUAWWAUHEGSQ-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-1,3-dihydrobenzimidazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)NC3=CC=2)=N1 SRJUAWWAUHEGSQ-UHFFFAOYSA-N 0.000 claims 1
- IEBWYVGIFWLKSV-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3-propan-2-yl-1,3-benzoxazol-2-one Chemical compound C=1C=C2OC(=O)N(C(C)C)C2=CC=1NC(C(=CN=1)C)=NC=1NC(C=N1)=CC=C1N1CCN(C)CC1 IEBWYVGIFWLKSV-UHFFFAOYSA-N 0.000 claims 1
- JWLHNISWUDDHTE-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3-propyl-1,3-benzoxazol-2-one Chemical compound C=1C=C2OC(=O)N(CCC)C2=CC=1NC(C(=CN=1)C)=NC=1NC(C=N1)=CC=C1N1CCN(C)CC1 JWLHNISWUDDHTE-UHFFFAOYSA-N 0.000 claims 1
- VRHMZZOLTHXZAU-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VRHMZZOLTHXZAU-UHFFFAOYSA-N 0.000 claims 1
- HTSLISMCOWZIQR-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-methylpiperidin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CC(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HTSLISMCOWZIQR-UHFFFAOYSA-N 0.000 claims 1
- FKQMJQXACPHULO-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 FKQMJQXACPHULO-UHFFFAOYSA-N 0.000 claims 1
- KAGGQRFDQVQNRZ-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(7-methyl-2,7-diazaspiro[4.4]nonan-2-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1N(C)CCC11CN(C=2N=CC(NC=3N=C(NC=4C=C5NC(=O)OC5=CC=4)C(C)=CN=3)=CC=2)CC1 KAGGQRFDQVQNRZ-UHFFFAOYSA-N 0.000 claims 1
- OITIGGHGNADBRB-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-(piperazine-1-carbonyl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1C(=O)N1CCNCC1 OITIGGHGNADBRB-UHFFFAOYSA-N 0.000 claims 1
- XPTOUMMAVKPVTF-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-[(1-methylpiperidin-4-yl)amino]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCC1NC(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 XPTOUMMAVKPVTF-UHFFFAOYSA-N 0.000 claims 1
- OFQFBNCCNMMUIC-SJORKVTESA-N 5-[[5-methyl-2-[[6-[(1s,4r)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)N2C[C@@]3(N(C[C@]2([H])C3)C)[H])=C1 OFQFBNCCNMMUIC-SJORKVTESA-N 0.000 claims 1
- AMKJBYCLEABNLA-HOTGVXAUSA-N 5-[[5-methyl-2-[[6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)N2C[C@]3(OC[C@]2([H])C3)[H])=C1 AMKJBYCLEABNLA-HOTGVXAUSA-N 0.000 claims 1
- FZPMAAQFPWUVIQ-HOTGVXAUSA-N 5-[[5-methyl-2-[[6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-5-(trifluoromethyl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C(F)(F)F)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 FZPMAAQFPWUVIQ-HOTGVXAUSA-N 0.000 claims 1
- OFQFBNCCNMMUIC-IRXDYDNUSA-N 5-[[5-methyl-2-[[6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)N2C[C@]3(N(C[C@]2([H])C3)C)[H])=C1 OFQFBNCCNMMUIC-IRXDYDNUSA-N 0.000 claims 1
- ZVLSDJJJGGPHRC-CQSZACIVSA-N 5-[[5-methyl-2-[[6-[(2r)-2-methylmorpholin-4-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CO[C@H](C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZVLSDJJJGGPHRC-CQSZACIVSA-N 0.000 claims 1
- NPKXAELPGPKYLG-CQSZACIVSA-N 5-[[5-methyl-2-[[6-[(3r)-3-methyl-4-(2,2,2-trifluoroacetyl)piperazin-1-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C(=O)C(F)(F)F)[C@H](C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NPKXAELPGPKYLG-CQSZACIVSA-N 0.000 claims 1
- LZMWAHPWCLZWAW-QGZVFWFLSA-N 5-[[5-methyl-2-[[6-[(3r)-3-methyl-4-propan-2-ylpiperazin-1-yl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1[C@@H](C)N(C(C)C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 LZMWAHPWCLZWAW-QGZVFWFLSA-N 0.000 claims 1
- DZQDSSRVPAHKDY-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(N=C2)NC2CC3CCC(C2)N3C)=C1 DZQDSSRVPAHKDY-UHFFFAOYSA-N 0.000 claims 1
- ZHSAOSOTLKMBIN-UHFFFAOYSA-N 5-[[5-methyl-2-[[6-[4-(2-methylpropyl)piperazine-1-carbonyl]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(CC(C)C)CCN1C(=O)C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZHSAOSOTLKMBIN-UHFFFAOYSA-N 0.000 claims 1
- AIEIEYNCQZONRV-OAHLLOKOSA-N 5-[[5-methyl-2-[[6-[[(3r)-piperidin-3-yl]amino]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N[C@@H]1CCCNC1 AIEIEYNCQZONRV-OAHLLOKOSA-N 0.000 claims 1
- AIEIEYNCQZONRV-HNNXBMFYSA-N 5-[[5-methyl-2-[[6-[[(3s)-piperidin-3-yl]amino]pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N[C@H]1CCCNC1 AIEIEYNCQZONRV-HNNXBMFYSA-N 0.000 claims 1
- XANSKTCCOFQXFI-UHFFFAOYSA-N 6-[[5-methyl-2-(2-morpholin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3OC(=O)NC3=CC=2)C(C)=CN=C1NC1=CC=CC=C1C1COCCN1 XANSKTCCOFQXFI-UHFFFAOYSA-N 0.000 claims 1
- BGZRVRCWLSHAKT-UHFFFAOYSA-N 6-[[5-methyl-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3OC(=O)NC3=CC=2)=N1 BGZRVRCWLSHAKT-UHFFFAOYSA-N 0.000 claims 1
- ZXUPXIDZRHWOSQ-UHFFFAOYSA-N 6-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-4h-1,4-benzoxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4NC(=O)COC4=CC=3)=NC=C2C)=C1 ZXUPXIDZRHWOSQ-UHFFFAOYSA-N 0.000 claims 1
- LXLRMUXKHSSRQL-UHFFFAOYSA-N 6-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-4h-pyrido[3,2-b][1,4]oxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3N=C4NC(=O)COC4=CC=3)=NC=C2C)=C1 LXLRMUXKHSSRQL-UHFFFAOYSA-N 0.000 claims 1
- HZKVPZGXVDDQJY-UHFFFAOYSA-N 7-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-4h-1,4-benzoxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4OCC(=O)NC4=CC=3)=NC=C2C)=C1 HZKVPZGXVDDQJY-UHFFFAOYSA-N 0.000 claims 1
- AFEMBWZWRXEWKI-UHFFFAOYSA-N 7-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-4h-pyrido[3,2-b][1,4]oxazin-3-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4OCC(=O)NC4=NC=3)=NC=C2C)=C1 AFEMBWZWRXEWKI-UHFFFAOYSA-N 0.000 claims 1
- DUXGUYJYNVTMKJ-UHFFFAOYSA-N 7-fluoro-5-[[2-(3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 DUXGUYJYNVTMKJ-UHFFFAOYSA-N 0.000 claims 1
- VTDGVDHUNMIGNK-UHFFFAOYSA-N 7-fluoro-5-[[2-(4-fluoro-3,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(F)C=2)C(C)=CN=C1NC1=CC(C)=C(F)C(C)=C1 VTDGVDHUNMIGNK-UHFFFAOYSA-N 0.000 claims 1
- PUQLNDCCKLOZTO-UHFFFAOYSA-N 7-fluoro-5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 PUQLNDCCKLOZTO-UHFFFAOYSA-N 0.000 claims 1
- QZSJYOKXQXYHLY-UHFFFAOYSA-N 7-fluoro-5-[[2-(4-fluoro-3-methylsulfonylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(F)C=2)C(C)=CN=C1NC1=CC=C(F)C(S(C)(=O)=O)=C1 QZSJYOKXQXYHLY-UHFFFAOYSA-N 0.000 claims 1
- MCYIJIIQGVGPMB-UHFFFAOYSA-N 7-fluoro-5-[[2-(4-methoxy-3-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=C(F)C=2)=N1 MCYIJIIQGVGPMB-UHFFFAOYSA-N 0.000 claims 1
- IEJSZMYRCNZGOY-UHFFFAOYSA-N 7-fluoro-5-[[2-[3-methoxy-5-(trifluoromethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 IEJSZMYRCNZGOY-UHFFFAOYSA-N 0.000 claims 1
- GVHWLUGPYHBMMX-UHFFFAOYSA-N 7-fluoro-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 GVHWLUGPYHBMMX-UHFFFAOYSA-N 0.000 claims 1
- GJRJDRNKLVJIRK-UHFFFAOYSA-N 7-fluoro-5-[[5-methyl-2-(3-methylsulfonylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(F)C=2)C(C)=CN=C1NC1=CC=CC(S(C)(=O)=O)=C1 GJRJDRNKLVJIRK-UHFFFAOYSA-N 0.000 claims 1
- ORKYVYLCAIFMCH-UHFFFAOYSA-N 7-fluoro-5-[[5-methyl-2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(F)C=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCOCC1 ORKYVYLCAIFMCH-UHFFFAOYSA-N 0.000 claims 1
- XGLSQCBXFSCEQB-UHFFFAOYSA-N 7-methyl-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C)C=2)C(C)=CN=C1NC1=CC(C)=C(C)C(C)=C1 XGLSQCBXFSCEQB-UHFFFAOYSA-N 0.000 claims 1
- DXSDRPXJSGHDKG-UHFFFAOYSA-N 7-methyl-5-[[5-methyl-2-(3-methylsulfonylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C)C=2)C(C)=CN=C1NC1=CC=CC(S(C)(=O)=O)=C1 DXSDRPXJSGHDKG-UHFFFAOYSA-N 0.000 claims 1
- CTMCMFCFRNYMNV-UHFFFAOYSA-N 7-methyl-5-[[5-methyl-2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C)C=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCOCC1 CTMCMFCFRNYMNV-UHFFFAOYSA-N 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- WDHNJDWXMDEHGD-ZTDHTWSHSA-N C1CN(P(O)(O)=O)[C@@](CC)(C)C(CC)N1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 Chemical compound C1CN(P(O)(O)=O)[C@@](CC)(C)C(CC)N1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WDHNJDWXMDEHGD-ZTDHTWSHSA-N 0.000 claims 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 239000004381 Choline salt Substances 0.000 claims 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 1
- DYVCZLDCYDPFNG-UHFFFAOYSA-N FC=1C(=NC=C(C=1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C)N1CC2C(C1)CN(C2)C(=O)O Chemical compound FC=1C(=NC=C(C=1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C)N1CC2C(C1)CN(C2)C(=O)O DYVCZLDCYDPFNG-UHFFFAOYSA-N 0.000 claims 1
- JDHVSCVYBNTLEQ-UHFFFAOYSA-N N12CCN(C(CC1)CC2)C1=NC=C(C=C1F)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C Chemical compound N12CCN(C(CC1)CC2)C1=NC=C(C=C1F)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C JDHVSCVYBNTLEQ-UHFFFAOYSA-N 0.000 claims 1
- MQXLMURRTWKWIM-UHFFFAOYSA-N N12CCN(CC2CCCC1)C1=NC=C(C=C1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C Chemical compound N12CCN(CC2CCCC1)C1=NC=C(C=C1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C MQXLMURRTWKWIM-UHFFFAOYSA-N 0.000 claims 1
- GQAXQYMKSMWAIM-GOSISDBHSA-N N12CCN(C[C@H]2CCC1)C1=NC=C(C=C1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C Chemical compound N12CCN(C[C@H]2CCC1)C1=NC=C(C=C1)NC1=NC=C(C(=N1)NC=1C=CC2=C(NC(O2)=O)C=1)C GQAXQYMKSMWAIM-GOSISDBHSA-N 0.000 claims 1
- YEQVMKFYJQFTJP-UHFFFAOYSA-N O1C(NC2=C1C=CC(=C2)NC1=NC(=NC=C1C)NC=1C=C2CN(CC2=CC=1)CC1CC1)=O Chemical compound O1C(NC2=C1C=CC(=C2)NC1=NC(=NC=C1C)NC=1C=C2CN(CC2=CC=1)CC1CC1)=O YEQVMKFYJQFTJP-UHFFFAOYSA-N 0.000 claims 1
- LPIZLGWUKGXGOG-UHFFFAOYSA-N O1C(NC2=C1C=CC(=C2)NC2=NC(=NC=C2C)NC=2C=C1CN(CC1=CC2)C(=O)OC(C)(C)C)=O Chemical compound O1C(NC2=C1C=CC(=C2)NC2=NC(=NC=C2C)NC=2C=C1CN(CC1=CC2)C(=O)OC(C)(C)C)=O LPIZLGWUKGXGOG-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- KZEITVNNSMBIIN-UHFFFAOYSA-N [5-[[2-(4-carbamoylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate Chemical compound N1=C(NC=2C=C3N(COP(O)(O)=O)C(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(N)=O)C=C1 KZEITVNNSMBIIN-UHFFFAOYSA-N 0.000 claims 1
- JTUBTEKGIDQZMZ-UHFFFAOYSA-N [5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate Chemical compound CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4N(COP(O)(O)=O)C(=O)OC4=CC=3)C(C)=CN=2)=C1 JTUBTEKGIDQZMZ-UHFFFAOYSA-N 0.000 claims 1
- DGFSIPIOGRXBJT-UHFFFAOYSA-N [5-[[2-[4-(cyclobutylcarbamoyl)anilino]-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate Chemical compound N1=C(NC=2C=C3N(COP(O)(O)=O)C(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCC1 DGFSIPIOGRXBJT-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000019417 choline salt Nutrition 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 229910052805 deuterium Inorganic materials 0.000 claims 1
- MWZKWMUSWDFDPE-UHFFFAOYSA-L disodium;[5-[[2-(3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound [Na+].[Na+].COC1=CC(C)=CC(NC=2N=C(NC=3C=C4N(COP([O-])([O-])=O)C(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 MWZKWMUSWDFDPE-UHFFFAOYSA-L 0.000 claims 1
- MWWMMPZUHSDYPB-UHFFFAOYSA-L disodium;[5-[[2-(4-carbamoylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound [Na+].[Na+].N1=C(NC=2C=C3N(COP([O-])([O-])=O)C(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(N)=O)C=C1 MWWMMPZUHSDYPB-UHFFFAOYSA-L 0.000 claims 1
- ZIEITLWJESBAKD-UHFFFAOYSA-L disodium;[5-[[2-[4-(cyclobutylcarbamoyl)anilino]-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound [Na+].[Na+].N1=C(NC=2C=C3N(COP([O-])([O-])=O)C(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCC1 ZIEITLWJESBAKD-UHFFFAOYSA-L 0.000 claims 1
- BLUKAULCDCYSAG-UHFFFAOYSA-N ditert-butyl [5-[[2-(4-carbamoylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound N1=C(NC=2C=C3N(COP(=O)(OC(C)(C)C)OC(C)(C)C)C(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C(N)=O)C=C1 BLUKAULCDCYSAG-UHFFFAOYSA-N 0.000 claims 1
- VRFQFBXPOACRCP-UHFFFAOYSA-N ditert-butyl [5-[[2-[4-(cyclobutylcarbamoyl)anilino]-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl phosphate Chemical compound N1=C(NC=2C=C3N(COP(=O)(OC(C)(C)C)OC(C)(C)C)C(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCC1 VRFQFBXPOACRCP-UHFFFAOYSA-N 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- OBUQQKCSPIZJPX-UHFFFAOYSA-N formic acid;5-[[2-(3-methoxy-4-pyridin-3-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C1=CC=CN=C1 OBUQQKCSPIZJPX-UHFFFAOYSA-N 0.000 claims 1
- YJHDLRIZVRWSPZ-UHFFFAOYSA-N formic acid;5-[[2-(3-methoxy-4-pyridin-4-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C1=CC=NC=C1 YJHDLRIZVRWSPZ-UHFFFAOYSA-N 0.000 claims 1
- KXCORTUFCJJYNC-UHFFFAOYSA-N formic acid;5-[[2-(4-methoxy-3-pyridin-3-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=C1C1=CC=CN=C1 KXCORTUFCJJYNC-UHFFFAOYSA-N 0.000 claims 1
- QFYHCQMJOMROIN-UHFFFAOYSA-N formic acid;5-[[2-(4-methoxy-3-pyridin-4-ylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)C=C1C1=CC=NC=C1 QFYHCQMJOMROIN-UHFFFAOYSA-N 0.000 claims 1
- QAQBJPAIHSJHGN-UHFFFAOYSA-N formic acid;5-[[5-methyl-2-(3-methyl-4-pyridin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C)=CC=C1C1=CC=CN=C1 QAQBJPAIHSJHGN-UHFFFAOYSA-N 0.000 claims 1
- JOGSWZWZZGGJIE-UHFFFAOYSA-N formic acid;5-[[5-methyl-2-(3-methyl-4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C)=CC=C1C1=CC=NC=C1 JOGSWZWZZGGJIE-UHFFFAOYSA-N 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- FRJPOLTVKMBIGK-UHFFFAOYSA-N methyl 2-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzoate Chemical compound C1=C(C)C(C(=O)OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 FRJPOLTVKMBIGK-UHFFFAOYSA-N 0.000 claims 1
- XJJBCOLRWBAMGZ-UHFFFAOYSA-N methyl 3-[3-methyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]-8-azabicyclo[3.2.1]octane-8-carboxylate Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CN=C(C(=C2)C)C2CC3CCC(C2)N3C(=O)OC)=C1 XJJBCOLRWBAMGZ-UHFFFAOYSA-N 0.000 claims 1
- HYGOWFLMHGEILA-UHFFFAOYSA-N methyl 4-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HYGOWFLMHGEILA-UHFFFAOYSA-N 0.000 claims 1
- ZIGORFUGHZOHGE-UHFFFAOYSA-N n,n-dimethyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZIGORFUGHZOHGE-UHFFFAOYSA-N 0.000 claims 1
- UIIAGWIMOVSYDR-UHFFFAOYSA-N n-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]acetamide Chemical compound C1C(NC(=O)C)CCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 UIIAGWIMOVSYDR-UHFFFAOYSA-N 0.000 claims 1
- WKKOQVVRBGIACX-UHFFFAOYSA-N n-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]cyclopropanecarboxamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N(C1)CCC1NC(=O)C1CC1 WKKOQVVRBGIACX-UHFFFAOYSA-N 0.000 claims 1
- CNDCKSHPBVFKID-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCCN(CC)CC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CNDCKSHPBVFKID-UHFFFAOYSA-N 0.000 claims 1
- ZRVYTBVQVANYDR-UHFFFAOYSA-N n-[2-[[2-(2,2-dimethylpropanoyl)-1,3-dihydroisoindol-5-yl]amino]-5-methylpyrimidin-4-yl]-n-[3-(2,2-dimethylpropanoyl)-2-oxo-1,3-benzoxazol-5-yl]-2,2-dimethylpropanamide Chemical compound C1=C2OC(=O)N(C(=O)C(C)(C)C)C2=CC(N(C(=O)C(C)(C)C)C2=NC(NC=3C=C4CN(CC4=CC=3)C(=O)C(C)(C)C)=NC=C2C)=C1 ZRVYTBVQVANYDR-UHFFFAOYSA-N 0.000 claims 1
- CRLTXQUPWANGRP-UHFFFAOYSA-N n-[4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-(trifluoromethyl)phenyl]acetamide Chemical compound C1=C(C(F)(F)F)C(NC(=O)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CRLTXQUPWANGRP-UHFFFAOYSA-N 0.000 claims 1
- PGZGGTHVZZRQGA-UHFFFAOYSA-N n-[5-[[5-methyl-4-[(3-methyl-2-oxo-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]methanesulfonamide Chemical compound N1=C(NC=2C=C3N(C)C(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(NS(C)(=O)=O)N=C1 PGZGGTHVZZRQGA-UHFFFAOYSA-N 0.000 claims 1
- BAJDZDKKWBKLCK-UHFFFAOYSA-N n-cyclobutyl-2-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C)=CC=C1C(=O)NC1CCC1 BAJDZDKKWBKLCK-UHFFFAOYSA-N 0.000 claims 1
- VRAFRQPUBUZYOV-UHFFFAOYSA-N n-cyclobutyl-3-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-5-(trifluoromethyl)benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C(C=1)C(F)(F)F)=CC=1C(=O)NC1CCC1 VRAFRQPUBUZYOV-UHFFFAOYSA-N 0.000 claims 1
- WSCCQDPQXRLRHG-UHFFFAOYSA-N n-cyclobutyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-(trifluoromethyl)benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C(F)(F)F)=CC=C1C(=O)NC1CCC1 WSCCQDPQXRLRHG-UHFFFAOYSA-N 0.000 claims 1
- YRNBGAHACCBHAY-UHFFFAOYSA-N n-cyclobutyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCC1 YRNBGAHACCBHAY-UHFFFAOYSA-N 0.000 claims 1
- MXYWEWQZFNKWGA-UHFFFAOYSA-N n-cyclobutyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide;formic acid Chemical compound OC=O.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCC1 MXYWEWQZFNKWGA-UHFFFAOYSA-N 0.000 claims 1
- ZUROZEVGKLRLEE-UHFFFAOYSA-N n-cyclobutyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridine-2-carboxamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1C(=O)NC1CCC1 ZUROZEVGKLRLEE-UHFFFAOYSA-N 0.000 claims 1
- LOPJPUZGWXRTPL-UHFFFAOYSA-N n-cyclopropyl-2-methoxy-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=CC=C1C(=O)NC1CC1 LOPJPUZGWXRTPL-UHFFFAOYSA-N 0.000 claims 1
- PLIBJUJTSHCRPH-UHFFFAOYSA-N n-cyclopropyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-(trifluoromethyl)benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1C(F)(F)F)=CC=C1C(=O)NC1CC1 PLIBJUJTSHCRPH-UHFFFAOYSA-N 0.000 claims 1
- MZHUDQNVEZBYHR-UHFFFAOYSA-N n-cyclopropyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CC1 MZHUDQNVEZBYHR-UHFFFAOYSA-N 0.000 claims 1
- RWVFVSITLJHJFM-UHFFFAOYSA-N n-cyclopropyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=C1)=CC=C1C(=O)NC1CC1 RWVFVSITLJHJFM-UHFFFAOYSA-N 0.000 claims 1
- YSKFIRHDBQKNLE-UHFFFAOYSA-N n-ethyl-2-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=C(C)C(C(=O)NCC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 YSKFIRHDBQKNLE-UHFFFAOYSA-N 0.000 claims 1
- ABOXPEKNTAUTTA-UHFFFAOYSA-N n-ethyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ABOXPEKNTAUTTA-UHFFFAOYSA-N 0.000 claims 1
- ZOZRTZXPJBINOA-UHFFFAOYSA-N n-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZOZRTZXPJBINOA-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 1
- QELDWMZDZWMAGM-UHFFFAOYSA-N tert-butyl 2-methyl-4-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)C(C)CN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 QELDWMZDZWMAGM-UHFFFAOYSA-N 0.000 claims 1
- RWAHYMDSYNWRPS-UHFFFAOYSA-N tert-butyl 3-[3-methyl-5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]-8-azabicyclo[3.2.1]octane-8-carboxylate Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C(C)C(C4CC5CCC(N5C(=O)OC(C)(C)C)C4)=NC=3)=NC=C2C)=C1 RWAHYMDSYNWRPS-UHFFFAOYSA-N 0.000 claims 1
- SAUUWMZIXAHQQD-UHFFFAOYSA-N tert-butyl 4-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperazine-1-carboxylate Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCN(C(=O)OC(C)(C)C)CC1 SAUUWMZIXAHQQD-UHFFFAOYSA-N 0.000 claims 1
- HCCLFAORGZOVIL-UHFFFAOYSA-N tert-butyl n-[1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]pyrrolidin-3-yl]carbamate Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCC(NC(=O)OC(C)(C)C)C1 HCCLFAORGZOVIL-UHFFFAOYSA-N 0.000 claims 1
- PEBWSSMLXHHNPP-HXUWFJFHSA-N tert-butyl n-methyl-n-[(3r)-1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperidin-3-yl]carbamate Chemical compound C1[C@H](N(C)C(=O)OC(C)(C)C)CCCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 PEBWSSMLXHHNPP-HXUWFJFHSA-N 0.000 claims 1
- PEBWSSMLXHHNPP-FQEVSTJZSA-N tert-butyl n-methyl-n-[(3s)-1-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperidin-3-yl]carbamate Chemical compound C1[C@@H](N(C)C(=O)OC(C)(C)C)CCCN1C(N=C1)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 PEBWSSMLXHHNPP-FQEVSTJZSA-N 0.000 claims 1
- GFFUHVDRUJOKES-UHFFFAOYSA-N trifluoromethyl 4-[5-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridin-2-yl]piperazine-1-carboxylate Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=N1)=CC=C1N1CCN(C(=O)OC(F)(F)F)CC1 GFFUHVDRUJOKES-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Dental Preparations (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Claims (19)
1. Spoj s formulom I:
[image]
ili njegova sol, naznačen time da:
X i Y su svaki neovisno O, S, S(O), SO2 ili NR1;
svaki R1 je neovisno za svaku pojavu H, proizvoljno supstituirani C1-6alkil, C(O)-C1-6alkil, CO2-C1-6alkil ili R50;
svaki R50 je C(R9)2-O-R10 ili C(R9)2-S-R10;
svaki R9 je neovisno za svaku pojavu H, proizvoljno supstituirani C1-6alkil, proizvoljno supstituirani C6-10aril ili proizvoljno supstituirani C7-16arilalkil; ili alternativno, dva R9, zajedno s ugljikom na koji su vezani, tvore proizvoljno supstituiranu C3-8cikloalkil skupinu ili proizvoljno supstituirani 3-8 člani heteroaliciklil; R10 je Ra ili -P(O)(OR11)2; svaki R11 je neovisno za svaku pojavu Ra ili jednovalentna kationska skupina; ili dva R11, zajedno s atomima na koje su oni vezani, tvore 4-8 članu cikličku fosfatnu skupinu, ili dva R11 zajedno predstavljaju dvovalentnu kationsku skupinu;
prsten A je C6-10aril ili 5-10 člani heteroaril;
svaki R2 je neovisno za svaku pojavu H, Re, Rb, Re supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -ORe supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -SRe supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -C(O)Re supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -N(Ra)Re gdje Re je supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -S(O)2Re supstituiran s jednim ili više istih ili različitih Ra i/ili Rb, -B(ORa)2, -B(N(Rc)2)2, -(C(Ra)2)m-Rb, -O-(C(Ra)2)m-Rb, -S-(C(Ra)2)m-Rb, -O-(C(Rb)2)m-Ra, -N(Ra)-(C(Ra)2)m-Rb, -O-(CH2)m-CH((CH2)mRb)Rb, -C(O)N(Ra)-(C(Ra)2)m-Rb, -O-(C(Ra)2)m-C(O)N(Ra)-(C(Ra)2)m-Rb,-N((C(Ra)2)mRb)2, -S-(C(Ra)2)m-C(O)N(Ra)-(C(Ra)2)m-Rb,-N(Ra)-C(O)-N(Ra)-(C(Ra)2)m-Rb, -N(Ra)-C(O)-(C(Ra)2)m-C(Ra)(Rb)2 ili -N(Ra)-(C(Ra)2)m-C(O)-N(Ra)-(C(Ra)2)m-Rb;
svaki Ra je neovisno za svaku pojavu H, deuterij, C1-6alkil, C3-8cikloalkil, C4-11cikloalkilalkil, C6-10aril, C7-16arilalkil, 2-6 člani heteroalkil, 3-10 člani heteroaliciklil, 4-11 člani heteroaliciklilalkil, 5-15 člani heteroaril ili 6-16 člani heteroarilalkil;
svaki Rb je neovisno za svaku pojavu =O, -ORa, -O-(C(Ra)2)m,-ORa, haloC1-3alkiloksi, =S, -SRa, =NRa, =NORa, -N(Rc)2, halo, -CF3, -CN, -NC, -OCN, -SCN, -NO, -NO2, =N2, -N3, -S(O)Ra, -S(O)2Ra, -SO3Ra, -S(O)N(Rc)2, -OS(O)Ra, -OS(O)2Ra, -OSO3Ra, -OS(O)2N(Rc)2, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -C(NRa)-N(Rc)2, -C(NOH)-Ra, -C(NOH)-N(Rc)2, -OC(O)Ra, -OC(O)ORa, -OC(O)N(Rc)2, -OC(NH)-N(Rc)2, -OC(NRa)-N(Rc)2, -[N(Ra)C(O)]nRa, -[N(Ra)C(O)]nORa, -[N(Ra)C(O)]nN(Rc)2 ili -[N(Ra)C(NRa)]n-N(Rc)2;
svaki Rc je neovisno za svaku pojavu Ra, ili, alternativno, dva Rc su uzeta zajedno s atomom dušika na koji su vezani tako da tvore 3 do 10-člani heteroaliciklil ili 5-10 člani heteroaril koji mogu proizvoljno uključivati jedan ili više istih ili različitih dodatnih heteroatoma i koji je proizvoljno supstituiran s jednom ili više jednakih ili različitih Ra i/ili Rd skupina;
svaki Rd je =O, -ORa, haloC1-3alkiloksi,C1-6alkil, =S, -SRa, =NRa, =NORa, -N(Ra)2, halo, -CF3, -CN, -NC, -OCN, -SCN, -NO, -NO2, =N2, -N3, -S(O)Ra, -S(O2)Ra, -SO3Ra, -S(O)N(Ra)2, -S(O)2N(Ra)2, -OS(O)Ra, -OS(O)2Ra, -OSO3Ra, -OS(O)2N(Ra)2, -C(O)Ra, -CO2Ra, -C(O)N(Ra)2, -C(NRa)N(Ra)2, -C(NOH)Ra, -C(NOH)N(Ra)2, -OCO2Ra, -OC(O)N(Ra)2, -OC(NRa)N(Ra)2, -[N(Ra)C(O)]nRa, -(C(Ra)2)n-ORa, -N(Ra)-S(O)2Ra, -C(O)-C1-6haloalkil, -S(O)2C1-6haloalkil, -OC(O)Ra, -O(C(Ra)2)m-ORa, -S(C(Ra)2)m-ORa, -N(Ra)C1-6haloalkil, -P(O)(ORa)2, -N(Ra)-(C(Ra)2)m-ORa, -[N(Ra)C(O)]nORa, -[N(Ra)C(O)]nN(Ra)2, -[N(Ra)C(NRa)]n(Ra)2 ili -N(Ra)C(O)C1-6haloalkil; ili dva Rd, zajedno s atomom ili atomima ugljika na koji su vezani, kombiniraju se tako da tvore 3-10 člani djelomično ili potpuno zasićen mono ili biciklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra;
svaki Re je neovisno za svaku pojavu C1-6alkil, C3-8cikloalkil, C4-11 cikloalkilalkil, C6-10aril, C7-16arilalkil, 2-6 člani heteroalkil, 3-10 člani heteroaliciklil, 4-11 člani heteroaliciklilalkil, 5-15 člani heteroaril ili 6-16 člani heteroarilalkil;
p je 0, 1, 2, 3 ili 4;
svaki m je 1, 2 ili 3;
svaki n je 0, 1,2 ili 3;
ili dvije R2 skupine, zajedno s atomom ili atomima ugljika na koji su vezani, kombiniraju se tako da tvore 4-10 člani djelomično ili potpuno zasićen mono ili biciklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra i/ili Rb;
Z1 i Z2 su svaki neovisno CH, CR2 ili N;
R3 je H, proizvoljno supstituirani C1-6alkil ili R50;
R4 je H, proizvoljno supstituirani C1-6alkil ili R50; i
R5 je halo, -CN, proizvoljno supstituirani C1-6alkil, alkinil, hidroksi, proizvoljno supstituirani C1-6alkoksi, nitro, -N(Ra)2, -C(O)N(Ra)2, -CO2Ra ili -C(O)Ra.
2. Spoj prema zahtjevu 1, prema formuli IA ili IB:
[image]
[image]
naznačen time da, u formuli IA:
X i Y su svaki neovisno O ili NR1;
svaki R1 je H, proizvoljno supstituiran C1-6alkil ili R50;
svaki od R2a, R2b, R2c i R2d je neovisno za svaku pojavu kako je definirano za R2; i R5 je halo, -CN, proizvoljno supstituiran C1-6alkil, nitro, -N(Ra)2, -C(O)N(Ra)2, -CO2Ra ili -C(O)Ra,
poželjno pri čemu jedan od X i Y je O i drugi je NR1; te
u formuli 1B:
Q1 i Q2 su svaki neovisno N ili CH pod uvjetom da barem jedan od Q1 i Q2 je N;
X i Y su svaki neovisno O ili NR1;
svaki R1 je neovisno za svaku pojavu H, proizvoljno supstituiran C1-6alkil ili R50;
p je 0, 1, 2 ili 3; i
R5 je halo, -CN, proizvoljno supstituiran C1-6alkil, nitro, -N(Ra)2, -C(O)N(Ra)2, -CO2Ra ili -C(O)Ra.
3. Spoj prema zahtjevu 2, prema formuli IA1 IA2, IB1, IB2 ili IB3:
[image]
[image]
[image]
[image]
[image]
naznačen time da u formulama IA1 i IA2 R2d je H; R5 je halo ili C1-6alkil; Z1 je CH, C-halo ili C-proizvoljno supstituiran C1-6alkil; i Z2 je CH;
i u formuli IB1, IB2, i IB3:
svaki od R2a, R2b,R2c i R2d je neovisno za svaku pojavu kako je definirano za R2.
4. Spoj formule IA1 ili IA2 prema zahtjevu 3, naznačen time da: R5 je F ili CH3, i svaki od R2a, R2b i R2cje proizvoljno neovisno za svaku pojavu C1-6alkil, -ORa, -OCF3, -SRa, -N(Rc)2, halo, -OCH2F,-OCF2H, -CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -(C(Ra)2)m-Rb, ili -[N(Ra)C(O)]nRa, poželjno pri čemu se primjenjuje jedna od slijedećih opcija (a) do (e):
(a) R2a, R2b i R2c su svaki neovisno C1-6alkil, -ORa, -OCF3, halo, -CF3 ili-CN;
(b) R2a je CH3; R2b je halo; i R2c je CH3;
(c) R2a je CH3; R2b je CH3; i R2c je halo;
(d) R2a je CH3; R2b je CH3; i R2c je CH3;
(e) R2b je H; i R5 je F ili CH3; i svaki od R2a i R2c je proizvoljno neovisno za svaku pojavu H, C1-6alkil, -ORa, -OCF3, -SRa, -N(Rc)2, halo, -OCF2H, -OCH2F,-CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -C(Ra)2-N(Rc)2 ili -[N(Ra)C(O)]nRa; i jedan od R2a i R2c nije H, poželjno H, C1-6alkil, -ORa, -OCF3, halo, -CF3, -C(Ra)2-N(Rc)2 ili -CN, poželjnije pri čemu R2a je -CF3 ili -CH3; i R2c je halo ili -CH3.
5. Spoj s formulom IA1 ili IA1 prema zahtjevu 2, naznačen time da:
(a) R2a je H, -CH3,-CF3,-ORa ili -OCF3; i R2c je -C(Ra)2-N(Rc)2; ili
(b) R2c je H; i R5 je F ili CH3; i pri čemu svaki od R2a i R2b je poželjno H, C1-6alkil, -ORa, -OCF2H, -OCF3, -OCH2F,-SRa, -N(Rc)2, halo, -CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -C(Ra)2-N(Rc)2 ili -[N(Ra)C(O)]nRa; i jedan od R2a i R2b poželjno nije H.
6. Spoj iz formule IA, IA1 ili IA2 prema zahtjevu 5 pri čemu se primjenjuje opcija (b), ili zahtjevu 2 ili 3, naznačen time da svaki od R2a i R2b je H, C1-6alkil, -ORa, -OCF3, halo, -N(Rc)2,-CF3, -C(Ra)2-N(Rc)2 ili -CN, i pri čemu se primjenjuje jedna od opcija (i), (ii) i (iii):
(i) R2b je -CF3 ili -CH3; i R2a je halo ili -CH3;
(ii) R2a je H, -CH3,-CF3,-ORa ili -OCF3; i R2b je -N(Rc)2 ili -C(Ra)2-N(Rc)2;
(iii) R2a je -N(Rc)2 ili -C(Ra)2-N(Rc)2; i R2b je H, -CH3,-CF3,-ORa ili -OCF3.
7. Spoj s formulom IA, IA1 ili IA2 prema zahtjevu 5, naznačen time da se primjenjuje opcija (b), ili zahtjevu 2, pri čemu R2a i R2b su uzeti zajedno s atomima ugljika na koje su vezani tako da tvore 4-10 člani djelomično ili potpuno zasićen mono ili biciklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra i/ili Rb; poželjno 5 člani djelomično ili potpuno zasićen monociklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra i/ili Rb; poželjnije s ciklopentan, pirolidin, imidazolidin, 1,3-dioksolan, oksazolidin ili tetrahidrofuran prstenom; proizvoljno supstituirani s jednim ili više Ra i/ili Rb.
8. Spoj prema zahtjevu 1 ili spoj s formulom IB1 ili IB2 prema zahtjevu 3, naznačen time da X i Y su svaki neovisno NR1, poželjno NH ili NC1-6alkil, poželjnije NH ili NCH3, te proizvoljno također pri čemu R5 je halo ili C1-6alkil; Z1 je C-H, C-halo ili C-proizvoljno supstituiran C1-6alkil; i Z2 je C, i poželjno također pri čemu R2c i R2d u formuli I ili R2a i R2d u formulama IB1 i IB2 su H; i R5 je F ili CH3; i poželjnije također pri čemu svaki od supstituenata R2a i R2b u formuli I ili supstituenti R2a i R2c u formulama IB 1 i IB2 su neovisno za svaku pojavu H, C1-6alkil, -ORa, -OCF3, -SRa, -N(Rc)2, halo, -OCF2H, -OCH2F,-CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, ili -[N(Ra)C(O)]nRa; i jedan od spomenutih supstituenata nije H, pri čemu:
(i) svaki od spomenutih supstituenata je poželjno neovisno za svaku pojavu H, -N(Rc)2, halo, -CF3, -CN, - -S(O)2Ra, -C(O)Ra, -CO2Ra, ili -C(O)N(Rc)2, poželjnije
(ii) pri čemu R2a u formuli I je H, halo ili cijano; i R2b u formuli I je halo, -CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, ili -C(O)N(Rc)2 ; još poželjnije
(iii) pri čemu R2a u formuli I je halo, -CF3, -CN, - -S(O)2Ra, -C(O)Ra, -CO2Ra, ili -C(O)N(Rc)2; i R2b u formuli I je H, halo ili cijano, još poželjnije
(iv) pri čemu spoj je prema formuli IA3
[image]
pri čemu Rb je OH, C1-6alkil, -CO2C1-6alkil, -C(O)C1-6alkil ili -S(O)2C1-6alkil;
i poželjno također pri čemu
(v) R2b u formulama IB1 i IB2 je H, halo, -CF3, -CN ili -CH3; i R2c je -N(Rc)2, -S(O)2Ra, -C(O)N(Rc)2 ili -C(Ra)2-N(Rc)2, ili
(vi) R2b u formuli IB2 je H, halo, -CF3, -CN ili -CH3; i R2c je -N(Rc)2 ili -C(Ra)2-N(Rc)2.
9. Spoj prema zahtjevu 8, naznačen time da se primjenjuje uvjet (i) i R2a i R2b u formuli I su uzeti zajedno s atomima ugljika na koje su vezani tako da tvore 6, 7 ili 8 člani djelomično ili potpuno zasićen monociklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra i/ili Rb, te je navedeni prsten poželjno cikloheksan, morfolin, piperidin, dioksan, oksatiazinan, cikloheptan, ciklohepten, azepan, tetrahidroazepin, diazepan, ciklooktan, ciklookten, azokan, heksahidroazocin, diazokan ili heksahidrodiazocin; proizvoljno supstituiran s jednim ili više Ra i/ili Rb.
10. Spoj s formulom IB1, IB2 ili IB3 prema zahtjevu 3 naznačen time da X je O i Y je NR1; i pri čemu R5 je proizvoljno halo ili C1-6alkil; Z1 je proizvoljno CH, C-Halo ili C-proizvoljno supstituiran C1-6alkil; i Z2 je proizvoljno CH, i poželjno također gdje R2a i R2d su H; i R5 je F ili CH3, te poželjnije također pri čemu
(i) svaki od R2b i R2cje neovisno za svaku pojavu H, C1-6alkil, -ORa, -OCF3, -SRa, -N(Rc)2, halo, -OCF2H, -OCH2F,-CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -C(Ra)2-N(Rc)2 ili -[N(Ra)C(O)]nRa; i jedan od R2b i R2c nije H,
(ii) svaki od R2b i R2c je neovisno za svaku pojavu H, C1-6alkil, -N(Rc)2, halo, -CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, ili -C(Ra)2-N(Rc)2, gdje
(a) R2b je poželjno H, halo, -CF3, -CN ili -CH3; i R2c je poželjno -N(Rc)2, -S(O)2Ra, -C(O)N(Rc)2 ili -C(Ra)2-N(Rc)2, ili pri čemu
(b) R2b je poželjno H, halo, -CF3, -CN ili -CH3; i R2c je poželjno -N(Rc)2 ili-C(Ra)2-N(Rc)2; ili
(iii) R2a i R2b su uzeti zajedno s atomima ugljika na koje su vezani tako da tvore 4-10 člani djelomično ili potpuno zasićen mono ili biciklički prsten, koji proizvoljno sadrži jedan ili više heteroatoma i proizvoljno supstituiran s jednim ili više Ra i/ili Rb, te je navedeni prsten poželjno ciklopentan, pirolidin, imidazolidin, 1,3-dioksolan, oksazolidin, tetrahidrofuran, cikloheksan, morfolin, piperidin, dioksan, oksatiazinan, piperazin, cikloheptan, ciklohepten, azepan, tetrahidroazepin, diazepan, ciklooktan, ciklookten, azokan, heksahidroazocin, diazokan ili heksahidrodiazocin prsten; proizvoljno supstituiran s jednim ili više Ra i/ili Rb.
11. Spoj prema zahtjevu 1, naznačen time da prsten A je indazol, benzoksazol, pirazolopiridin ili izoksozolopiridin; X je O; Y je NR1; R5 je halo ili C1-6alkil; Z1 je CH, C-Halo ili C-proizvoljno supstituiran C1-6alkil; Z2 je CH; i svaki R2 je neovisno za svaku pojavu H, C1-6alkil, -ORa, -OCF3, -SRa, -N(Rc)2, halo, -OCF2H, -OCH2F,-CF3, -CN, -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, -N(Ra)-S(O)2Ra ili -[N(Ra)C(O)]nRa; pri čemu spoj je poželjno prema formuli II:
[image]
pri čemu prsten B je ciklopentan, pirolidin, imidazolidin, 1,3-dioksolan, oksazolidin, tetrahidrofuran, cikloheksan, morfolin, piperidin, dioksan, oksatiazinan, piperazin, cikloheptan, ciklohepten, azepan, tetrahidroazepin, diazepan, ciklooktan, ciklookten, azokan, heksahidroazocin, diazokan ili heksahidrodiazocin; Ra je C1-6alkil; i svaki Rb je neovisno za svaku pojavu =O, -ORa, haloC1-3alkiloksi, -SRa, -N(Rc)2, halo, -CF3, -CN, - -S(O)2Ra, -C(O)Ra, -CO2Ra, -C(O)N(Rc)2, ili -C(Ra)2-N(RC)2; poželjnije pri čemu R1 je H ili R50; R50 je -CH2OP(O)(OR11)2; i svaki R11 je neovisno za svaku pojavu Ra ili jednovalentna kationska skupina; ili dva R11, zajedno s atomima na koje su oni vezani, tvore 4-8 članu cikličku fosfatnu skupinu, ili dva R11 zajedno predstavljaju dvovalentnu kationsku skupinu; najpoželjnije pri čemu svaki R11 je neovisno za svaku pojavu H, t-butil, HOCH2CH2N(CH3)3+, Na+, Li+ ili K+.
12. Spoj prema zahtjevu 5, naznačen time da se primjenjuje opcija (a) i ili
(i) jedan od R2a, R2b i R2c je:
[image]
[image]
proizvoljno supstituiran s jednom ili više istih ili različitih Ra i/ili Rb skupina; ili
(ii) jedan od R2a, R2b i R2c je -C(Ra)2-N(Rc)2, gdje -C(Ra)2-N(Rc)2 je:
[image]
[image]
[image]
proizvoljno supstituiran s jednom ili više istih ili različitih Ra i/ili Rb skupina;
poželjno pri čemu R1 je H ili R50; R50 je -CH2OP(O)(OR11)2; i svaki R11 je neovisno za svaku pojavu Ra ili jednovalentna kationska skupina; ili dva R11, zajedno s atomima na koje su oni vezani, tvore 4-8 članu cikličku fosfatnu skupinu, ili dva R11 zajedno predstavljaju dvovalentnu kationsku skupinu, poželjnije svaki R11 je neovisno za svaku pojavu H, t-butil, HOCH2CH2N(CH3)3+, Na+, Li+ ili K+.
13. Spoj prema zahtjevu 1, naznačen time da spoj je:
I-1 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-formilfenil)-5-metilpirimidin-2,4-diamin;
I-2 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-aminokarbonilfenil)-5-metilpirimidin-2,4-diamin;
I-3 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-aminokarbonilfenil)-5-metilpirimidin-2,4-diamin;
I-4 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-formilfenil)-5-metilpirimidin-2,4-diamin;
I-5 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-metil-4-(1,5,7-trimetil-3,7-diazabiciklo[3.3.1]nonan-3-il)fenil)-5-metilpirimidin-2,4-diamin;
I-6 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-fluoro-4-(1,5,7-trimetil-3,7-diazabiciklo[3.3.1]nonan-3-il)fenil)-5-metilpirimidin-2,4-diamin;
I-7 N4-(3-n-propilbenzo[d]oksazol-2(3H)-on-5-il)-N2-((3-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-9 N4-(3-izopropilbenzo[d]oksazol-2(3H)-on-5-il)-N2-((3-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-16 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-17 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-20 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-metilsulfonil)fenil)-5-fluoropirimidin-2,4-diamin;
I-21 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-metilsulfonil)fenil)-5-fluoropirimidin-2,4-diamin;
I-22 N4-(benzimidazolin-2-on-5-il)-N2-(3-metilsulfonil)fenil-5-metilpirimidin-2,4-diamin;
I-23 N4-(benzimidazolin-2-on-5-il)-N2-(4-metilsulfonil)fenil-5-fluoropirimidin-2,4-diamin;
I-26 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-cijanofenil)-5-metilpirimidin-2,4-diamin;
I-27 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-cijanofenil)-5-metilpirimidin-2,4-diamin;
I-28 N4-(benzimidazolin-2-on-5-il)-N2-(3-cijanofenil)-5-metilpirimidin-2,4-diamin;
I-29 N4-(benzimidazolin-2-on-5-il)-N2-(4-cijanofenil)-5-metilpirimidin-2,4-diamin;
I-33 N4-(3-fosforilmetilbenzo[d]oksazol-2(3H)-on-5-il)-N2-((3-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-36 N4-(1,3-dimetilbenzimidazolin-2-on-5-il)-N2-((3-metilsulfonil)fenil)-5-metilpirimidin-2,4-diamin;
I-41 N4-(1,3-dimetilbenzimidazolin-2-on-5-il)-N2-((3-metilsulfonil)fenil)-5-fluoropirimidin-2,4-diamin;
I-44 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-cijanofenil)-5-fluoropirimidin-2,4-diamin;
I-45 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-cijanofenil)-5-fluoropirimidin-2,4-diamin;
I-46 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((3-morfolinil)fenil)-5-metilpirimidin-2,4-diamin;
I-47 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((3-morfolinil)fenil)-5-fluoropirimidin-2,4-diamin;
I-48 N4-(benzo[d]oksazol-2(3H)-on-6-il)-N2-((3-morfolinil)fenil)-5-metilpirimidin-2,4-diamin;
I-49 N4-(3-metilbenzo[d]oksazol-2(3H)-on-6-il)-N2-((3-morfolinil)fenil)-5-metilpirimidin-2,4-diamin;
I-59 N2-((3-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-fluoropirimidin-2,4-diamin;
I-60 N2-(4-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-fluoropirimidin-2,4-diamin;
I-65 N2-((3-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-metilpirimidin-2,4-diamin;
I-66 N2-((4-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-metilpirimidin-2,4-diamin;
I-69 N2-((3-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-metilpirimidin-2,4-diamin;
I-70 N2-((4-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-metilpirimidin-2,4-diamin;
I-77 N2-((3-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-fluoropirimidin-2,4-diamin;
I-78 N2-((4-metilsulfonil)fenil)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-fluoropirimidin-2,4-diamin;
I-100 N2-((3-metilsulfonil)fenil)-N4-(2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-metilpirimidin-2,4-diamin;
I-101 N2-((4-metilsulfonil)fenil)-N4-(2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-metilpirimidin-2,4-diamin;
I-106 N4-(benzoksazolin-2-on-5-il)-N2-(3-trifluorometoksifenil)-5-metilpirimidin-2,4-diamintrifluoroacetatna sol;
I-107 N4-(benzoksazolin-2-on-5-il)-N2-(3-trifluorometoksifenil)-5-fluoropirimidin-2,4-diamin trifluoroacetatna sol;
I-108 N4-(benzoksazolin-2-on-5-il)-N2-(4-trifluorometoksifenil)-5-metilpirimidin-2,4-diamin trifluoroacetatna sol;
I-109 N4-(benzoksazolin-2-on-5-il)-N2-(4-trifluorometoksifenil)-5-fluoropirimidin-2,4-diamintrifluoroacetatna sol;
I-110 N4-(benzoksazolin-2-on-5-il)-N2-[3-trifluorometil-4-(4-etilpiperazin-1-il)fenil]-5-metilpirimidin-2,4-diamin;
I-111 N4-(benzoksazolin-2-on-5-il)-N2-[3-metil-4-(4-metilpiperazin-1-il)fenil]-5-metilpirimidin-2,4-diamin;
I-115 N4-(benzoksazolin-2-on-5-il)-N2-(3,4,5-trimetoksifenil)-5-fluoropirimidin-2,4-diamin;
I-116 N2-(3-(difluorometoksi)-4-metoksifenil)-N4-(benzo[d]oksazol-2(3H)-on-5-il)-5-metilpirimidin-2,4-diamin;
I-117 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-trifluorometilsulfonil)fenil-5-metilpirimidin-2,4-diamin;
I-118 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-trifluorometilsulfonil)fenil-5-metilpirimidin-2,4-diamin;
I-119 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3,4,5-trimetoksi)fenil-5-metilpirimidin-2,4-diamin;
I-120 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((4-(1,4-diazabiciklo[3.2.2]nonan-4-il)-3-metil)fenil)-5-metilpirimidin-2,4-diamin;
I-121 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-(8-metil-8-azabiciklo[3.2.1]oktan-3-ilamino)fenil)-5-metilpirimidin-2,4-diamin;
I-122 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((4-(dihidro-1H-pirido[1,2-a]pirazin-2(6H,7H,8H,9H,9aH)-il)-3-metil)fenil)-5-metilpirimidin-2,4-diamin;
I-123 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-(8-metil-2,8-diazabiciklo[3.2.1]oktan-2-il)fenil)-5-metilpirimidin-2,4-diamin;
I-124 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-5-metil-N2-[3-(morfolin-4-il)-4-trifluorometoksifenil]-2,4-pirimidindiamin;
I-125 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[3-trifluorometil-2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
I-126 4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzojeva kiselina;
I-127 N-(2-dietilamino-etil)-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-128 5-{2-[4-(3-dietilamino-pirolidin-1-karbonil)-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-129 5-[2-(4-Acetil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-130 5-[2-(3-Acetil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-131 2-metil-5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzonitril;
I-132 N,N-dimetil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-133 N-metil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-134 N-ciklopropil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid formijatna sol
I-135 4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-N-fenil-benzamid;
I-136 4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-2-pirolidin-1-il-benzamid;
I-137 N-etil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-138 sol N-ciklobutil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid formijatne kiseline;
I-139 N-izopropil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-140 N-ciklopropil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid formijatna sol;
I-141 2-kloro-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-142 sol N-ciklopropil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid trifluorooctene kiseline;
I-143 N-ciklopropil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-144 N-ciklobutil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-145 4-[5-metil-4-(2-okso-3-propionil-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-146 di-tert-butil (5-(2-(4-carbamoilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
I-147 (5-(2-(4-carbamoilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil dihidrogen fosfat;
I-148 natrijev (5-(2-(4-carbamoilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
I-150 (5-(2-(4-(ciklobutilcarbamoil)fenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil dihidrogen fosfat;
I-151 natrijev (5-(2-(4-(ciklobutilcarbamoil)fenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
I-152 di-tert-butil (5-(2-(4-(ciklobutilcarbamoil)fenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
I-153 5-[2-(4-kloro-3-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-154 5-[5-metil-2-(4-metil-3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-155 5-[5-metil-2-(4-metilsulfanil-3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-156 4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-2-(4-metil-piperidin-1-il)-benzamid;
I-157 5-[2-(3-ciklopentansulfonil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-158 5-[5-metil-2-(3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-159 metil ester 2-metil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzojeve kiseline;
I-160 5-[5-metil-2-(4-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-161 5-[5-metil-2-(4-trifluorometoksi-3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-162 5-[2-(3-fluoro-5-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on triflouroacetatna sol;
I-163 5-[2-(4-fluoro-3-trifluorometoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-164 sol 5-[5-metil-2-(4-metil-3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on trifluorooctene kiseline;
I-165 5-{2-[4-(2-metoksi-etoksi)-3-trifluorometil-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-166 5-[2-(4-izopropil-3-metil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-167 5-[2-(3-kloro-4-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-168 5-[2-(4-etoksi-3-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-169 5-[2-(3,5-bis-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-170 2-metil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzojeva kiselina;
I-171 N-etil-2-metil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-172 5-[2-(4-kloro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-173 5-[2-(3-kloro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-174 5-(5-metil-2-fenilamino-pirimidin-4-ilamino)-3H-benzooksazol-2-on;
I-175 5-[2-(3-bromo-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-176 5-[2-(4-kloro-2,5-dimetil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-177 N-{4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-2-trifluorometil-fenil}-acetamid;
I-178 5-[2-(3,4-dimetil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-179 5-[2-(4-cikloheksilmetoksi-3-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-180 5-[2-(4-kloro-3-trifluorometoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-181 5-[2-(4-kloro-3-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-182 5-[2-(4-kloro-3-etoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-183 5-[2-(4-fluoro-3-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-184 5-[2-(3,5-Dikloro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-185 5-[2-(3-bromo-5-kloro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-186 5-[2-(3-kloro-5-fluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-187 3-kloro-5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzonitril;
I-188 5-[2-(4-bromo-3-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-189 5-[2-(3-bromo-5-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-190 N-ciklobutil-2-metil-4-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-benzamid;
I-191 5-{2-[3-kloro-4-(2-morfolin-4-il-etoksi)-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-192 5-{5-metil-2-[4-(2-morfolin-4-il-etoksi)-fenilamino]-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-193 5-[2-(2,4-difluoro-5-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-194 5-[2-(3-kloro-4-etoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-195 5-[2-(4-ciklobutilmetoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-196 5-[2-(4-Izobutoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-197 5-{5-metil-2-[4-(3-metil-butoksi)-fenilamino]-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-198 sol 5-[2-(3-kloro-4-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on trifluorooctene kiseline;
I-199 5-[2-(3-fluoro-5-metil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-200 5-[2-(2,4-difluoro-3-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-201 5-(2-(4-(1-(azetidin-1-il)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-202 5-(2-(4-(1-(ciklopropilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-203 5-(5-metil-2-(4-(1-(pirolidin-1-il)etil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-204 5-(5-metil-2-(4-(1-morfolinoetil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-205 5-(2-(4-(1-(3-(dietilamino)pirolidin-1-il)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-206 5-(2-(4-(1-(benzilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-207 5-(2-(4-(1-(izopropilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-208 5-(5-metil-2-(3-(1-(propilamino)etil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-209 5-(2-(3-(1-(izopropilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-210 5-(2-(3-(1-(izopropilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-211 5-(2-(3-(1-(azetidin-1-il)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-212 5-(5-metil-2-(3-(1-(pirolidin-1-il)etil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-213 5-(2-(3-(1-(benzilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-214 5-(2-(3-(1-(3-(dietilamino)pirolidin-1-il)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-215 5-(5-metil-2-(3-(1-(piperidin-1-il)etil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-216 5-(2-(3-(1-(dietilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-217 5-(5-metil-2-(3-(1-morfolinoetil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-218 N-ciklobutil-4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-2-(trifluorometil)benzamid;
I-219 4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-N-fenil-2-(trifluorometil)benzamid;
I-220 N-ciklopropil-2-metoksi-4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)benzamid;
I-221 2-metoksi-4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-N-fenilbenzamid;
I-222 4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-2-(trifluorometil)benzojeva kiselina;
I-223 N-ciklopropil-4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-2-(trifluorometil)benzamid;
I-224 -(2-(3-izobutoksi-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-225 5-(2-(3-(ciklopropilmetoksi)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-226 5-(2-(3-ciklobutoksi-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-227 5-(2-(3-(ciklobutilmetoksi)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-228 5-(2-(3-deuteratedmetoksi-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
1-229 5-(2-(3-acetil-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-230 5-(2-(3-kloro-4-fluoro-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-231 5-(2-(3-(1-(izopropilamino)etil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-232 5-(2-(3-metoksi-5-(1-(propilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-233 5-(2-(3-(1-(ciklopropilamino)etil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-234 5-(2-(3-metoksi-5-(1-(pirolidin-1-il)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-235 5-(2-(3-(1-(azetidin-1-il)etil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
1-236 5-(2-(3-metoksi-5-(1-(metilamino)etil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-237 5-(2-(3-(difluorometil)-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-238 5-(2-(3-(fluorometil)-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-239 5-(5-metil-2-(4-metil-3-(metilsulfonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-240 5-(2-(3-fluoro-5-morfolinofenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-241 5-(2-(3-fluoro-5-(4-metilpiperazin-1-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-242 5-(2-(4-fluoro-3-(metilsulfonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-244 7-metil-5-(5-metil-2-(3-(metilsulfonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-245 5-(2-(4-fluoro-3-(metilsulfonil)fenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-246 5-(5-metil-2-(3-(pirolidin-1-karbonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-247 5-(5-metil-2-(4-(pirolidin-1-karbonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-249 7-fluoro-5-(5-metil-2-(3-(metilsulfonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-250 7-fluoro-5-(2-(4-fluoro-3-(metilsulfonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-251 7-fluoro-5-(2-(3-metoksi-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-252 3-metoksi-N,N-dimetil-5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)benzamid;
I-253 5-(2-(3-metoksi-5-(pirolidin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-254 5-(2-(3-metoksi-5-(morfolin-4-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-255 5-(2-(3-metoksi-5-(4-metilpiperazin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-256 5-(5-metil-2-(3-(morfolin-4-karbonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-257 5-(5-metil-2-(4-(morfolin-4-karbonil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-258 5-(2-(4-metoksi-3-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-259 5-(2-(3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-260 2-metoksi-N,N-dimetil-5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)benzamid;
I-261 5-(2-(4-metoksi-3-(pirolidin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-262 5-(2-(4-metoksi-3-(morfolin-4-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-263 5-(2-(4-metoksi-3-(4-metilpiperazin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-264 5-(2-(3-metil-4-trideuterometoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-265 5-(2-(3-kloro-4-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-266 5-(2-(3-metil-5-trideuterometoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-267 2-metoksi-N,N-dimetil-4-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)benzamid;
I-268 5-(2-(3-metoksi-4-(pirolidin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-269 5-(2-(3-metoksi-4-(morfolin-4-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-270 5-(2-(3-metoksi-4-(4-metilpiperazin-1-karbonil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-271 5-(2-(3-(difluorometil)-4-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-272 5-(2-(4-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-273 5-(2-(3-(difluorometil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-274 5-(2-(3-(fluorometil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-275 N2-[4-(4,4-difluoropiperidinil)-3-fluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-276 N2-[4-(4,4-difluoropiperidinil)-3-trifluorometil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-277 N2-[3-kloro-4-(4,4-difluoropiperidinil)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-278 N2-[3-kloro-4-(4-etilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-279 N2-[4-(4,4-difluoropiperidinil)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-280 N2-(3,5-dimetoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-281 N2-[3-fluoro-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-282 N2-[3,5-difluoro-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-283 N2-[4-kloro-3-(4-etilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-284 N2-[4-kloro-3-(3,4,5-trimetilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-285 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[3-(4-propilpiperazino)-4-trifluorometil]fenil-2,4-pirimidindiamin;
I-286 5-metil-N2-[3-(1,3-oksazol-5-il)]fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-287 N2-(3-bromo)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-288 N2-(4-bromo)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-289 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[3-(piridin-4-il)]fenil-2,4-pirimidindiamin;
I-290 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[3-(piridin-3-il)]fenil-2,4-pirimidindiamin;
I-291 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[4-(piridin-3-il)]fenil-2,4-pirimidindiamin;
I-292 N2-[4-metoksi-3-(2-metoksietoksi)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-293 N2-[3-(ciklopropilaminokarbonilmetoksi)-4-metoksi]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-294 N2-(3-cijano-4-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-295 N2-[3-cijano-4-(1H-pirol-1-il)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-296 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-297 N2-(4-metoksi-3-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-298 N2-{4-metoksi-3-[(piridin-4-il)metoksi]}fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-299 N2-{4-metoksi-3-[(piridin-3-il)metoksi]}fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-300 N2-{4-metoksi-3-[2-(dimetilamino)etoksi]}fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-301 N2-[3,5-bis(trifluorometil)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-302 N2-(3,5-dimetil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-303 N2-(4-cijano-3-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-304 N2-[3-(1-hidroksi-2,2,2-trifluoroetil)]fenil-5-metil-N4-(2-okso-2,3-dihidro1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-305 N2-(3-metoksikarbonilmetoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-306 5-metil-N2-(3-metilaminokarbonilmetoksi)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-307 N2-(4-aminokarbonilmetoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-308 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-(4-fenilkarbonilamino)fenil-2,4-pirimidindiamin;
I-309 N2-[4-(N-acetil-N-metil)amino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-310 N2-[3-cijano-4-(pirolidin-1-il)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-311 N2-(4-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-312 N2-(3-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-313 N2-(4-difluorometoksi-3-etoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-314 N2-(3-kloro-4-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-315 N2-[3-(ciklopropilaminokarbonilmetoksi)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-316 N2-[3-aminokarbonil-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-317 N2-[4-(izopropoksikarbonilmetoksi)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-318 N2-[4-(etilaminokarbonilamino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-319 N2-[3-(aminokarbonilmetoksi)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-320 5-metil-N2-[3-(morfolinokarbonilmetoksi)]fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-321 5-metil-N2-[3-(4-metilpiperazin-1-il)karbonil]fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-322 5-metil-N2-[4-(4-metilpiperazin-1-il)karbonil]fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-323 5-metil-N2-[3-metilaminokarbonil-4-(4-metilpiperazino)]fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-324 N2-[4-(1-aminokarbonil-1-metil)etoksi]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-325 5-metil-N2-(2-metil-3-metilaminokarbonilmetoksi)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-326 N2-(3-dimetilaminokarbonilmetoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-327 N2-(3-cijano-4-morfolino)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-328 N2-(3-metoksi-2-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-329 N2-[3-kloro-4-(piridin-4-il)]fenil 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-330 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[4-(piridin-4-il)-3-trifluorometil]fenil-2,4-pirimidindiamin;
I-331 N2-[3-hidroksimetil-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-332 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-(4-piperazino)fenil-2,4-pirimidindiamin;
I-333 N2-[4-(4-etilaminokarbonil)piperazino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-334 N2-[4-(1-cijano-1-metil)etoksi]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-335 N2-[3-(1-aminokarbonil-1-metil)etoksi]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-336 N2-(3-metoksi-4-metoksikarbonil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-337 N2-(3-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-338 5-metil-N2-(4-morfolino)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-339 N2-(3-cijano-4-tiomorfolino)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-340 N2-[3-metoksi-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-341 N2-[3-cijano-4-(4-metilpiperazino)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-342 N2-[3-(1-cijano-1-metil)etoksi]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-343 N2-[4-(4-acetil)piperazino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-344 N2-[4-(4-etoksikarbonil)piperazino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-345 N2-[3-(4-acetil)piperazino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-346 N2-[3-(4-etoksikarbonil)piperazino]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-347 N2-(4-difluorometoksi-3-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-348 N2-(3,5-dikloro-4-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-349 N2-(4-fluoro-3-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-350 N2-(3-fluoro-4-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-351 N2-(3-metoksi-4-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-352 N2-(3-fluoro-5-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-353 N2-(3-difluorometoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-354 N2-(3-metoksi-4-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-355 N2-(3,5-di-tert-butil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-356 N4-{3-[bis(1,1-dimetiletoksi)]fosfiniloksimetil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il}-N2-(3-metoksi-5-trifluorometil)fenil-5-metil-2,4-pirimidindiamin;
I-357 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-2,4-pirimidindiamin;
I-358 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-2,4-pirimidindiamin bis-natrijeva sol;
I-359 N2-(3,5-difluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-360 N2-(3-fluoro-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-361 N2-(4-fluoro-3-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-362 N2-(4-fluoro-3-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-363 N2-(3-fluoro-4-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-364 N2-(3-kloro-4-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-366 N2-(3-kloro-4-trifluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-367 N2-(4-trifluorometiltio)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-368 N2-(3-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-369 N2-(3,5-dimetil-4-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-370 N2-(3-karboksamid-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-371 N2-(3,5-diizopropil-4-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-372 N2-(3-izopropoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-373 N2-(3-cijano-4-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-374 N2-(3,5-dimetil-4-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-375 N2-(4-fluoro-3-trifluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-376 N2-(3-fluoro-4-trifluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-377 N2-(4-kloro-3-trifluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-378 N2-(3-kloro-5-trifluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-379 5-metil-N2-(3-metil-5-trifluorometoksi)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-380 N2-(4-cijano-3-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-381 N2-(3,5-difluoro-4-metoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-382 5-metil-N2-(4-morfolinometil)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-383 N2-(4-kloro-3-cijano-5-etil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-384 N2-[3-(2-metoksi)etoksi-5-trifluorometil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-385 N2-(4-difluorometoksi-3,5-dimetil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-386 N2-[3-(1-aminokarbonil-1-metil)etoksi-4-fluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-387 N2-(4-difluorometoksi-3-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-388 N2-(3,5-difluoro-4-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-389 N2-[4-(1-aminokarbonil-1-metil)etoksi-3,5-dimetil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-390 N2-(3-difluorometoksi-4-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-391 N2-[4-(1-aminokarbonil-1-metil)etoksi-3-metil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-392 N2-[3-(1-aminokarbonil-1-metil)etoksi-4-metil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-393 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin besilatna sol;
I-394 N2-(4-kloro-3,5-dimetil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-395 N2-[4-(1-aminokarbonil-1-metil)etoksi-3,5-difluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-396 N2-[3-(1-metoksi-2,2,2-trifluoroetil)]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-397 N2-[3-(1-cijano-1-metil)etoksi-4-metil]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-398 N2-(3,4-difluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-399 N2-(3-kloro-4-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-400 N2-(4-kloro-3-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-401 N2-(3-difluorometoksi-5-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-402 N2-[3-(1-aminokarbonil-1-metil)etoksi-5-fluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-403 5-(5-metil-2-m-tolilamino-pirimidin-4-ilamino)-3H-benzooksazol-2-on;
I-404 5-{2-[4-(3-dimetilamino-propoksi)-3-trifluorometil-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-405 N4-{3-[bis(1,1-dimetiletoksi)]fosfiniloksimetil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il}-N2-(3,4,5-trimetil)fenil-5-metil-2,4-pirimidindiamin;
I-406 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin;
I-407 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin bis-natrijeva sol;
I-408 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-(3,4,5-trifluoro)fenil-2,4-pirimidindiamin;
I-409 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin tozilatna sol;
I-410 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin mezilatna sol;
I-411 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin sulfatna sol;
I-412 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin klorovodična sol;
I-413 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin natrijeva sol;
I-414 N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin kolin sol;
I-415 N2-(3,5-difluoro-4-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-416 N2-[3-(1-cijano-1-metil)etoksi-5-fluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-417 N2-[3-(1-cijano-1-metil)etoksi-4-fluoro]fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-418 N2-(4-kloro-3-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-419 5-(2-(4-izopropilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-420 5-(2-(4-tert-butilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-421 5-(2-(p-toluidino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-422 5-(2-(3-(izopropoksimetil)-4-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-423 5-(2-(3-(1-hidroksietil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-424 5-[2-(3-kloro-4-hidroksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-425 5-[2-(4-hidroksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-426 5-{2-[4-(2-dimetilamino-etoksi)-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-427 5-(2-(3-metoksi-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-428 5-(2-(3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-429 5-(2-(4-metoksi-3-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-430 7-fluoro-5-(2-(3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-431 7-fluoro-5-(2-(4-metoksi-3-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-432 5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-433 5-(2-(4-(difluorometoksi)-3-(fluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-434 N2-(4-cijano-3-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-435 N2-(3-difluorometoksi-4-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-436 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin natrijeva sol;
I-437 N2-(3,5-dimetil-4-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin natrijeva sol;
I-438 5-(2-(3-(difluorometil)-4-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-439 5-(2-(3-(fluorometil)-4-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-440 5-(2-(3-(difluorometil)-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-441 5-(2-(4-d3-metoksi-3-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-442 5-(2-(4-(difluorometoksi)-3-(difluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-443 5-(5-metil-2-(4-metil-3-(piridin-4-il)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-444 5-(5-metil-2-(4-metil-3-(piridin-3-il)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-445 5-(2-(3-acetil-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-446 5-(2-(3-(1-hidroksietil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-447 5-[2-(4-d3-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-448 5-[2-(3-kloro-4-d3-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-449 5-{2-[4-(2-dietilamino-etoksi)-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-450 N4-{3-[bis(1,1-dimetiletoksi)]fosfiniloksimetil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il}-N2-(3,5-dimetil-4-fluoro)fenil-5-metil-2,4-pirimidindiamin;
I-451 N2-(3,5-dimetil-4-fluoro)fenil-5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-2,4-pirimidindiamin bis-natrijeva sol;
I-452 5-(2-(3,4-dimetoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-453 5-(2-(3,4-dimetoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-454 5-(2-(3,4-dimetoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-fluorobenzo[d]oksazol-2(3H)-on;
I-455 5-{2-[3-kloro-4-(2-dietilamino-etoksi)-fenilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
I-456 5-[2-(2,4-difluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-457 5-(5-metil-2-(3-(1-(metilamino)etil)-5-(trifluorometil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-458 5-(2-(3-kloro-4,5-dimetoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-459 5-(2-(3,5-dimetil-4-(2-morfolinoetoksi)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-460 5-(5-metil-2-(3-(1-(metilamino)butil)-5-(trifluorometil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-461 5-(2-(3-(1-(ciklopropilamino)etil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-462 5-(2-(3-(1-(etilamino)etil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-463 5-(5-metil-2-(3-(1-(pirolidin-1-il)etil)-5-(trifluorometil)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-464 5-(2-(3-(1-(azetidin-1-il)etil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-465 5-(2-(3-(1-(ciklobutilamino)etil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-466 5-[2-(2,5-difluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-467 5-[2-(2,3-difluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-468 5-[2-(2-fluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-469 N-ciklobutil-3-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-5-trifluorometil-benzamid;
I-470 5-[2-(4-fluoro-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-471 5-(2-(4-fluoro-3-(piridin-4-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-472 5-(2-(4-fluoro-3-(piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-473 5-(2-(3-(1-(izopropilamino)etil)-5-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-474 5-(2-(3,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-475 7-metil-5-(5-metil-2-(3,4,5-trimetilfenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-476 5-(2-(4-fluoro-3,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-477 5-[5-metil-2-(2,3,4,5-tetrafluoro-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-478 N2-(3-cijano-5-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-479 5-metil-N2-(3-metil-5-trifluorometil)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-480 5-[5-metil-2-(2,3,5-trifluoro-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-481 5-[5-metil-2-(2,4,5-trifluoro-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-482 5-(5-metil-2-(3-metil-4-(piridin-4-il)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-483 5-(5-metil-2-(3-metil-4-(piridin-3-il)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-484 5-(2-(3-fluoro-4-(piridin-4-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-485 N2-(3,4-dimetoksi-5-trifluorometil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-486 5-(2-(4-metoksi-3-(piridin-4-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-487 5-(2-(4-metoksi-3-(piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-488 5-(2-(3,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)-7-fluorobenzo[d]oksazol-2(3H)-on;
I-489 7-fluoro-5-(5-metil-2-(3,4,5-trimetilfenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-490 7-fluoro-5-(2-(4-fluoro-3,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-491 5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-492 7-fluoro-5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-493 N2-(3,4-dimetil-2-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-494 5-(2-(3-metoksi-4-(piridin-4-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-495 N2-(3-kloro-5-difluorometoksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-496 5-[2-(3-kloro-4-metoksi-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-497 5-[2-(3-kloro-5-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-498 5-[2-(2-metoksi-5-trifluorometil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-499 5-(2-(o-toluidino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-500 5-(2-(2,3-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-501 5-(2-(2,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-502 5-(2-(2-etilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-503 5-(2-(3-etilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-504 5-(2-(4-etilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-505 sol 5-(2-(3-fluoro-4-(piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on trifluorooctene kiseline;
I-506 5-(2-(3-metoksi-4-(piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on formijatna sol;
I-507 5-(2-(2,4-difluoro-3-metoksifenilamino)-5-metilpirimidin-4-ilamino)-7-metilbenzo[d]oksazol-2(3H)-on;
I-508 5-(2-(2,4-difluoro-3-metoksifenilamino)-5-metilpirimidin-4-ilamino)-7-fluorobenzo[d]oksazol-2(3H)-on;
I-509 5-(2-(4-(6-kloropiridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on trifluoroacetatna sol;
I-510 5-(2-(4-(6-(3-(dimetilamino)propoksi)piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on trifluoroacetatna sol;
I-511 5-(2-(4-(6-(3-(dimetilamino)propoksi)piridin-3-il)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on trifluoroacetatna sol;
I-512 5-(5-metil-2-(4-(6-morfolinopiridin-3-il)fenilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on trifluoroacetatna sol;
I-513 5-(2-(2-fluoro-3-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-514 5-(2-(2-fluoro-4-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-515 5-(2-(2-fluoro-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-516 N2-(3-difluorometoksi-5-metil)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-517 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin kalcijeva sol;
I-518 5-[5-metil-2-(2-metil-3-trifluorometil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-519 5-(2-(5-acetil-2-fluorofenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-520 5-(2-(2-klorofenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-521 5-(2-(2-kloro-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-522 N4-(7-kloro-2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-5-metil-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin;
I-523 5-(2-(2-fluoro-5-(1-hidroksietil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-524 N4-{3-[bis(1,1-dimetiletoksi)]fosfiniloksimetil-7-kloro-2-okso-2,3-dihidro-1,3-benzoksazol-5-il}-N2-(3,4,5-trimetil)fenil-5-metil-2,4-pirimidindiamin;
I-525 N4-[7-kloro-3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-5-metil-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin;
I-526 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin magnezijeva sol;
I-527 5-[2-(4-jodo-3,5-dimetil-fenilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
I-528 N4-[7-kloro-3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-5-metil-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin bis-natrijeva sol;
I-529 5-(2-(3,5-dimetoksi-4-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-530 5-(2-(2-fluoro-4,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-531 sol 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin bis-kolina;
I-532 5-(2-(2-fluoro-4-metil-3-(trifluorometil)fenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-533 5-(2-(2-fluoro-5-metoksifenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-534 5-(2-(2-fluoro-3,4,5-trimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-535 5-(2-(3-metoksi-4,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
I-536 natrijev (5-(2-(3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-7-metil-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
I-537 N2-(3,4-dimetil-5-fluoro)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
I-538 natrijev (5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat;
II-1 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-dimetilaminopiridin-3-il)-5-metilpirimidin-2,4-diamin;
II-2 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-((1S,4R)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)-piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-3 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-metil-1,4-diazepan-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-4 N4-(3-n-propilbenzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-metilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-5 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-tert-butiloksikarbonilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-6 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-metilpiperidin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-7 N2-(6-(4-metilpiperazin-1-il)piridin-3-il)-N4-(3-izopropilbenzo[d]oksazol-2(3H)-on-5-il)-5-metilpirimidin-2,4-diamin;
II-8 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-trifluorometoksikarbonilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-9 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-metoksikarbonilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-10 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(piperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-11 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(3-metil-4-tert-butoksikarbonilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-12 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(3-metilpiperazin-1-il)piridin-3-il)-5-metilpirimidin-2,4-diamin;
II-13 N4-(benzoksazolin-2-on-5-il)-N2-[2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-14 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(4-metilpiperazin-1-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-15 N4-(benzimidazolin-2-on-5-il)-N2-[2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-16 N4-(benzimidazolin-2-on-5-il)-N2-[2-(4-metilpiperazin-1-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-17 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((2-morfolinil)piridin-5-il)-5-metilpirimidin-2,4-diamin;
II-18 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-((2-morfolinil)piridin-5-il)-5-fluoropirimidin-2,4-diamin;
II-19 N4-(benzimidazolin-2-on-5-il)-N2-((2-morfolinil)piridin-5-il)-5-fluoropirimidin-2,4-diamin;
II-20 N4-(1,3-dimetilbenzimidazolin-2-on-5-il)-N2-[2-(4-metilpiperazino)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-21 N4-(1,3-dimetilbenzimidazolin-2-on-5-il)-N2-[2-(4-metilpiperazino)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-22 N2-(6-(4-metilpiperazin-1-il)piridin-3-il)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-metilpirimidin-2,4-diamin;
II-23 N2-(6-(4-metilpiperazin-1-il)piridin-3-il)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-6-il)-5-metilpirimidin-2,4-diamin trifluoroacetatna sol;
II-24 N2-(6-(4-metilpiperazin-1-il)piridin-3-il)-N4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-il)-5-fluoropirimidin-2,4-diamin;
II-25 6-(5-metil-2-(6-(4-metilpiperazin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-26 N4-(benzoksazolin-2-on-5-il)-N2-[3-metil-2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-27 N4-(benzimidazolin-2-on-5-il)-N2-[3-metil-2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-28 N4-(benzoksazolin-2-on-5-il)-N2-[3-metil-2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-29 N4-(benzoksazolin-2-on-5-il)-N2-[3-metil-2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-30 N4-(benzoksazolin-2-on-5-il)-N2-[3-metil-2-(4-metilpiperazin-1-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-31 N4-(benzoksazolin-2-on-5-il)-N2-[2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-32 N4-(benzoksazolin-2-on-5-il)-N2-[2-((1S,4S)-2-oksa-5-azabiciklo[2.2.1]heptan-5-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-33 N4-(benzoksazolin-2-on-5-il)-N2-[2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-34 N4-(benzoksazolin-2-on-5-il)-N2-[2-((1S,4S)-2-oksa-5-azabiciklo[2.2.1]heptan-5-il)piridin-5-il]-5-fluoropirimidin-2,4-diamin;
II-35 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(1-metilpiperidin-4-il)aminopiridin-5-il]-5-metilpirimidin-2,4-diamin;
II-36 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(1H-piperidin-4-il)aminopiridin-5-il]-5-metilpirimidin-2,4-diamin;
II-37 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(8-metil-8-aza-biciklo[3.2.1]oct-3-il)aminopiridin-5-il]-5-metilpirimidin-2,4-diamin;
II-38 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(4-(8-metil-2,8-diazabiciklo [3.2.1]oktan-2-il)fenil)-5-metilpirimidin-2,4-diamin;
II-39 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[3-trifluorometil-2-(4-metilpiperazin-1-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-40 N4-(benzoksazolin-2-on-5-il)-N2-[3-fluoro-2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-metilpirimidin-2,4-diamin;
II-41 tert-butil ester (S)-2-metil-4-{5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-piridin-2-il}-piperazin-1-karboksilne kiseline;
II-42 5-[5-metil-2-(piridin-3-ilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
II-43 5-[2-(6-Metansulfonil-piridin-3-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
II-44 5- {5-metil-2-[6-((S)-3-metil-piperazin-1-il)-piridin-3-ilamino]-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-45 5-{5-metil-2-[6-(piperazin-1-karbonil)-piridin-3-ilamino]-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-46 5-{2-[6-(4-ciklopropilmetil-piperazin-1-karbonil)-piridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-47 5-{2-[6-(4-izobutil-piperazin-1-karbonil)-piridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-48 tert-butil ester 5-{3-fluoro-5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-piridin-2-il}-heksahidro-pirolo[3,4-c]pirol-2-karboksilne kiseline;
II-49 tert-butil ester 5-{3-fluoro-5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-piridin-2-il}-2,5-diaza-biciklo[2.2.1]heptan-2-karboksilne kiseline;
II-50 5-{2-[5-fluoro-6-(heksahidro-pirolo[3,4-c]pirol-2-il)-piridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-51 5-{2-[6-(2,5-diaza-biciklo[2.2.1]hept-2-il)-5-fluoro-piridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-52 5-{2-[6-(5-ciklopropilmetil-heksahidro-pirolo[3,4-c]pirol-2-il)-5-fluoropiridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-53 5-{2-[6-(5-ciklopropankarbonil-heksahidro-pirolo[3,4-c]pirol-2-il)-5-fluoropiridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-54 5-{2-[6-(5-ciklopropilmetil-2,5-diaza-biciklo[2.2.1]hept-2-il)-5-fluoro-piridin-3-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
II-55 (R)-5-(2-(6-(3,4-dimetilpiperazin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-56 (R)-5-(2-(6-(4-(ciklopropilmetil)-3-metilpiperazin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo [d] oksazol-2(3H)-on;
II-57 (R)-5-(5-metil-2-(6-(3-metil-4-(2,2,2-trifluoroacetil)piperazin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-58 (R)-dietil2-metil-4-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)piperazin-1-ilfosfonat;
II-59 5-(2-(6-(4,4-difluoropiperidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-60 5-(2-(6-(4,4-dimetilpiperidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-61 5-(2-(6-(3,8-diaza-biciklo[3.2.1]oktan-3-il)-5-metilpiridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-62 5-(5-metil-2-(5-metil-6-(8-acetil)-3,8-diaza-biciklo[3.2.1]oktan-3-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-63 5-(5-metil-2-(5-metil-6-(8-(2,2,2-trifluoroacetil)-3,8-diaza-biciklo[3.2.1]oktan-3-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-64 5-(5-metil-2-(5-metil-6-(8-metil-3,8-diaza-biciklo[3.2.1]oktan-3-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-65 tert-butil3-(3-metil-5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)-8-azabiciklo[3.2.1]oktan-8-karboksilat;
II-66 5-(2-(6-(8-aza-biciklo[3.2.1]oktan-3-il)-5-metilpiridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-67 5-(2-(6-(8-(ciklopropilmetil)-8-aza-biciklo[3.2.1]oktan-3-il)-5-metilpiridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-68 metil 3-(3-metil-5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)-8-azabiciklo[3.2.1]oktan-8-karboksilat;
II-69 5-(5-metil-2-(5-metil-6-(8-(2,2,2-trifluoroacetil)-8-aza-biciklo[3.2.1]oktan-3-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-70 (R)-5-(2-(6-(4-izopropil-3-metilpiperazin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-71 5-(5-metil-2-(6-(pirolidin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-72 7-metil-5-(5-metil-2-(6-(4-metilpiperazin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-73 7-metil-5-(5-metil-2-(6-morfolinopiridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-74 5-(2-(6-(ciklopropilmetilamino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-75 7-fluoro-5-(5-metil-2-(6-(4-metilpiperazin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-76 7-fluoro-5-(5-metil-2-(6-morfolinopiridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-77 5-(2-(5-bromopiridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-79 N-(5-(5-metil-4-(3-metil-2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)metansulfonamid;
II-80 5-(2-(6-(3-(dimetilamino)pirolidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-81 N-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)acetamid;
II-82 5-(2-(6-(3-(dietilamino)pirolidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-83 2,2,2-trifluoro-N-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)acetamid;
II-84 5-(5-metil-2-(6-(3-morfolinopirolidin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-85 5-(2-(6-(4-metilpiperazin-1-il)piridin-3-ilamino)-5-(trifluorometil)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-86 tert-butil 1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-ilkarbamat;
II-87 (S)-tert-butil metil(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)piperidin-3-il)karbamat;
II-88 (R)-5-(5-metil-2-(6-(3-(metilamino)piperidin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-89 (R)-5-(2-(6-(3-(dimetilamino)pirolidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-90 (S)-5-(2-(6-(3-(dimetilamino)pirolidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-91 (R)-tert-butil metil(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)piperidin-3-il)karbamat;
II-92 (R)-5-(5-metil-2-(6-(3-(metilamino)piperidin-1-il)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-94 5-(2-(6-(3-(ciklopropilmetilamino)pirolidin-1-il)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-95 (5)-5-(2-(6-((1-benzilpiperidin-3-il)(metil)amino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-96 1-etil-3-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)urea;
II-97 1-tert-butil-3-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)urea;
II-98 1-benzil-3-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)urea;
II-99 (S)-5-(2-(6-(1-benzilpiperidin-3-ilamino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-100 (S)-5-(2-(6-((1-benzilpiperidin-3-il)(metil)amino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-101 N-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)ciklopropankarboksamid;
II-102 N-(1-(5-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)piridin-2-il)pirolidin-3-il)pivalamid;
II-103 (S)-5-(5-metil-2-(6-(metil(piperidin-3-il)amino)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-104 (S)-5-(5-metil-2-(6-(piperidin-3-ilamino)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-105 (S)-5-(2-(6-(1-benzilpiperidin-3-ilamino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-106 (R)-5-(2-(6-((1-benzilpiperidin-3-il)(metil)amino)piridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-107 (R)-5-(5-metil-2-(6-(piperidin-3-ilamino)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-108 (R)-5-(5-metil-2-(6-(metil(piperidin-3-il)amino)piridin-3-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-109 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-5-metil-N2-[2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)-3-trifluorometilpiridin-5-il]-2,4-pirimidindiamin;
II-110 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[2-(4-etilpiperazin-1-il)-3-trifluorometilpiridin-5-il]-5-metil-2,4-pirimidindiamin;
II-111 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[3-fluoro-2-(4-metilpiperazin-1-il)piridin-5-il]-5-metil-2,4-pirimidindiamin;
II-112 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-{2-[(8S)-1,4-diazabiciklo[4.3.0]nonan-1-il]-3-fluoropiridin-5-il}-5-metil-2,4-pirimidindiamin;
II-113 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-12-[(8R)-1,4-diazabiciklo[4.3.0]nonan-1-il]-3-fluoropiridin-5-il}-5-metil-2,4-pirimidindiamin;
II-114 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[2-(4-etilpiperazin-1-il)-3-fluoropiridin-5-il]-5-metil-2,4-pirimidindiamin;
II-115 N4-(benzo[d]oksazolin-2(3H)-on-5-il)-N2-[3-cijano-2-((1S,4S)-5-metil-2,5-diazabiciklo[2.2.1]heptan-2-il)piridin-5-il]-5-metil-2,4-pirimidindiamme;
II-116 N2-[3-kloro-2-(4-metilpiperazino)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-117 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[2-(1,3,5-trimetil-3,7-diazabiciklo[3.3.1]nonan-7-il)piridin-5-il]-2,4-pirimidindiamin;
II-118 N2-[3-kloro-2-(3-etil-3,7-diazabiciklo[3.3.0]oktan-7-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-119 N2-[2-(3-etil-3,7-diazabiciklo[3.3.0]oktan-7-il)-3-trifluorometilpiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-120 5-metil-N2-[2-(3-metil-3,7-diazabiciklo[3.3.0]oktan-7-il)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-121 5-metil-N2-[2-(oktahidroizoindol-1-il)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-122 N2-[3-kloro-2-(oktahidroizoindol-1-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-123 N2-(2-metoksipiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-124 N2-[2-(S-1,4-diazabiciklo[4.3.0]nonan-4-il)-3-trifluorometilpiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-125 N2-[2-(1,4-diazabiciklo[3.2.2]nonan-4-il)-3-fluoropiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-126 N2-[2-(4R-hidroksi-2-metiliden-pirolidin-1-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-127 5-metil-N4-(2-okso-2,3-dihidro-l,3-benzoksazol-5-il)-N2-[2-(cis-3,4,5-trimetilpiperazino)piridin-5-il]-2,4-pirimidindiamin;
II-128 N2-[2-(1,4-diazabiciklo[4.4.0]decan-4-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-129 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-[2-(trans-2,4,5-trimetilpiperazino)piridin-5-il]-2,4-pirimidindiamin;
II-130 N2-[2-(trans-2,5-dimetilpiperazino)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)- 2,4-pirimidindiamin;
II-131 N2-[2-(cis-3,5-dimetilpiperazino)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-132 N2-[2-(R-1,4-diazabiciklo[4.3.0]nonan-4-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-133 5-metil-N2-[2-(7-metil-2,7-diazaspiro[4.4]nonan-2-il)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-134 5-metil-N2-[2-(3S-metilmorfolino)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-135 5-metil-N2-[2-(2R-metilmorfolino)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-136 N2-[2-(4-izopropilpiperazino)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-137 N2-[2-(3-N,N-dimetilamino-8-azabiciklo[3.2.1]oktan-8-il)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-138 5-metil-N2-[2-(2S-metilmorfolino)piridin-5-il]-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-139 5-inetil-N2-{2-[(1R,4R)-2-oksa-5-azabiciklo[2.2.1]heptan-5-il]piridin-5-il}-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-140 N2-(2,3-dimetoksipiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-141 N2-(2-metoksi-3-metilpiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-142 N2-[2-(2-hidroksi)etoksipiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-143 N2-[4-metil-2-(4-metilpiperazino)piridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-144 N2-(2-izopropoksipiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-145 N2-[2-(2-metoksi)etoksipiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-146 N2-[2-(1-aminokarbonil-1-metil)etoksipiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-147 N2-(2-rnetoksi-3-trifluorometilpiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-148 N2-[2-(3-hidroksi)propoksipiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-149 N2-[2-(3-metoksi)propoksipiridin-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-150 5-(2-(6-(1,4-diazabiciklo[3.2.2]nonan-4-il)-5-kloropiridin-3-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
II-151 ciklobutilamid 5-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-piridin-2-karboksilne kiseline;
II-152 N2-(S-metoksipiridin-3-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
II-153 N2-(2,3-dimetilpiridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
III-1 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(izoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-2 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2hidroksiizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-3 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-tert-butoksoksikarbonilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-4 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-metilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-5 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-etilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-6 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-n-propilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-7 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-ciklopropilmetililizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-8 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-izobutilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-9 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-izopentilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-10 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-ciklopentilmetilizoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-11 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(2-(biciklo[2.2.1]heptan-2-ilmetil)izoindolin-5-il)-5-metilpirimidin-2,4-diamin;
III-12 5-[2-(2-Acetil-2,3-dihidro-1H-izoindol-5-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
III-13 N-{2-[2-(2,2-dimetil-propionil)-2,3-dihidro-1H-izoindol-5-ilamino]-5-metil-pirimidin-4-il}-N-[3-(2,2-dimetil-propionil)-2-okso-2,3-dihidro-benzooksazol-5-il]-2,2-dimetil-propionamid;
III-14 5-[2-(2-Metansulfonil-2,3-dihidro-1H-izoindol-5-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-1 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(7-(pirolidin-1-il)-6,7,8,9-tetrahidro-5H-benzo[7]anulen-2-il)-5-metilpirimidin-2,4-diamin;
IV-2 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6,7,8,9-tetrahidro-5H-benzo[7]anulen-5-on-3-il)-5-metilpirimidin-2,4-diamin;
IV-3 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(6-(4-metilpiperazin-1-il)piridazin-3-il)-5-metilpirimidin-2,4-diamin;
IV-4 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(1H-indazol-6-il)-5-metilpirimidin-2,4-diamin;
IV-5 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(1,2-benzizoksazol-6-il)-5-metilpirimidin-2,4-diamin;
IV-6 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(1H-indazol-5-il)-5-metilpirimidin-2,4-diamin;
IV-7 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(piperazino)piridin-4-il]-5-metilpirimidin-2,4-diamin;
IV-8 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-[2-(4-metilpiperazino)piridin-4-il]-5-metilpirimidin-2,4-diamin;
IV-9 N4-(benzo[d]oksazol-2(3H)-on-5-il)-N2-(3-metil-1,2-benzizoksazol-5-il)-5-metilpirimidin-2,4-diamin;
IV-10 (Z)-2-metil-9-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-3,6-dihidro-2H-benzo[c]azocin-1-on;
IV-11 5-[2-(2,2-difluoro-benzo[1,3]dioksol-4-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-12 5-[2-(9-izopropilamino-6,7,8,9-tetrahidro-5H-benzociklohepten-2-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-13 5-{2-[9-(3-dietilamino-pirolidin-1-il)-6,7,8,9-tetrahidro-5H-benzociklohepten-2-ilamino]-5-metil-pirimidin-4-ilamino}-3H-benzooksazol-2-on;
IV-14 2-metil-9-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-3,4,5,6-tetrahidro-2H-benzo[c]azocin-1-on;
IV-15 6-[5-metil-4-(2-okso-2,3-dihidro-benzooksazol-5-ilamino)-pirimidin-2-ilamino]-3,4-dihidro-2H-izokinolin-1-on;
IV-16 5-[2-(2,2-diokso-1H-benzo[e][1,3,4]oksatiazin-7-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-17 5-[2-(2,2-dimetil-benzo[1,3]dioksol-5-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-18 (Z)-5-(5-metil-2-(1-okso-2,3-dihidro-1H-benzo[c]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-19 (Z)-5-(5-metil-2-(2-metil-1-okso-2,3-dihidro-1H-benzo[c]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-20 (Z)-5-(5-metil-2-(2-metil-1-okso-2,3-dihidro-1H-benzo[c]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-21 5-(5-metil-2-(2-metil-1-okso-2,3,4,5-tetrahidro-1H-benzo[c]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-22 5,5'-(5-metilpirimidin-2,4-diil)bis(azandiil)dibenzo[d]oksazol-2(3H)-on
IV-23 5-(5-metil-2-(2-okso-2,3,4,5-tetrahidro-1H-benzo[b]azepin-8-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-24 5-(5-metil-2-(2-okso-1,2,3,4-tetrahidrokinolin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-25 6-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-2H-benzo[b][1,4]oksazin-3(4H)-on;
IV-26 5-(2-(3,3-dimetil-2-oksoindolin-6-ilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-27 5-(5-metil-2-(1-metil-2-oksoindolin-5-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-28 5-(5-metil-2-(1-metil-2-okso-2,3-dihidro-1H-benzo[d]imidazol-5-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-29 5-(5-metil-2-(2-okso-2,3-dihidro-1H-benzo[d]imidazol-5-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-30 5-(5-metil-2-(1-metil-2-okso-2,3,4,5-tetrahidro-1H-benzo[b]azepin-8-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-31 5-(5-metil-2-(2-okso-2,3,4,5-tetrahidro-1H-benzo[b]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-32 7-(5-metil-4-(2-okso-2,3-dihidrobenzo[d]oksazol-5-ilamino)pirimidin-2-ilamino)-2H-benzo[b] [1,4]oksazin-3(4H)-on;
IV-33 5-(5-metil-2-(2-okso-1,2,3,4-tetrahidrokinolin-6-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-34 5-(5-metil-2-(1-metil-2-okso-2,3,4,5-tetrahidro-1H-benzo[b]azepin-7-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-35 5-metil-N2-(3,4-metilenedioksi)fenil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-36 N2-(2,2-difluoro-2H-1,3-benzodioksol-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-37 N2-(3,4-etilendioksi)fenil-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-38 N2-(2,2-dimetil-2H-1,3-benzodioksol-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-39 N2-[spiro(2,1'-cikloheksan)-1,3-benzodioksol-5-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-40 N2-(1,3-dimetil-1H-pirazolo[3,4-b]piridin-5-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-41 5-metil-N2-(1-metilindazol-6-il)-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-42 5-metil-N2-(1-metilindazol-5-il)-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-43 5-metil-N2-(3-metilizoksazolo[5,4-b]piridin-5-il)-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-44 N2-[4-(2-metoksietil)-2H-1,4-benzoksazin-3(4H)-on-7-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-45 N2-[2,2-dimetil-4-(2-metoksietil)-2H-pirido[3,2-b][1,4]oksazin-3(4H)-on-7-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-46 5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-N2-(2H-pirido[3,2-b][1,4]oksazin-3(4H)-on-7-il)-2,4-pirimidindiamin;
IV-47 5-metil-N4-(2-okso-2,3 -dihidro-1,3-benzoksazol-5-il)-N2-(2H-pirido[3,2-b][1,4]oksazin-3(4H)-on-6-il)-2,4-pirimidindiamin;
IV-48 5-metil-N2-(3-metilindazol-6-il)-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-49 5-metil-N2-(3-metilindazol-5-il)-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-50 N2-[2,2-dimetil-2H-1,4-benzoksazin-3(4H)-on-7-il]-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-51 5-(5-metil-2-(6-metilpiridin-2-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-52 5-(5-metil-2-(5-metilpiridin-2-ilamino)pirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-53 5-[2-(Izokinolin-6-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-54 5-[5-metil-2-(naftalen-2-ilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-55 5-[2-(4-metoksi-naftalen-2-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-56 5-[2-(4-hidroksi-naftalen-2-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-57 5-[2-(Izokinolin-7-ilamino)-5-metil-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-58 N2-(4-metoksipiridin-2-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin;
IV-59 5-[5-metil-2-(2,4,6-trifluoro-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-60 5-(2-(2,6-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-61 5-[5-metil-2-(2,4,6-trimetil-fenilamino)-pirimidin-4-ilamino]-3H-benzooksazol-2-on;
IV-62 5-(2-(2-fluoro-6-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on;
IV-63 N2-(3-fluoropiridin-4-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin; ili
IV-64 sol N2-(3-fluoropiridin-4-il)-5-metil-N4-(2-okso-2,3-dihidro-1,3-benzoksazol-5-il)-2,4-pirimidindiamin trifluorooctene kiseline.
14. Spoj prema zahtjevu 1 naznačen time da je 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin, ili njegova farmaceutski prihvatljiva sol, poželjno 5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-N2-(3,4,5-trimetil)fenil-2,4-pirimidindiamin bis-natrijeva sol.
15. Spoj prema zahtjevu 1, naznačen time da spoj je N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-2,4-pirimidindiamin, ili njegova farmaceutski prihvatljiva sol, poželjno N2-(3-metoksi-5-trifluorometil)fenil-5-metil-N4-[3-(fosfonooksi)metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il]-2,4-pirimidindiamin bis-natrijeva sol.
16. Spoj prema zahtjevu 1, naznačen time da spoj je 5-(2-(3-metoksi-4,5-dimetilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on, ili njegova farmaceutski prihvatljiva sol.
17. Spoj prema zahtjevu 1, naznačen time da spoj je (5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil dihidrogen fosfat, 5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on, ili njegova farmaceutski prihvatljiva sol, poželjno natrijev (5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)-2-oksobenzo[d]oksazol-3(2H)-il)metil fosfat ili 5-(2-(4-fluoro-3-metoksi-5-metilfenilamino)-5-metilpirimidin-4-ilamino)benzo[d]oksazol-2(3H)-on.
18. Farmaceutski pripravak naznačen time da sadrži spoj prema bilo kojem od zahtjeva 1-17.
19. Spoj prema bilo kojem od zahtjeva 1-17 ili farmaceutski pripravak prema zahtjevu 18 naznačen time da je za uporabu za liječenje bolesti posredovane s JAK kinazom, odbacivanja transplantata alografta kod primatelja transplantata, autoimune bolesti posredovane T-stanicama ili bolesti i/ili poremećaja oka.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14705909P | 2009-01-23 | 2009-01-23 | |
US24163009P | 2009-09-11 | 2009-09-11 | |
EP10701189.2A EP2389372B1 (en) | 2009-01-23 | 2010-01-22 | Compositions and methods for inhibition of the jak pathway |
PCT/US2010/021856 WO2010085684A1 (en) | 2009-01-23 | 2010-01-22 | Compositions and methods for inhibition of the jak pathway |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20151325T1 true HRP20151325T1 (hr) | 2016-01-01 |
Family
ID=42091548
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20140454AT HRP20140454T1 (hr) | 2009-01-23 | 2014-05-21 | Pripravci i postupci inhibicije jak puta |
HRP20151325TT HRP20151325T1 (hr) | 2009-01-23 | 2015-12-04 | Pripravci i postupci za inhibiciju jak puta |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20140454AT HRP20140454T1 (hr) | 2009-01-23 | 2014-05-21 | Pripravci i postupci inhibicije jak puta |
Country Status (24)
Country | Link |
---|---|
US (13) | US8324200B2 (hr) |
EP (2) | EP2565193B1 (hr) |
JP (1) | JP5802136B2 (hr) |
KR (1) | KR101762967B1 (hr) |
CN (1) | CN102356075B (hr) |
AU (1) | AU2010206683B2 (hr) |
BR (1) | BRPI1006942A2 (hr) |
CA (1) | CA2749217C (hr) |
DK (2) | DK2389372T3 (hr) |
EA (1) | EA022802B1 (hr) |
ES (2) | ES2473584T3 (hr) |
HK (2) | HK1163076A1 (hr) |
HR (2) | HRP20140454T1 (hr) |
HU (1) | HUE026315T2 (hr) |
IL (1) | IL214208A (hr) |
MX (1) | MX2011007750A (hr) |
NZ (1) | NZ594323A (hr) |
PE (2) | PE20110924A1 (hr) |
PL (2) | PL2565193T3 (hr) |
PT (2) | PT2565193E (hr) |
SG (2) | SG2014005318A (hr) |
SI (2) | SI2389372T1 (hr) |
SM (2) | SMT201400071B (hr) |
WO (1) | WO2010085684A1 (hr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105348203B (zh) | 2005-06-08 | 2018-09-18 | 里格尔药品股份有限公司 | 抑制jak途径的组合物和方法 |
US20070203161A1 (en) * | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
EP2565193B1 (en) * | 2009-01-23 | 2014-03-19 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
JP5732453B2 (ja) * | 2009-06-25 | 2015-06-10 | アルカーメス ファーマ アイルランド リミテッド | Nh酸性化合物のプロドラッグ |
US8431576B2 (en) | 2009-06-25 | 2013-04-30 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
US8343954B2 (en) * | 2010-07-28 | 2013-01-01 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
EA022623B1 (ru) | 2010-10-06 | 2016-02-29 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Производные бензимидазола в качестве ингибиторов pi3-киназ |
US9115133B2 (en) | 2011-03-22 | 2015-08-25 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
EP2694486B1 (en) | 2011-04-01 | 2018-01-10 | University of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
WO2012135800A1 (en) * | 2011-04-01 | 2012-10-04 | University Of Utah Research Foundation | Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase |
EP2696869B1 (en) | 2011-04-12 | 2017-08-23 | Rigel Pharmaceuticals, Inc. | Methods for inhibiting allograft rejection |
EP2554544A1 (en) * | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
CA2858787C (en) | 2011-12-15 | 2017-11-21 | Alkermes Pharma Ireland Limited | Prodrugs of tertiary amine compounds |
WO2013173506A2 (en) | 2012-05-16 | 2013-11-21 | Rigel Pharmaceuticals, Inc. | Method of treating muscular degradation |
ES2717279T3 (es) | 2012-08-17 | 2019-06-20 | Concert Pharmaceuticals Inc | Baricitinib deuterada |
JP2015529242A (ja) | 2012-09-21 | 2015-10-05 | アドヴィヌス セラピューティクス リミテッドAdvinus Therapeutics Limited | 置換された縮合三環式化合物、組成物およびその医薬用途 |
WO2014055928A2 (en) | 2012-10-04 | 2014-04-10 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
CA2887465A1 (en) | 2012-10-04 | 2014-04-10 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
CN103788066A (zh) * | 2012-10-31 | 2014-05-14 | 韩冰 | 一类保护移植器官的化合物及其用途 |
EP2948150A1 (en) * | 2013-01-25 | 2015-12-02 | Rigel Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory bowel diseases |
CN105308033B (zh) | 2013-03-14 | 2018-08-24 | 特雷罗药物股份有限公司 | Jak2和alk2抑制剂及其使用方法 |
WO2014168986A1 (en) | 2013-04-08 | 2014-10-16 | Brown Dennis M | Therapeutic benefit of suboptimally administered chemical compounds |
US9549988B2 (en) | 2013-06-09 | 2017-01-24 | RJS Biologics | Pharmaceutical compounds targeted by MIF affinity-tethered moieties |
IN2013MU02611A (hr) | 2013-08-07 | 2015-06-12 | Cadila Healthcare Ltd | |
CN105017159B (zh) * | 2014-04-28 | 2019-05-17 | 四川大学 | 5-氟-2,4-二取代氨基嘧啶衍生物及其制备方法和用途 |
US10314942B2 (en) * | 2014-06-30 | 2019-06-11 | Bacterin International, Inc. | Manufacture of biomaterial implants via three-dimensional printing technology |
WO2016100452A2 (en) * | 2014-12-17 | 2016-06-23 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
WO2017007658A1 (en) * | 2015-07-07 | 2017-01-12 | Rigel Pharmaceuticals, Inc. | A combination for immune mediated cancer treatment |
PL3380465T3 (pl) * | 2015-11-26 | 2021-01-25 | Novartis Ag | Pochodne diaminopirydyny |
SG11201900157RA (en) | 2016-07-12 | 2019-02-27 | Revolution Medicines Inc | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
AU2017382830A1 (en) * | 2016-12-19 | 2019-06-13 | Epizyme, Inc. | Amine-substituted heterocyclic compounds as EHMT2 inhibitors and methods of use thereof |
EP3571189B1 (en) | 2017-01-23 | 2023-03-29 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
JP7240319B2 (ja) | 2017-01-23 | 2023-03-15 | レヴォリューション・メディスンズ,インコーポレイテッド | アロステリックshp2阻害剤としての二環式化合物 |
US11672800B2 (en) | 2017-04-21 | 2023-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
KR102628675B1 (ko) * | 2017-05-26 | 2024-01-25 | 캔써 리서치 테크놀로지 리미티드 | 벤즈이미다졸론 유래된 bcl6의 저해제 |
EP3679027A1 (en) * | 2017-09-04 | 2020-07-15 | C4 Therapeutics, Inc. | Dihydrobenzimidazolones |
WO2019075265A1 (en) | 2017-10-12 | 2019-04-18 | Revolution Medicines, Inc. | PYRIDINE, PYRAZINE AND TRIAZINE COMPOUNDS AS ALLOSTERIC INHIBITORS OF SHP2 |
WO2019099311A1 (en) * | 2017-11-19 | 2019-05-23 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use |
MX2020006273A (es) | 2017-12-15 | 2020-09-14 | Revolution Medicines Inc | Compuestos policiclicos como inhibidores alostericos de shp2. |
US11273158B2 (en) | 2018-03-05 | 2022-03-15 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
CN112533602A (zh) | 2018-04-05 | 2021-03-19 | 大日本住友制药肿瘤公司 | Axl激酶抑制剂及其用途 |
US20210198248A1 (en) * | 2018-05-24 | 2021-07-01 | Astrazeneca Ab | Fumarate salt of 5-((5-methyl-2-((3,4,5-trimethylphenyl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one |
CN112512597A (zh) | 2018-07-26 | 2021-03-16 | 大日本住友制药肿瘤公司 | 用于治疗与acvr1表达异常相关的疾病的方法以及用于此的acvr1抑制剂 |
WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
EP3935050A4 (en) | 2019-03-06 | 2023-01-04 | C4 Therapeutics, Inc. | HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT |
MX2022001596A (es) | 2019-08-08 | 2022-03-11 | Rigel Pharmaceuticals Inc | Compuestos y metodos para tratar sindrome de liberacion de citocinas. |
TW202207934A (zh) | 2020-03-27 | 2022-03-01 | 瑞典商阿斯特捷利康公司 | 用於肺遞送的乾粉配製物及使用方法 |
CN113549018B (zh) * | 2020-04-24 | 2024-02-27 | 中国药科大学 | 蛋白激酶抑制剂及其衍生物,制备方法、药物组合物和应用 |
CA3180623A1 (en) * | 2020-05-29 | 2021-12-02 | Changyou MA | Pyrimidine compound as axl inhibitor |
WO2022188735A1 (en) * | 2021-03-08 | 2022-09-15 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Heterocyclic compounds as hpk1 inhibitors |
CN116178434A (zh) * | 2021-11-26 | 2023-05-30 | 南京正大天晴制药有限公司 | Axl激酶抑制剂的单对甲苯磺酸盐及其晶型 |
CN116178433A (zh) * | 2021-11-26 | 2023-05-30 | 南京正大天晴制药有限公司 | Axl激酶抑制剂的盐及其制备方法和用途 |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
ES2087911T3 (es) | 1989-04-28 | 1996-08-01 | Riker Laboratories Inc | Dispositivo de inhalacion de polvo seco. |
US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
IE66203B1 (en) | 1989-12-04 | 1995-12-13 | Searle & Co | System for transdermal albuterol administration |
US5364833A (en) | 1990-05-09 | 1994-11-15 | Basf Aktiengesellschaft | Cyclohexenone oxime ethers, their preparation and their use as herbicides |
US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
DE69212850T2 (de) | 1991-01-15 | 1997-03-06 | Alcon Lab Inc | Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
US5492112A (en) | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5327883A (en) | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
US6060069A (en) | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
US5277195A (en) | 1992-02-03 | 1994-01-11 | Dura Pharmaceuticals, Inc. | Portable spirometer |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
SK279327B6 (sk) | 1992-10-19 | 1998-10-07 | Dura Pharmaceuticals | Zariadenie na vytváranie aerosolu z práškového lie |
ES2154673T3 (es) | 1993-01-29 | 2001-04-16 | Aradigm Corp | Suministro intrapulmonar de hormonas. |
US6131567A (en) | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5364838A (en) | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5743250A (en) | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5661130A (en) | 1993-06-24 | 1997-08-26 | The Uab Research Foundation | Absorption enhancers for drug administration |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
PT748213E (pt) | 1994-03-07 | 2004-08-31 | Nektar Therapeutics | Metodos e composicoes para administracao pulmonar de insulina |
IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
US5622166A (en) | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
US5700904A (en) | 1995-06-07 | 1997-12-23 | Eli Lilly And Company | Preparation of an acylated protein powder |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
WO1999033846A2 (en) | 1997-12-31 | 1999-07-08 | The University Of Kansas | Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof |
US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
US6241969B1 (en) | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
US20020006901A1 (en) | 1999-02-05 | 2002-01-17 | Aldo T. Iacono | Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
WO2001051030A1 (en) | 2000-01-10 | 2001-07-19 | Dura Pharmaceuticals, Inc. | Pharmaceutical formulation and method for pulmonary and oral delivery |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
AU2003265336B8 (en) | 2002-07-29 | 2009-04-23 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
PL1656372T3 (pl) | 2003-07-30 | 2013-08-30 | Rigel Pharmaceuticals Inc | Związki 2,4-pirymidynodiaminy do stosowania w leczeniu lub zapobieganiu chorobom autoimmunologicznym |
PT2287156E (pt) | 2003-08-15 | 2013-08-26 | Novartis Ag | 2,4-di(fenilamino)-pirimidinas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário |
ATE519759T1 (de) | 2004-12-30 | 2011-08-15 | Exelixis Inc | Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren |
ATE451381T1 (de) | 2005-01-19 | 2009-12-15 | Rigel Pharmaceuticals Inc | Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen |
CN105348203B (zh) | 2005-06-08 | 2018-09-18 | 里格尔药品股份有限公司 | 抑制jak途径的组合物和方法 |
US7713987B2 (en) * | 2005-12-06 | 2010-05-11 | Rigel Pharmaceuticals, Inc. | Pyrimidine-2,4-diamines and their uses |
AU2007276369A1 (en) * | 2006-07-21 | 2008-01-24 | Novartis Ag | 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as JAK kinases inhibitors |
GB0615619D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | Chemical process for preparation of intermediates |
DK2089369T3 (da) * | 2006-10-19 | 2011-05-09 | Rigel Pharmaceuticals Inc | 2,4-pyrimidindiaminderivater som hæmmere af JAK-kinaser til behandling af autoimmune sygdomme |
US7947698B2 (en) | 2007-03-23 | 2011-05-24 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
WO2009063240A1 (en) * | 2007-11-16 | 2009-05-22 | Arrow Therapeutics Limited | 2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase |
EP2565193B1 (en) * | 2009-01-23 | 2014-03-19 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
US8343954B2 (en) * | 2010-07-28 | 2013-01-01 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
-
2010
- 2010-01-22 EP EP12195147.9A patent/EP2565193B1/en active Active
- 2010-01-22 EA EA201190082A patent/EA022802B1/ru unknown
- 2010-01-22 JP JP2011548150A patent/JP5802136B2/ja active Active
- 2010-01-22 ES ES12195147.9T patent/ES2473584T3/es active Active
- 2010-01-22 MX MX2011007750A patent/MX2011007750A/es active IP Right Grant
- 2010-01-22 US US12/692,493 patent/US8324200B2/en active Active
- 2010-01-22 HU HUE10701189A patent/HUE026315T2/en unknown
- 2010-01-22 AU AU2010206683A patent/AU2010206683B2/en active Active
- 2010-01-22 CN CN201080013555.XA patent/CN102356075B/zh active Active
- 2010-01-22 SI SI201031075T patent/SI2389372T1/sl unknown
- 2010-01-22 PE PE2011001374A patent/PE20110924A1/es active IP Right Grant
- 2010-01-22 SG SG2014005318A patent/SG2014005318A/en unknown
- 2010-01-22 BR BRPI1006942A patent/BRPI1006942A2/pt not_active Application Discontinuation
- 2010-01-22 PT PT121951479T patent/PT2565193E/pt unknown
- 2010-01-22 PT PT107011892T patent/PT2389372E/pt unknown
- 2010-01-22 SG SG2011049400A patent/SG172885A1/en unknown
- 2010-01-22 DK DK10701189.2T patent/DK2389372T3/en active
- 2010-01-22 EP EP10701189.2A patent/EP2389372B1/en active Active
- 2010-01-22 DK DK12195147.9T patent/DK2565193T3/da active
- 2010-01-22 PL PL12195147T patent/PL2565193T3/pl unknown
- 2010-01-22 PE PE2015000361A patent/PE20150621A1/es active IP Right Grant
- 2010-01-22 PL PL10701189T patent/PL2389372T3/pl unknown
- 2010-01-22 WO PCT/US2010/021856 patent/WO2010085684A1/en active Application Filing
- 2010-01-22 KR KR1020117019451A patent/KR101762967B1/ko active IP Right Grant
- 2010-01-22 CA CA2749217A patent/CA2749217C/en active Active
- 2010-01-22 ES ES10701189.2T patent/ES2555491T3/es active Active
- 2010-01-22 NZ NZ594323A patent/NZ594323A/xx unknown
- 2010-01-22 SI SI201030631T patent/SI2565193T1/sl unknown
-
2011
- 2011-07-20 IL IL214208A patent/IL214208A/en active IP Right Grant
- 2011-09-22 US US13/241,024 patent/US8530656B2/en active Active
- 2011-09-22 US US13/241,037 patent/US8524901B2/en active Active
- 2011-09-22 US US13/241,041 patent/US8507675B2/en active Active
- 2011-09-22 US US13/241,036 patent/US8563716B2/en active Active
- 2011-10-27 US US13/283,471 patent/US8563569B2/en active Active
-
2012
- 2012-04-12 HK HK12103576.2A patent/HK1163076A1/zh unknown
- 2012-04-12 HK HK13110352.6A patent/HK1183023A1/xx not_active IP Right Cessation
-
2013
- 2013-07-16 US US13/943,599 patent/US9084795B2/en active Active
- 2013-09-10 US US14/023,158 patent/US8735400B2/en active Active
-
2014
- 2014-04-10 US US14/250,329 patent/US9248132B2/en active Active
- 2014-05-21 HR HRP20140454AT patent/HRP20140454T1/hr unknown
- 2014-06-13 SM SM201400071T patent/SMT201400071B/xx unknown
-
2015
- 2015-07-07 US US14/793,506 patent/US9566283B2/en active Active
- 2015-12-04 HR HRP20151325TT patent/HRP20151325T1/hr unknown
- 2015-12-09 SM SM201500308T patent/SMT201500308B/it unknown
-
2017
- 2017-01-30 US US15/419,660 patent/US10005767B2/en active Active
-
2018
- 2018-05-24 US US15/988,920 patent/US10556891B2/en active Active
-
2020
- 2020-01-03 US US16/733,571 patent/US20200216431A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20151325T1 (hr) | Pripravci i postupci za inhibiciju jak puta | |
JP2012515793A5 (hr) | ||
JP2010533733A5 (hr) | ||
US11518764B2 (en) | Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction | |
CN104193750B (zh) | 通过抑制极光激酶抑制有丝分裂的化合物和方法 | |
US8575197B2 (en) | Pyrolinone derivative and pharmaceutical composition comprising the same | |
US20070117859A1 (en) | Heterocyclic antiviral compounds | |
US5763616A (en) | Indazolesulfonylurea derivative, its use and intermediate for its production | |
US20220249475A1 (en) | Compounds and method for treating cytokine release syndrome | |
CN101628881B (zh) | 取代氰基乙酸酯类化合物及其应用 |